<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Self‐monitoring and self‐management of oral anticoagulation - Heneghan, CJ - 2016 | Cochrane Library</title> <meta content="Self‐monitoring and self‐management of oral anticoagulation - Heneghan, CJ - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003839.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Self‐monitoring and self‐management of oral anticoagulation - Heneghan, CJ - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003839.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD003839.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Self‐monitoring and self‐management of oral anticoagulation" name="citation_title"/> <meta content="Carl J Heneghan" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="carl.heneghan@phc.ox.ac.uk" name="citation_author_email"/> <meta content="Josep M Garcia-Alamino" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Elizabeth A Spencer" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Alison M Ward" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Rafael Perera" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Clare Bankhead" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Pablo Alonso Coello" name="citation_author"/> <meta content="CIBER Epidemiología y Salud Pública (CIBERESP)" name="citation_author_institution"/> <meta content="David Fitzmaurice" name="citation_author"/> <meta content="Clinical Sciences Building, University of Birmingham" name="citation_author_institution"/> <meta content="Kamal R Mahtani" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Igho J Onakpoya" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD003839.pub3" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/07/05" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003839.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003839.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003839.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Administration, Oral; Anticoagulants [*administration &amp; dosage]; Cause of Death; Hemorrhage [mortality, prevention &amp; control]; International Normalized Ratio; Point-of-Care Systems; Randomized Controlled Trials as Topic; Risk Assessment; Self Care [*methods]; Thromboembolism [mortality, *prevention &amp; control]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003839.pub3&amp;doi=10.1002/14651858.CD003839.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003839.pub3&amp;doi=10.1002/14651858.CD003839.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003839.pub3&amp;doi=10.1002/14651858.CD003839.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003839.pub3&amp;doi=10.1002/14651858.CD003839.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003839.pub3&amp;doi=10.1002/14651858.CD003839.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003839.pub3&amp;doi=10.1002/14651858.CD003839.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003839.pub3&amp;doi=10.1002/14651858.CD003839.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003839.pub3&amp;doi=10.1002/14651858.CD003839.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003839.pub3&amp;doi=10.1002/14651858.CD003839.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003839.pub3&amp;doi=10.1002/14651858.CD003839.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003839.pub3&amp;doi=10.1002/14651858.CD003839.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003839.pub3&amp;doi=10.1002/14651858.CD003839.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003839.pub3&amp;doi=10.1002/14651858.CD003839.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003839.pub3&amp;doi=10.1002/14651858.CD003839.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003839.pub3&amp;doi=10.1002/14651858.CD003839.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003839.pub3&amp;doi=10.1002/14651858.CD003839.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003839.pub3&amp;doi=10.1002/14651858.CD003839.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003839.pub3&amp;doi=10.1002/14651858.CD003839.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003839.pub3&amp;doi=10.1002/14651858.CD003839.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003839.pub3&amp;doi=10.1002/14651858.CD003839.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003839.pub3&amp;doi=10.1002/14651858.CD003839.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003839.pub3&amp;doi=10.1002/14651858.CD003839.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003839.pub3&amp;doi=10.1002/14651858.CD003839.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="eLIOL3Be";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD003839\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD003839\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003839\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003839\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANS","ru","ms","hr","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD003839.pub3",title:"Self\\u2010monitoring and self\\u2010management of oral anticoagulation",firstPublishedDate:"Jul 5, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Heart Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=eLIOL3Be&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003839.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003839.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD003839.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD003839.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003839.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD003839.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD003839.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD003839.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD003839.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD003839.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5112 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD003839.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/full#CD003839-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/full#CD003839-sec-0055"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/full#CD003839-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/full#CD003839-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/full#CD003839-sec-0015"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/full#CD003839-sec-0016"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/full#CD003839-sec-0031"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/full#CD003839-sec-0052"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/appendices#CD003839-sec-0059"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/table_n/CD003839StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/table_n/CD003839StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Self‐monitoring and self‐management of oral anticoagulation</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/information#CD003839-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Carl J Heneghan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/information#CD003839-cr-0005">Josep M Garcia-Alamino</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/information#CD003839-cr-0006">Elizabeth A Spencer</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/information#CD003839-cr-0007">Alison M Ward</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/information#CD003839-cr-0008">Rafael Perera</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/information#CD003839-cr-0009">Clare Bankhead</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/information#CD003839-cr-0010">Pablo Alonso Coello</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/information#CD003839-cr-0011">David Fitzmaurice</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/information#CD003839-cr-0012">Kamal R Mahtani</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003839.pub3/information#CD003839-cr-0013">Igho J Onakpoya</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/information/en#CD003839-sec-0078">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 05 July 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD003839.pub3">https://doi.org/10.1002/14651858.CD003839.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD003839-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003839-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003839-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD003839-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD003839-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD003839-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD003839-abs-0001" lang="en"> <section id="CD003839-sec-0001"> <h3 class="title" id="CD003839-sec-0001">Background</h3> <p>The introduction of point‐of‐care devices for the management of patients on oral anticoagulation allows self‐testing by the patient at home. Patients who self‐test can either adjust their medication according to a pre‐determined dose‐INR (international normalized ratio) schedule (self‐management), or they can call a clinic to be told the appropriate dose adjustment (self‐monitoring). Increasing evidence suggests self‐testing of oral anticoagulant therapy is equal to or better than standard monitoring. This is an updated version of the original review published in 2010. </p> </section> <section id="CD003839-sec-0002"> <h3 class="title" id="CD003839-sec-0002">Objectives</h3> <p>To evaluate the effects on thrombotic events, major haemorrhages, and all‐cause mortality of self‐monitoring or self‐management of oral anticoagulant therapy compared to standard monitoring. </p> </section> <section id="CD003839-sec-0003"> <h3 class="title" id="CD003839-sec-0003">Search methods</h3> <p>For this review update, we re‐ran the searches of the Cochrane Central Register of Controlled Trials (CENTRAL), 2015, Issue 6, the Cochrane Library, MEDLINE (Ovid, 1946 to June week 4 2015), Embase (Ovid, 1980 to 2015 week 27) on 1 July 2015. We checked bibliographies and contacted manufacturers and authors of relevant studies. We did not apply any language restrictions . </p> </section> <section id="CD003839-sec-0004"> <h3 class="title" id="CD003839-sec-0004">Selection criteria</h3> <p>Outcomes analysed were thromboembolic events, mortality, major haemorrhage, minor haemorrhage, tests in therapeutic range, frequency of testing, and feasibility of self‐monitoring and self‐management. </p> </section> <section id="CD003839-sec-0005"> <h3 class="title" id="CD003839-sec-0005">Data collection and analysis</h3> <p>Review authors independently extracted data and we used a fixed‐effect model with the Mantzel‐Haenzel method to calculate the pooled risk ratio (RR) and Peto’s method to verify the results for uncommon outcomes. We examined heterogeneity amongst studies with the Chi<sup>2</sup> and I<sup>2</sup> statistics and used GRADE methodology to assess the quality of evidence. </p> </section> <section id="CD003839-sec-0006"> <h3 class="title" id="CD003839-sec-0006">Main results</h3> <p>We identified 28 randomised trials including 8950 participants (newly incorporated in this update: 10 trials including 4227 participants). The overall quality of the evidence was generally low to moderate. Pooled estimates showed a reduction in thromboembolic events (RR 0.58, 95% CI 0.45 to 0.75; participants = 7594; studies = 18; moderate quality of evidence). Both, trials of self‐management or self‐monitoring showed reductions in thromboembolic events (RR 0.47, 95% CI 0.31 to 0.70; participants = 3497; studies = 11) and (RR 0.69, 95% CI 0.49 to 0.97; participants = 4097; studies = 7), respectively; the quality of evidence for both interventions was moderate. No reduction in all‐cause mortality was found (RR 0.85, 95% CI 0.71 to 1.01; participants = 6358; studies = 11; moderate quality of evidence). While self‐management caused a reduction in all‐cause mortality (RR 0.55, 95% CI 0.36 to 0.84; participants = 3058; studies = 8); self‐monitoring did not (RR 0.94, 95% CI 0.78 to 1.15; participants = 3300; studies = 3); the quality of evidence for both interventions was moderate. In 20 trials (8018 participants) self‐monitoring or self‐management did not reduce major haemorrhage (RR 0.95, 95% CI, 0.80 to 1.12; moderate quality of evidence). There was no significant difference found for minor haemorrhage (RR 0.97, 95% CI 0.67 to 1.41; participants = 5365; studies = 13). The quality of evidence was graded as low because of serious risk of bias and substantial heterogeneity (I<sup>2</sup> = 82%). </p> </section> <section id="CD003839-sec-0007"> <h3 class="title" id="CD003839-sec-0007">Authors' conclusions</h3> <p>Participants who self‐monitor or self‐manage can improve the quality of their oral anticoagulation therapy. Thromboembolic events were reduced, for both those self‐monitoring or self‐managing oral anticoagulation therapy. A reduction in all‐cause mortality was observed in trials of self‐management but not in self‐monitoring, with no effects on major haemorrhage. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD003839-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003839-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD003839-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD003839-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD003839-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD003839-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD003839-abs-0008">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD003839-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD003839-abs-0006">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD003839-abs-0005">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD003839-abs-0002" lang="en"> <h3>Self‐monitoring and self‐management of oral anticoagulation therapy</h3> <p><b>Background</b> </p> <p>Point‐of‐care testing devices have made it possible for people on long‐term oral anticoagulation to monitor their blood clotting time, measured as the international normalized ratio (INR). Patients who self‐test can either adjust their medication dose according to a pre‐determined dose‐INR schedule (self‐management) or they can call a clinic to be told the appropriate dose adjustment (self‐monitoring). Several published studies and systematic reviews have suggested these methods of monitoring anticoagulation therapy may be equal to or better than standard monitoring by a physician. </p> <p><b>Study characteristics</b> </p> <p>This is an update of the original review published in 2010. We performed a new search and found 10 new studies (with 4227 participants) to add to the original review, which changed some of the findings. </p> <p><b>Main results</b> </p> <p>In total, we found 28 randomised trials including 8950 participants that compared self‐monitoring and self‐management with standard monitoring. The quality of the evidence was generally low to moderate. The combined results of the 28 trials showed a halving of thromboembolic events with self‐monitoring and self‐management and no reduction in the number of major bleeds. Self‐management had similar reductions in thromboembolic events and mortality to the overall benefit, with no effect on major bleeds. Self‐monitoring halved the number of major haemorrhages that occurred but did not significantly reduce the rates of thrombotic events or all‐cause mortality. </p> <p><b>Conclusion</b> </p> <p>In conclusion, self‐monitoring or self‐management can improve the quality of oral anticoagulant therapy, leading to fewer thromboembolic events and lower mortality, without a reduction in the number of major bleeds. Self‐monitoring and self‐management are not feasible for all patients, which requires the identification and education of suitable patients. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD003839-sec-0055" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD003839-sec-0055"></div> <h3 class="title" id="CD003839-sec-0056">Implications for practice</h3> <section id="CD003839-sec-0056"> <p>Self‐monitoring or self‐management by patients can improve the quality of oral anticoagulation therapy compared to standard monitoring. Patients spend more time within the therapeutic range resulting in decreases in thromboembolic events with no increase in harms. Self‐monitoring or self‐management is potentially not feasible for half of the patients requiring anticoagulation. In addition, National Institute for Health and Care Excellence (NICE) guidance in the UK (<a href="./references#CD003839-bbs2-0099" title="NICE. Atrial fibrillation and heart valve disease: self‑monitoring coagulation status using point‑of‑care coagulometers (the CoaguChek XS system and the INRatio2 PT/INR monitor). NICE diagnostics guidance [DG14] September 2014. [www.nice.org.uk/guidance/dg14]">NICE diagnostics guidance [DG14]</a>) for atrial fibrillation and heart valve disease currently recommends both the CoaguChek XS and InRatio2 PT/INR meters for patients if they are able and suitably trained. NICE also recommends not routinely offering self‐monitoring to patients who have had a deep vein thrombosis or a pulmonary embolism (<a href="./references#CD003839-bbs2-0100" title="NICE. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing. NICE June 2012. [www.nice.org.uk/guidance/CG144]">NICE Venous thromboembolic diseases (CG144)</a>. The British Committee for Standards in Haematology guidance (<a href="./references#CD003839-bbs2-0093" title="JenningsI , KitchenD , KeelingD , FitzmauriceD , HeneghanC , BCSH Committee. Patient self-testing and self-management of oral anticoagulation with vitamin K antagonists: guidance from the British Committee for Standards in Haematology. British Journal of Haematology2014;167(5):600-7. [DOI: doi: 10.1111/bjh.13070]">Jennings 2014</a>) highlights the need for motivated patients to demonstrate competency and to be trained. Patients should also be reviewed at least every six months with documentation of their results and dosing, with external quality assessment to be undertaken at least every six months. The guidance also recommends that an INR &gt; 8·0 (if confirmed on a repeat sample) requires a venous sample to be analysed in a hospital laboratory and that medical advice is sought. </p> </section> <h3 class="title" id="CD003839-sec-0057">Implications for research</h3> <section id="CD003839-sec-0057"> <p>For the results to be generalisable to the population at large, there is a need for population‐based studies that collect data on adverse event rates, time in range, and factors that impinge on successful self‐monitoring and self‐management (<a href="./references#CD003839-bbs2-0098" title="NaglerM , BachmannLM , SchmidP , Raddatz MüllerP , WuilleminWA . Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study. PLoS one2014;9(4):e95761.">Nagler 2014</a>). The nature of this intervention lends itself to a registry to guarantee its safety and effectiveness in clinical practice. Future studies should set out to understand why people decide to use self‐management (or not) and should incorporate consumer knowledge about self‐management, triggers to seek care, self‐efficacy or self‐confidence to self‐manage, and perceived or actual support. Further studies should explore components of the intervention that affect the feasibility of self‐monitoring and self‐management and identify means to improve uptake and effectiveness. In addition, given the low rates of adverse events in trials of self‐monitoring, studies comparing its use to newer oral anticoagulants, which do not require monitoring, are warranted. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD003839-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD003839-sec-0008"></div> <div class="table" id="CD003839-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Self‐monitoring or self‐management of oral anticoagulation vs. standard care</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Self‐monitoring or self‐management of oral anticoagulation vs. standard care</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients on long‐term anticoagulant therapy (treatment duration longer than two months) irrespective of the indication for treatment </p> <p><b>Settings:</b> Primary care, specialist clinics (Europe, America, Canada) </p> <p><b>Intervention:</b> Self‐monitoring or self‐management </p> <p><b>Comparison:</b> Standard care </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Standard care</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Self‐monitoring or self‐management</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Thromboembolic events</b> </p> <p>Follow‐up: 3 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.58</b> </p> <p>(0.45 to 0.74)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>7594</p> <p>(18 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>35 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>21 per 1000</b> </p> <p>(16 to 26)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>22 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>12 per 1000</b> </p> <p>(10 to 16)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>All‐cause mortality</b> </p> <p>Follow‐up: 6 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.85</b><br/>(0.71 to 1.01) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>6358<br/>(11 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>64 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>54 per 1000</b><br/>(45 to 64) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Major haemorrhage</b> </p> <p>Follow‐up: 4 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.95</b> </p> <p>(0.80 to 1.12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>8018</p> <p>(20 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>62 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>59 per 1000</b> </p> <p>(50 to 69)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>17 per 1000</b> </p> <p>(14 to 20)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Minor haemorrhage</b> </p> <p>Follow‐up: 4 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.97</b><br/>(0.67 to 1.41) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>5365<br/>(13 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>217 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>210 per 1000</b><br/>(145 to 306) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>45 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>44 per 1000</b><br/>(30 to 63) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/><b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded from high to moderate because of serious risk of bias. </p> <p><sup>2</sup> Downgraded from high to low because of serious risk of bias and substantial heterogeneity. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD003839-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Self‐monitoring of oral anticoagulation vs. standard care</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Self‐monitoring of oral anticoagulation vs. standard care</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients on long‐term anticoagulant therapy (treatment duration longer than two months) irrespective of the indication for treatment </p> <p><b>Settings:</b> Primary care, specialist clinics (Europe, America, Canada) </p> <p><b>Intervention:</b> Self‐monitoring </p> <p><b>Comparison:</b> Standard care </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Standard care</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Self‐monitoring</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Thromboembolic events</b> </p> <p>Follow‐up: 3 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.69</b><br/>(0.49 to 0.97) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>4097<br/>(7 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>35 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>24 per 1000</b><br/>(17 to 34) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>34 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>23 per 1000</b><br/>(17 to 33) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>All‐cause mortality</b> </p> <p>Follow‐up: 6 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.94</b><br/>(0.78 to 1.15) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>3300<br/>(3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>90 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>85 per 1000</b><br/>(70 to 104) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Major haemorrhage</b> </p> <p>Follow‐up: 4 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.90</b><br/>(0.74 to 1.09) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>4038<br/>(7 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>91 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>82 per 1000</b><br/>(67 to 99) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>44 per 1000</b><br/>(36 to 53) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Minor haemorrhage</b> </p> <p>Follow‐up: 4 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.16</b><br/>(0.95 to 1.42) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>3503<br/>(6 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>275 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>319 per 1000</b><br/>(259 to 391) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>188 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>218 per 1000</b><br/>(177 to 267) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/><b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded from high to low because of serious risk of bias and strong suspicion of publication bias. </p> <p><sup>2</sup> Downgraded from high to moderate because of serious risk of bias. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD003839-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">self‐management of oral anticoagulation vs. standard care</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Self‐management of oral anticoagulation vs. standard care</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients on long‐term anticoagulant therapy (treatment duration longer than two months) irrespective of the indication for treatment </p> <p><b>Settings:</b> Primary care, specialist clinics (Europe, America, Canada) </p> <p><b>Intervention:</b> Self‐management </p> <p><b>Comparison:</b> Standard care </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Standard care</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Self‐management</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Thromboembolic events</b> </p> <p>Follow‐up: 3 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.47</b><br/>(0.31 to 0.70) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>3497<br/>(11 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>36 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>17 per 1000</b><br/>(12 to 25) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>16 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>7 per 1000</b><br/>(5 to 11) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>All‐cause mortality</b> </p> <p>Follow‐up: 6 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.55</b><br/>(0.36 to 0.84) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>3058<br/>(8 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>33 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b><br/>(12 to 28) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>17 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>9 per 1000</b><br/>(6 to 14) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Major haemorrhage</b> </p> <p>Follow‐up:4 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.08</b><br/>(0.79 to 1.47) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>3980<br/>(13 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>33 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>36 per 1000</b><br/>(22 to 44) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>19 per 1000</b><br/>(14 to 26) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Minor haemorrhage</b> </p> <p>Follow‐up: 4 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.91</b><br/>(0.47 to 1.76) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1862<br/>(7 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low<sup>3</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>137 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>125 per 1000</b><br/>(64 to 241) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>2 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>2 per 1000</b><br/>(1 to 4) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/><b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded from high to low because of serious risk of bias and imprecision of effect estimate. </p> <p><sup>2</sup> Downgraded from high to moderate because of serious risk of bias. </p> <p><sup>3</sup> Downgraded from high to low because of serious risk of bias and substantial heterogeneity. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD003839-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD003839-sec-0009"></div> <section id="CD003839-sec-0010"> <h3 class="title" id="CD003839-sec-0010">Terminology</h3> <p> <ul id="CD003839-list-0001"> <li> <p>Point‐of‐care testing (POC): diagnostic testing performed in a clinic, home, or other site of patient care (rather than in standard reference laboratory) </p> </li> <li> <p>Point‐of‐care device: portable monitor used by a healthcare provider (physician, nurse, or other) or patient to determine a clinical measure </p> </li> <li> <p>Self‐monitoring: the trained participant uses point‐of‐care testing to perform the international normalized ratio (INR) test and inform his or her healthcare provider of the result. The physician or another healthcare provider adjusts the anticoagulant dose using the results obtained by the participant </p> </li> <li> <p>Self‐management: trained participant uses point‐of‐care testing to perform the INR test, interpret the result, and adjust the dosage of anticoagulant accordingly (adapted from <a href="./references#CD003839-bbs2-0064" title="BrownA , WellsP , JaffeyJ , McGahanL , Poon M-C, CimonK , et al. Point-of-care monitoring devices for long-term oral anticoagulation therapy: clinical and cost effectiveness. Canadian Agency for Drugs and Technologies in Health2007. [www.cadth.ca]">Brown 2007</a>) </p> </li> </ul> </p> </section> <section id="CD003839-sec-0011"> <h3 class="title" id="CD003839-sec-0011">Description of the condition</h3> <p>Oral anticoagulation therapy has been shown to reduce thromboembolic events in atrial fibrillation, treatment of deep‐vein thrombosis, prosthetic heart valves, and acute myocardial infarction (<a href="./references#CD003839-bbs2-0071" title="ConnollySJ , LaupacisA , GentM , RobertsRS , CairnsJA , JoynerC . Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. Journal of the American College of Cardiology1991;18(2):349-55.">Connolly 1991</a>; <a href="./references#CD003839-bbs2-0081" title="GoAS , HylekEM , ChangY , PhillipsKA , HenaultLE , CapraAM , et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?JAMA2003;290(20):2685-92.">Go 2003</a>; <a href="./references#CD003839-bbs2-0106" title="Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet1996;348(9028):633-8.">SPAF 1996</a>). Optimal anticoagulation with warfarin or other vitamin K antagonists like acenocoumarol or phenprocoumon could potentially prevent more than half of the strokes related to atrial fibrillation and heart valve replacements with a relatively low risk of major bleeding complications (<a href="./references#CD003839-bbs2-0065" title="BuckinghamTA , HatalaR . Anticoagulants for atrial fibrillation: why is the treatment rate so low?Clinical Cardiology2002;25(10):447-54.">Buckingham 2002</a>; <a href="./references#CD003839-bbs2-0084" title="HartRG , PearceLA , AguilarMI . Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Annals of Internal Medicine2007;146:857-67.">Hart 2007</a>); however, much of this potential is still not obtained because of under and suboptimal use (<a href="./references#CD003839-bbs2-0107" title="StaffordRS , SingerDE . Recent national patterns of warfarin use in atrial fibrillation. Circulation1998;97(13):1231-3.">Stafford 1998</a>). </p> <p>The number of patients receiving oral anticoagulant drugs has been increasing. Reasons include improvements in clinical outcomes, increasing common disease indications for their use (<a href="./references#CD003839-bbs2-0097" title="ManottiC , MoiaM , PalaretiG , PengoV , RiaL , DettoriAG . Effect of computer-aided management on the quality of treatment in anticoagulated patients: a prospective, randomized, multicenter trial of APROAT (Automated Program for Oral Anticoagulant Treatment). Haematologica2001;86:1060-70.">Manotti 2001</a>), and improvements in anticoagulant safety (<a href="./references#CD003839-bbs2-0054" title="AnsellJ , HirshJ , DalenJ , BusseyH , AndersonD , PollerL , et al. Managing oral anticoagulant therapy. Chest2001;119 Suppl(1):22-38.">Ansell 2001</a>). In 1994, 250,000 patients in the UK were receiving anticoagulant therapy (<a href="./references#CD003839-bbs2-0057" title="BaglinT . Decentralization of anticoagulant control. Clinical and Laboratory Haematology1994;16:327-9.">Baglin 1994</a>); 10 years later this had increased to around 950,000 patients (<a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a>). Vitamin K antagonist (warfarin, acenocoumarol, or phenprocoumon) treatment usually requires regular monitoring of prothrombin time (PT) with dose‐adjustment by a specialised hospital service, primary care physician, registered nurse, nurse practitioner, or pharmacist (<a href="./references#CD003839-bbs2-0090" title="HirshJ , DalenJE , AndersonDR , PollerL , BusseyH , AnsellJ , et al. Oral anticoagulation mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest1998;114 Suppl:445-69.">Hirsh 1998</a>). </p> <p>Numerous obstacles to the use of warfarin exist; including practical, patient, physician, and healthcare system‐related barriers. Due to the complex pharmacokinetics of warfarin, continuous monitoring and dose adjustments are required. Different values and preferences amongst physicians and patients about the relative importance of bleeding and thromboembolic events, non‐adherence to drug treatment, drug interactions, and increased costs of monitoring have significant roles to play in the management of anticoagulation therapy (<a href="./references#CD003839-bbs2-0086" title="HeneghanC , PereraR . Oral anticoagulation therapy. In: GlasziouP , IrwigL , AronsonJK , editors(s). Evidence Based Medical Monitoring. 1 edition. Oxford: Blackwells, 2008:229-244.">Heneghan 2008</a>). </p> </section> <section id="CD003839-sec-0012"> <h3 class="title" id="CD003839-sec-0012">Description of the intervention</h3> <p>Vitamin K antagonists belong to the drug class known as coumarins and produce their anticoagulant effect by interfering with the metabolism of vitamin K. There are various different types of coumarins but warfarin is the most prescribed. Warfarin has a high bioavailability (<a href="./references#CD003839-bbs2-0063" title="BreckenridgeAM . Oral anticoagulant drugs: pharmacokinetic aspects. Seminars in Hematology1978;15:19-26.">Breckenridge 1978</a>), and is rapidly absorbed from the gastrointestinal tract, with maximal blood concentrations reached 90 minutes after oral administration. Warfarin has a half‐life of 36 to 42 hours; in the blood it is bound to plasma proteins (mainly albumin). It accumulates in the liver where the two isomers are metabolically transformed by different pathways (<a href="./references#CD003839-bbs2-0055" title="AnsellJ , HirshJ , PollerL , BusseyH , JacobsonA , HylekE . The pharmacology and management of the vitamin K antagonist. Chest2004;126:204-33.">Ansell 2004</a>). An anticoagulation effect generally occurs within 24 hours of treatment imitation, and peak effect for warfarin takes two to five days. </p> <p>Another vitamin K antagonist is acenocoumarol, which has a similar action to warfarin but differs in some pharmacological properties (for example, it has a shorter half‐life <a href="./references#CD003839-bbs2-0058" title="BarcellonaD , VanniniML , FenuL , BalestrieriC , MarongiuF . Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?Thrombosis and Haemostostasis1998;80(6):899-902.">Barcellona 1998</a>). Phenprocoumon is another vitamin K antagonist that has traditionally been the oral anticoagulant of choice in Europe. It has similar actions to other vitamin K antagonists but has a half‐life of 144 hours. As a result of their pharmacokinetic properties, these agents interact with many other drugs and their blood levels are affected by vitamin K intake in the diet, changes in metabolism, and concomitant illnesses, which makes the levels difficult to control (<a href="./references#CD003839-bbs2-0083" title="GreenblattDJ , vonMoltkeLL . Interaction of warfarin with drugs, natural substances, and foods. Journal of Clinical Pharmacology2005;45:127-32.">Greenblatt 2005</a>). </p> <p>The pharmacodynamics of warfarin are subject to genetic and environmental variability (<a href="./references#CD003839-bbs2-0091" title="HirshJ , DalenJE , AndersonDR , PollerL , BusseyH , AnsellJ , et al. Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest2001;119 Suppl 1:8-21.">Hirsh 2001</a>), such that there is considerable variation in the action of these drugs both between different individuals (inter‐individually) and within the same individual (intra‐individually). A 'therapeutic target range' has been established to deal with this variability and is expressed as the international normalized ratio (INR). This INR was established as a standard way of reporting the prothrombin time (PT). Furthermore, using the INR formula (INR = patient PT/mean normal PT) the ratio between patient PT and normal PT is calculated to the power of the ISI (International Sensitivity Index), which is the conversion factor for the used thromboplastin against the World Health Organization (WHO) standard. </p> <p>The ‘therapeutic range’ for anticoagulants is narrow. INR values over 4.5 increase the risk of major bleeding and an INR less than 2 increases the risk of thromboembolism (<a href="./references#CD003839-bbs2-0066" title="CannegieterSC , RosendaalFR , WintzenAR , van derMeerFJ , VandenbrouckeJP , BriëtE . Optimal oral anticoagulant therapy in patients with mechanical heart valves. New England Journal of Medicine1995;333(1):11-7.">Cannegieter 1995</a>; <a href="./references#CD003839-bbs2-0092" title="HylekEM , SkatesSJ , SheehanMA , SingerDE . An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. New England Journal of Medicine1996;335(8):540-6.">Hylek 1996</a>; <a href="./references#CD003839-bbs2-0094" title="KearonC , GinsbergJS , KovacsMJ , AndersonDR , WellsP , JulianJA , et al, Extended Low-Intensity Anticoagulation for Thrombo-Embolism Investigators. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. New England Journal of Medicine2003;349(7):631-9.">Kearon 2003</a>). The inter‐ and intra‐individual variability and the narrow target range generally requires frequent testing and appropriate adjustment of the drug dose. In addition, time within the therapeutic INR target range is highly dependent on the frequency of testing (<a href="./references#CD003839-bbs2-0013" title="HorstkotteD , PiperC , WiemerM . Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. Journal of Thrombosis and Thrombolysis1998;5 Suppl 1(3):19-24. ">Horstkotte 1998</a>). Different values and preferences amongst patients and physicians have also been described with the former willing to accept a much higher risk of bleeding for an associated reduction in risk of stroke (<a href="./references#CD003839-bbs2-0074" title="DevereauxPJ , AndersonDR , GardnerMJ , PutnamW , FlowerdewGJ , BrownellBF , et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ2001;323:1-7.">Devereaux 2001</a>). </p> <p>An economic model analysed the cost of suboptimal oral anticoagulation and showed the following. If 50% of those not receiving warfarin prophylaxis had optimal anticoagulation, 19,380 emboli would be prevented and 1.1 billion US dollars could be saved. If 50% of those currently receiving warfarin as part of routine medical care had optimal anticoagulation, 9852 emboli would be prevented and 1.3 billion US dollars could be saved (<a href="./references#CD003839-bbs2-0067" title="CaroJJ . An economic model of stroke in atrial fibrillation: the cost of suboptimal oral anticoagulation. American Journal of Managed Care2004;10(14 Suppl):451-8.">Caro 2004</a>). </p> </section> <section id="CD003839-sec-0013"> <h3 class="title" id="CD003839-sec-0013">How the intervention might work</h3> <p>Current models of oral anticoagulation management within the UK include the traditional hospital outpatient model and various forms of community‐based models, all requiring patient attendance at a clinic (<a href="./references#CD003839-bbs2-0007" title="FitzmauriceDA , MurrayET , GeeKM , AllanTF , HobbsFD . A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology2002;55(11):845-9. McCahonD , MurrayET , MurrayK , HolderRL , FitzmauriceDA . Does self-management of oral anticoagulation therapy improve quality of life and anxiety?Family Practice2011;28(2):134-40. ">Fitzmaurice 2002</a>). In other countries, such as Canada, a primary care physician monitors the INR and adjusts the warfarin dose (<a href="./references#CD003839-bbs2-0025" title="SunderjiR , CampbellL , ShalanskyK , FungA , CarterC , GinK . Outpatient self-management of warfarin therapy: A pilot study. Pharmacotherapy1999;19(6):787-93. SunderjiR , GinK , ShalanskyK , CarterC , ChambersK , DaviesC , et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Canadian Journal of Cardiology2004;20(11):1117-23. ">Sunderji 2004</a>). </p> <p>The introduction of point‐of‐care devices allows the patient to self‐test at home with a drop of whole blood. Portable monitors for monitoring long‐term oral anticoagulation were introduced in the 1990s. Devices have proved to be reliable with regard to analytical accuracy, although INR measurements tend to be lower with the portable coagulometers compared to laboratory analysers (<a href="./references#CD003839-bbs2-0069" title="ChristensenTD , LarsenTB , JensenC , MaegaardM , SørensenB . International normalised ratio (INR) measured on the CoaguChek S and XS compared with the laboratory for determination of precision and accuracy. Thrombosis and Haemostasis2009;101(3):563-9.">Christensen 2009</a>; <a href="./references#CD003839-bbs2-0102" title="PollerL , KeownM , IbrahimSA , van derMeerFJ , vanden BesselaarAM , TripodiA , et al, European Concerted Action on Thrombosis. Quality assessment of CoaguChek point-of-care prothrombin time monitors: comparison of the European community-approved procedure and conventional external quality assessment. Clinical Chemistry2006;52(10):1843-7.">Poller 2006</a>), and have proved to be reliable devices for monitoring INR when checked regularly (<a href="./references#CD003839-bbs2-0059" title="BarcellonaD , FenuL , CornacchiniS , MarongiuF . Point-of-care (POCT) prothrombin time monitors: is a periodical control of their performance useful?Thromb Res.2009;123:775-9.">Barcellona 2009</a>). </p> <p>Generally, patients receive a structured educational programme given by the nurses or physicians responsible for their care. In addition, they receive training in self‐testing, instructions to prevent bleeding and thromboembolic complications, and are made aware of the effects of diet and medications. Patients who self‐test can either adjust their therapy according to a pre‐determined dose‐INR schedule (self‐management) or they can call a clinic to be told the appropriate dose adjustment (self‐monitoring). </p> </section> <section id="CD003839-sec-0014"> <h3 class="title" id="CD003839-sec-0014">Why it is important to do this review</h3> <p>In some countries, such as Germany, self‐monitoring and self‐management with portable monitors are established therapeutic methods. There are several available point‐of‐care devices and the most well known is the CoaguChek® monitor. Other available monitors are the ProTime® Microcoagulation System, INRatio® Monitor, Hemochron Junior Signature, and the TAS near‐patient test system. Potential advantages of self‐monitoring and self‐management include improved convenience for patients, better treatment adherence, more frequent monitoring, and fewer thromboembolic and haemorrhagic complications (<a href="./references#CD003839-bbs2-0108" title="TaborskiU , WittstammFJ , BernardoA . Cost-effectiveness of self-managed anticoagulant therapy in Germany. Seminars in Thrombosis and Hemostasis1999;25(1):103-7.">Taborski 1999</a>). Near‐patient testing devices have made self‐testing of anticoagulation therapy with vitamin K antagonists possible. Guidelines generally do not endorse self‐monitoring or self‐management (<a href="./references#CD003839-bbs2-0079" title="FitzmauriceDA , MachinSJ , for The Bristish Society of Haematology Task Force for Haemostasis and Thrombosis. Recommendations for patients undertaking self management of oral anticoagulation. BMJ2001;323:985-9.">Fitzmaurice 2001</a>), despite several authors of trials suggesting this approach may be equal to or better than standard monitoring (<a href="./references#CD003839-bbs2-0052" title="AndersonDR , HarrisonL , HirshJ . Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Archives of Internal Medicine1993;153:1441-7.">Anderson 1993</a>; <a href="./references#CD003839-bbs2-0005" title="CromheeckeME , LeviM , CollyLP , deMolBJ , PrinsMH , HuttenBA , et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet2000;356(9224):97-102. ">Cromheecke 2000</a>; <a href="./references#CD003839-bbs2-0021" title="SawickiPT , GlaserB , KleespiesC , StubbeJ , SchmitzN , KaiserT , et al. Long-term results of patients' self-management of oral anticoagulation. Journal of Clinical &amp; Basic Cardiology2003;6(1-4):59-62. SawickiPT . A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA1999;281(2):145-50. ">Sawicki 1999</a>). A recent study suggested that self‐monitoring and self‐management are cost‐effective strategies for those receiving long‐term oral anticoagulation (<a href="./references#CD003839-bbs2-0103" title="RegierDA , SunderjiR , LyndLD , GinK , MarraCA . Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy. CMAJ: Canadian Medical Jurnal Association2006;174(13):1847-52.">Regier 2006</a>). In addition, newer oral anticoagulants that do not require monitoring have not been established in heart valve patients (<a href="./references#CD003839-bbs2-0078" title="EikelboomJW , ConnollySJ , BrueckmannM , GrangerCB , KappeteinAP , Mack MJ et al, RE-ALIGN Investigators. Dabigatran versus Warfarin in Patients with Mechanical Heart Valves. New England Journal of Medicine2013;369(13):1206-14.">Eikelboom 2013</a>) and are not suitable for all because of the numerous exclusion and individuals who cannot tolerate these drugs (<a href="./references#CD003839-bbs2-0077" title="DiNicolantonioJJ . Dabigatran or warfarin for the prevention of stroke in atrial fibrillation? A closer look at the RE-LY trial.. Expert Opinion in Pharmacotherapy2012;13(8):1101-11.">DiNicolantonio 2012</a>). </p> <p>To establish the current strength of the available evidence, we updated our systematic review of the impact of patient self‐monitoring or self‐management on treatment with oral anticoagulation therapy. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD003839-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD003839-sec-0015"></div> <p>To evaluate the effects on thrombotic events, major haemorrhages, and all‐cause mortality of self‐monitoring or self‐management of oral anticoagulation compared with standard monitoring. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD003839-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD003839-sec-0016"></div> <section id="CD003839-sec-0017"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD003839-sec-0018"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs) assessing the therapeutic effectiveness and safety of self‐monitoring or self‐management of oral anticoagulation therapy. </p> </section> <section id="CD003839-sec-0019"> <h4 class="title">Types of participants</h4> <p>All patients, adults and children, on long‐term anticoagulant therapy (treatment duration longer than two months), irrespective of the indication for treatment (for example, valve replacement, venous thromboembolism, atrial fibrillation). </p> </section> <section id="CD003839-sec-0020"> <h4 class="title">Types of interventions</h4> <p>Self‐monitoring or self‐management of oral anticoagulation compared with:</p> <p> <ul id="CD003839-list-0002"> <li> <p>control of and dosage by personal physician;</p> </li> <li> <p>anticoagulation managed services (hospital anticoagulation service);</p> </li> <li> <p>anticoagulation clinics (management conducted by registered nurses, nurse practitioners, or pharmacists using dosage‐adjustment protocols). </p> </li> </ul> </p> </section> <section id="CD003839-sec-0021"> <h4 class="title">Types of outcome measures</h4> <section id="CD003839-sec-0022"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD003839-list-0003"> <li> <p>Thromboembolic events</p> </li> <li> <p>All‐cause mortality</p> </li> <li> <p>Major haemorrhage (e.g. haemorrhage requiring hospital admission or transfusion)</p> </li> <li> <p>Time in range, and proportion of measurements within the therapeutic range for each particular condition </p> </li> </ul> </p> </section> <section id="CD003839-sec-0023"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD003839-list-0004"> <li> <p>Minor haemorrhage (e.g. bleeding after minor trauma, nose bleed)</p> </li> <li> <p>Frequency of testing</p> </li> <li> <p>Feasibility of testing: participant factors (e.g. physical limitations), and non‐participant factors (e.g. inability to attend training) </p> </li> <li> <p>Quality of life and general satisfaction with treatment</p> </li> </ul> </p> </section> </section> </section> <section id="CD003839-sec-0024"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD003839-sec-0025"> <h4 class="title">Electronic searches</h4> <p>The searches for the initial review were run in November 2007 (<a href="./appendices#CD003839-sec-0060">Appendix 1</a>). We re‐ran the searches on 27 November 2013 (<a href="./appendices#CD003839-sec-0065">Appendix 2</a>). We updated the searches on 1 July 2015 (<a href="./appendices#CD003839-sec-0065">Appendix 2</a>) with exception of CINAHL which was last searched on 27 November 2013 (an updated search of CINAHL was not mandatory): </p> <p> <ul id="CD003839-list-0005"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) 2015, Issue 6, the Cochrane Library, </p> </li> <li> <p>MEDLINE (Ovid, 1946 to June week 4 2015),</p> </li> <li> <p>Embase (Ovid, 1980 to 2015 week 27), and</p> </li> <li> <p>CINAHL (EBSCO, 1982 to November 2013).</p> </li> </ul> </p> <p>We limited our searches to randomised controlled trials by using a maximally sensitive strategy (<a href="./references#CD003839-bbs2-0076" title="DickersinK , SchererR , LefebvreC . Identifying relevant studies for systematic reviews. BMJ1994;309:1286-91.">Dickersin 1994</a>; <a href="./references#CD003839-bbs2-0095" title="LefebvreC , McDonaldS . Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE. Paper presented at the Fourth International Cochrane Colloquium, 20-24 Oct 1996; Adelaide. Australia1996.">Lefebvre 1996</a> in 2007 and <a href="./references#CD003839-bbs2-0096" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: HigginsJPT , GreenS , editors(s). Cochrane Handbook for Systematic Reviews of InterventionsVersion 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Lefebvre 2011</a> in 2015). </p> </section> <section id="CD003839-sec-0026"> <h4 class="title">Searching other resources</h4> <p>We also searched for ongoing trials on the UK National Research Register (webarchive.nationalarchives.gov.uk), Trials Central, Current Controlled Trials (<a href="http://www.controlled-trials.com/mrct/" target="_blank">www.controlled-trials.com/mrct/</a>) (November 2013) and handsearched reference lists of all retrieved papers. We contacted Roche<sup>®</sup> Diagnostics (one manufacturer of PT and INR monitors) in order to identify further published and unpublished studies. There were no language restrictions. </p> </section> </section> <section id="CD003839-sec-0027"> <h3 class="title" id="CD003839-sec-0027">Data collection and analysis</h3> <section id="CD003839-sec-0028"> <h4 class="title">Data extraction</h4> <p>Two review authors (EAS and IJO) screened studies for inclusion and retrieved all potentially relevant studies. Three review authors (JM, PA, CH) independently extracted data on study population, intervention, pre‐specified outcomes, methodology, and quality from eligible trials. The authors were not blinded to any aspect of the studies (for example, journal type, authors' names, institution). We resolved disagreements by consensus. If needed, we sought additional information from trial authors. We used Cohen’s kappa to assess agreement between the two authors on the selection of articles for inclusion. </p> <p>We extracted information on disease characteristics and training provided to the different groups. In the self‐management group, we extracted information on the actions participants subsequently undertook. We extracted the characteristics of the population studied, including the number of, and reasons for, participants not entering the trial (for example, refusal or exclusion). Additionally, we sought information on the reasons for discontinuation by participants allocated to the intervention. </p> <p>In the case of cross‐over studies, the outcomes of interest are potentially confounded by the cross‐over and we only used data from the first part of the trial (before cross‐over). </p> </section> <section id="CD003839-sec-0029"> <h4 class="title">Quality assessment</h4> <p>Three review authors (EAS, IJO, CH) independently extracted methodological information for the assessment of risk of bias. They used the following five components: method of randomisation, concealment of allocation, intention‐to‐treat, number of, and reasons for, participant losses to follow‐up, and blinding. We performed a sensitivity analyses for study quality by including only those studies with clear methods of randomisation and concealment of allocation (high‐quality studies). We also used the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) (<a href="./references#CD003839-bbs2-0082" title="GuyattGH , OxmanAD , VistG , KunzR , Falck-YtterY , Alonso-CoelloP , SchünemannHJ , for the GRADE Working Group. Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336:924-6.">GRADE 2008</a>) to assess the quality of the included studies. </p> </section> <section id="CD003839-sec-0030"> <h4 class="title">Quantitative data synthesis</h4> <p>For the analysis we used Review Manager (RevMan) Version 5.3. For the statistical analysis we calculated risk ratios (RRs) and 95% confidence intervals (CIs) as summary statistics. We used a fixed‐effect model with the Mantzel‐Haenzel method to calculate the pooled odds ratio; and Peto’s method to verify the results in uncommon outcomes.  We examined heterogeneity amongst studies with the Chi<sup>2</sup> and I<sup>2</sup> statistics (<a href="./references#CD003839-bbs2-0088" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557-60.">Higgins 2003</a>). Where significant heterogeneity existed, we used the random‐effects model (<a href="./references#CD003839-bbs2-0072" title="DerSimonianR , LairdN . Meta-analysis in clinical trials. Controlled Clinical Trials1986;7:177-88.">DerSimonian 1986</a>). </p> <p>We examined publication bias by constructing a funnel plot of precision (SE of the log RR) against RR for the endpoints of major haemorrhage and thromboembolic episodes. We performed a sensitivity analysis by excluding studies with high risk of bias and pre‐specified subgroup analyses according to clinical indication (mechanical valve replacement or atrial fibrillation), and self‐monitoring or self‐management therapy. We performed a post‐hoc subgroup analysis according to who provided the control group care (specialist anticoagulation clinic, family physician). Meta‐regression in STATA tested any subgroup interaction on the outcomes. The ratio of the average test frequency per individual patient/year between intervention and control groups was calculated and linear regression was used to assess the association with study duration. Pooling of the mean percentage of tests in the therapeutic range was not possible; results were summarised using means and ranges. We tested subgroup interactions using meta‐regression (Intercooled STATA 9.1 for Windows).  </p> <p>To provide further insight into the adequacy of the total sample size across all trials, we calculated a posteriori the optimal information needed for our meta‐analysis (<a href="./references#CD003839-bbs2-0101" title="PogueJM , YusufS . Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis. Controlled Clinical Trials1997;18(6):580-93.">Pogue 1997</a>)<i>.</i> To determine this optimal information size, we assumed a 2% risk of thromboembolism (median control event rate from trials in the review) and a 50% RR reduction with a power of 95% and a two‐sided alpha = 0.01. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD003839-sec-0031" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD003839-sec-0031"></div> <section id="CD003839-sec-0032"> <h3 class="title">Description of studies</h3> <section id="CD003839-sec-0033"> <h4 class="title">Results of the search</h4> <p>The search for the initial review retrieved 463 citations, which included 18 relevant trials. The updated searches in November 2013 and July 2015 identified 5136 new citations and identified an additional 10 trials (with 4227 participants) for inclusion. </p> <p>In total, we identified 5894 citations through database searching as well as one additional unpublished citation (<a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a>). Of these, we excluded 758 duplicate records, leaving 5136 potentially relevant studies. A further 5067 citations were removed after being deemed irrelevant to our research question. We independently assessed 69 full‐text articles for eligibility. Of these, 22 articles were excluded and 20 articles were secondary publications of primary studies already included in the review (<a href="#CD003839-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD003839-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Flowchart showing the results of combined searches" data-id="CD003839-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Flowchart showing the results of combined searches</p> </div> </div> </div> </section> <section id="CD003839-sec-0034"> <h4 class="title">Included studies</h4> <p>A total of 27 included publications provided data on 28 trials including 8950 participants (one publication, <a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>; <a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a>, contained data on two trials that compared self‐monitoring or self‐management of oral anticoagulation with standard monitoring). Trials were published between 1989 and 2013 and were largely undertaken in Europe (five each in UK and Germany; three each in the Netherlands and Denmark; one in each of Ireland, France, Spain and Austria); seven were undertaken in United States and Canada; and one was conducted in Australia. In total, 4723 participants on long‐term anticoagulation were included in our analysis. Three trials (<a href="./references#CD003839-bbs2-0005" title="CromheeckeME , LeviM , CollyLP , deMolBJ , PrinsMH , HuttenBA , et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet2000;356(9224):97-102. ">Cromheecke 2000</a>; <a href="./references#CD003839-bbs2-0012" title="GrunauBE , WiensMO , HarderKK . Patient self-management of warfarin therapy: pragmatic feasibility study in Canadian primary care. Canadian Family Physician Medecin de Famille Canadien2011;57(8):e292-8. ">Grunau 2011</a>; <a href="./references#CD003839-bbs2-0020" title="RyanF , ByrneS , O'SheaS . Randomized controlled trial of supervised patient self-testing of warfarin therapy using an internet-based expert system. Journal of Thrombosis and Haemostasis : JTH2007;7(8):1284-90. ">Ryan 2009</a>) used a cross‐over design. The remaining 25 trials were parallel design; this included the unpublished study for which we were given access to the complete data by the authors (<a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a>). </p> <p>One trial (<a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>; <a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a>) presented results on four groups. One group used self‐management therapy (<a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>), one used self‐monitoring therapy (<a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a>). The two other arms with no self‐monitoring were combined (trained and untrained participants) to provide an overall control group and were then subdivided for the independent comparisons. </p> <p>Six trials included only participants on life‐long anticoagulation therapy following mechanical valve insertion (<a href="./references#CD003839-bbs2-0001" title="AzarnoushK , CamilleriL , Aublet-CuvelierB , GeoffroyE , DauphinC , DubrayC , et al. Results of the first randomized French study evaluating self-testing of the International Normalized Ratio. Journal of Heart Valve Disease2011;20(5):518-25. DauphinC , LegaultB , JaffeuxP , MotreffP , AzarnoushK , JolyH , et al. Comparison of INR stability between self-monitoring and standard laboratory method: preliminary results of a prospective study in 67 mechanical heart valve patients. Archives of Cardiovascular Diseases2008;101(11-12):753-61. ">Azarnoush 2009</a>; <a href="./references#CD003839-bbs2-0013" title="HorstkotteD , PiperC , WiemerM . Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. Journal of Thrombosis and Thrombolysis1998;5 Suppl 1(3):19-24. ">Horstkotte 1998</a>; <a href="./references#CD003839-bbs2-0016" title="EitzT , SchenkS , FritzscheD , BairaktarisA , WagnerO , KoertkeH , et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Annals of Thoracic Surgery2008;85(3):949-54. KörtkeH , KörferR . International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?Annals of Thoracic Surgery2001;72(1):44-8. KörtkeH , MinamiK , BreymannT , SeifertD , BaraktarisA , WagnerO , et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Zeitschrift fur Kardiologie2001;90 Suppl:6118-24. KoertkeH , MinamiK , BairaktarisA , WagnerO , KoerferR . INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis2000;9 Suppl 1:41-5. KoertkeH , MinamiK , BoethigD , BreymannTH , SeifertD , WagnerO , et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation2003;108(10 Suppl 1):II-75-II-78. KoertkeH , ZittermannA , MinamiK , TenderichG , WagnerO , El-ArousyM , et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Annals of Thoracic Surgery2005;79(6):1909-14. KoertkeH , ZittermannA , TenderichG , WagnerO , El-ArousyM , KrianA , et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. European Heart Journal2007;28(20):2479-84. KoertkeH , ZittermannA , WagnerO , EnnkerJ , SaggauW , SackFU , et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2010;90(5):1487-93. KoertkeH , ZittermannA , WagnerO , KoerferR . Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2007;83(1):24-9. ">Körtke 2001</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0024" title="Soliman HamadMA , vanEekelenE , vanAgtT , vanStratenAH . Self-management program improves anticoagulation control and quality of life: a prospective randomized study. European Journal of Cardiothoracic Surgery2009;35(2):265-9. ">Soliman Hamad 2009</a>; <a href="./references#CD003839-bbs2-0026" title="ThompsonJL , BurkhartHM , DalyRC , DearaniJA , JoyceLD , SuriRM , et al. Anticoagulation early after mechanical valve replacement: improved management with patient self-testing. Journal of Thoracic and Cardiovascular Surgery2013;146:599-604. ">Thompson 2013</a>); two trials included participants on long‐term anticoagulation for atrial fibrillation (<a href="./references#CD003839-bbs2-0015" title="KhanTI , KamaliF , KestevenP , AveryP , WynneH . The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology2004;126(4):557-64. ">Khan 2004</a>; <a href="./references#CD003839-bbs2-0028" title="VöllerH , GlatzJ , TaborskiU , BernardoA , DovifatC , HeidingerK . Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Zeitschrift fur Kardiologie2005;94(3):182-6. ">Voller 2005</a>); 20 trials included participants on long‐term anticoagulation for any indication (<a href="./references#CD003839-bbs2-0002" title="BeythRJ , QuinnL , LandefeldCS . A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Annals of Internal Medicine2000;133(9):687-95. ">Beyth 2000</a>; <a href="./references#CD003839-bbs2-0003" title="ChristensenTD , MaegaardM , SørensenHT , HjortdalVE , HasenkamJM . Self-management versus conventional management of oral anticoagulant therapy: A randomized, controlled trial. European Journal of Internal Medicine2006;17(4):260-6. ">Christensen 2006</a>; <a href="./references#CD003839-bbs2-0004" title="ChristensenH , LauterleinJJ , SørensenPD , PetersenERB , MadsenJS , BrandslundI . Home management of oral anticoagulation via telemedicine versus conventional hospital-based treatment. Telemedicine and e-Health2011;17(3):169-76. ">Christensen 2011</a>; <a href="./references#CD003839-bbs2-0005" title="CromheeckeME , LeviM , CollyLP , deMolBJ , PrinsMH , HuttenBA , et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet2000;356(9224):97-102. ">Cromheecke 2000</a>; <a href="./references#CD003839-bbs2-0006" title="DignanR , KeechAC , GebskiVJ , MannKP , HughesCF , Warfarin SMART Investigators. Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial. International Journal of Cardiology2013;168(6):5378-84. ">Dignan 2013</a>; <a href="./references#CD003839-bbs2-0007" title="FitzmauriceDA , MurrayET , GeeKM , AllanTF , HobbsFD . A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology2002;55(11):845-9. McCahonD , MurrayET , MurrayK , HolderRL , FitzmauriceDA . Does self-management of oral anticoagulation therapy improve quality of life and anxiety?Family Practice2011;28(2):134-40. ">Fitzmaurice 2002</a>; <a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a>; <a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>; <a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a>; <a href="./references#CD003839-bbs2-0011" title="GardinerC , WilliamsK , LongairI , MackieIJ , MachinSJ , CohenH . A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing.. British Journal of Haematolgy2006;132(5):598-603. GardinerC , WilliamsK , MackieIJ , MachinSJ , CohenH . Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. British Journal of Haematology2005;128(2):242-7. ">Gardiner 2005</a>; <a href="./references#CD003839-bbs2-0012" title="GrunauBE , WiensMO , HarderKK . Patient self-management of warfarin therapy: pragmatic feasibility study in Canadian primary care. Canadian Family Physician Medecin de Famille Canadien2011;57(8):e292-8. ">Grunau 2011</a>; <a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a>; <a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>; <a href="./references#CD003839-bbs2-0019" title="RasmussenRS , CorellP , MadsenP , OvergaardK . Effects of computer-assisted oral anticoagulant therapy. Thrombosis Journal2012;10(1):17. ">Rasmussen 2012</a>; <a href="./references#CD003839-bbs2-0020" title="RyanF , ByrneS , O'SheaS . Randomized controlled trial of supervised patient self-testing of warfarin therapy using an internet-based expert system. Journal of Thrombosis and Haemostasis : JTH2007;7(8):1284-90. ">Ryan 2009</a>; <a href="./references#CD003839-bbs2-0021" title="SawickiPT , GlaserB , KleespiesC , StubbeJ , SchmitzN , KaiserT , et al. Long-term results of patients' self-management of oral anticoagulation. Journal of Clinical &amp; Basic Cardiology2003;6(1-4):59-62. SawickiPT . A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA1999;281(2):145-50. ">Sawicki 1999</a>; <a href="./references#CD003839-bbs2-0023" title="SiebenhoferA , HemkensLG , RakovacI , SpatS , DidjurgeitU , SPOG 60+ Study Group. Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thrombosis Research2012;130:e60-e6. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thrombosis and Haemostasis2007;97(3):408-16. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thrombosis &amp; Haemostasis2008;100(6):1089-98. ">Siebenhofer 2007</a>; <a href="./references#CD003839-bbs2-0025" title="SunderjiR , CampbellL , ShalanskyK , FungA , CarterC , GinK . Outpatient self-management of warfarin therapy: A pilot study. Pharmacotherapy1999;19(6):787-93. SunderjiR , GinK , ShalanskyK , CarterC , ChambersK , DaviesC , et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Canadian Journal of Cardiology2004;20(11):1117-23. ">Sunderji 2004</a>; <a href="./references#CD003839-bbs2-0027" title="VerretL , CouturierJ , RozonA , Saudrais-JanecekS , St-OngeA , NguyenA , et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy2012;32(10):871-9. ">Verret 2012</a>; <a href="./references#CD003839-bbs2-0029" title="WhiteRH , McCurdySA , vonMarensdorffH , Woodruff DE Jr, LeftgoffL . Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Annals of Internal Medicine1989;111(9):730-7. ">White 1989</a>). In 15 trials the intervention group used self‐management (<a href="./references#CD003839-bbs2-0003" title="ChristensenTD , MaegaardM , SørensenHT , HjortdalVE , HasenkamJM . Self-management versus conventional management of oral anticoagulant therapy: A randomized, controlled trial. European Journal of Internal Medicine2006;17(4):260-6. ">Christensen 2006</a>; <a href="./references#CD003839-bbs2-0005" title="CromheeckeME , LeviM , CollyLP , deMolBJ , PrinsMH , HuttenBA , et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet2000;356(9224):97-102. ">Cromheecke 2000</a>; <a href="./references#CD003839-bbs2-0006" title="DignanR , KeechAC , GebskiVJ , MannKP , HughesCF , Warfarin SMART Investigators. Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial. International Journal of Cardiology2013;168(6):5378-84. ">Dignan 2013</a>; <a href="./references#CD003839-bbs2-0007" title="FitzmauriceDA , MurrayET , GeeKM , AllanTF , HobbsFD . A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology2002;55(11):845-9. McCahonD , MurrayET , MurrayK , HolderRL , FitzmauriceDA . Does self-management of oral anticoagulation therapy improve quality of life and anxiety?Family Practice2011;28(2):134-40. ">Fitzmaurice 2002</a>; <a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a>; <a href="./references#CD003839-bbs2-0012" title="GrunauBE , WiensMO , HarderKK . Patient self-management of warfarin therapy: pragmatic feasibility study in Canadian primary care. Canadian Family Physician Medecin de Famille Canadien2011;57(8):e292-8. ">Grunau 2011</a>; <a href="./references#CD003839-bbs2-0016" title="EitzT , SchenkS , FritzscheD , BairaktarisA , WagnerO , KoertkeH , et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Annals of Thoracic Surgery2008;85(3):949-54. KörtkeH , KörferR . International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?Annals of Thoracic Surgery2001;72(1):44-8. KörtkeH , MinamiK , BreymannT , SeifertD , BaraktarisA , WagnerO , et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Zeitschrift fur Kardiologie2001;90 Suppl:6118-24. KoertkeH , MinamiK , BairaktarisA , WagnerO , KoerferR . INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis2000;9 Suppl 1:41-5. KoertkeH , MinamiK , BoethigD , BreymannTH , SeifertD , WagnerO , et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation2003;108(10 Suppl 1):II-75-II-78. KoertkeH , ZittermannA , MinamiK , TenderichG , WagnerO , El-ArousyM , et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Annals of Thoracic Surgery2005;79(6):1909-14. KoertkeH , ZittermannA , TenderichG , WagnerO , El-ArousyM , KrianA , et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. European Heart Journal2007;28(20):2479-84. KoertkeH , ZittermannA , WagnerO , EnnkerJ , SaggauW , SackFU , et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2010;90(5):1487-93. KoertkeH , ZittermannA , WagnerO , KoerferR . Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2007;83(1):24-9. ">Körtke 2001</a>; <a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>; <a href="./references#CD003839-bbs2-0021" title="SawickiPT , GlaserB , KleespiesC , StubbeJ , SchmitzN , KaiserT , et al. Long-term results of patients' self-management of oral anticoagulation. Journal of Clinical &amp; Basic Cardiology2003;6(1-4):59-62. SawickiPT . A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA1999;281(2):145-50. ">Sawicki 1999</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0023" title="SiebenhoferA , HemkensLG , RakovacI , SpatS , DidjurgeitU , SPOG 60+ Study Group. Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thrombosis Research2012;130:e60-e6. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thrombosis and Haemostasis2007;97(3):408-16. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thrombosis &amp; Haemostasis2008;100(6):1089-98. ">Siebenhofer 2007</a>; <a href="./references#CD003839-bbs2-0024" title="Soliman HamadMA , vanEekelenE , vanAgtT , vanStratenAH . Self-management program improves anticoagulation control and quality of life: a prospective randomized study. European Journal of Cardiothoracic Surgery2009;35(2):265-9. ">Soliman Hamad 2009</a>; <a href="./references#CD003839-bbs2-0025" title="SunderjiR , CampbellL , ShalanskyK , FungA , CarterC , GinK . Outpatient self-management of warfarin therapy: A pilot study. Pharmacotherapy1999;19(6):787-93. SunderjiR , GinK , ShalanskyK , CarterC , ChambersK , DaviesC , et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Canadian Journal of Cardiology2004;20(11):1117-23. ">Sunderji 2004</a>; <a href="./references#CD003839-bbs2-0027" title="VerretL , CouturierJ , RozonA , Saudrais-JanecekS , St-OngeA , NguyenA , et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy2012;32(10):871-9. ">Verret 2012</a>; <a href="./references#CD003839-bbs2-0028" title="VöllerH , GlatzJ , TaborskiU , BernardoA , DovifatC , HeidingerK . Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Zeitschrift fur Kardiologie2005;94(3):182-6. ">Voller 2005</a>) and 12 trials used self‐monitoring (<a href="./references#CD003839-bbs2-0001" title="AzarnoushK , CamilleriL , Aublet-CuvelierB , GeoffroyE , DauphinC , DubrayC , et al. Results of the first randomized French study evaluating self-testing of the International Normalized Ratio. Journal of Heart Valve Disease2011;20(5):518-25. DauphinC , LegaultB , JaffeuxP , MotreffP , AzarnoushK , JolyH , et al. Comparison of INR stability between self-monitoring and standard laboratory method: preliminary results of a prospective study in 67 mechanical heart valve patients. Archives of Cardiovascular Diseases2008;101(11-12):753-61. ">Azarnoush 2009</a>; <a href="./references#CD003839-bbs2-0002" title="BeythRJ , QuinnL , LandefeldCS . A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Annals of Internal Medicine2000;133(9):687-95. ">Beyth 2000</a>; <a href="./references#CD003839-bbs2-0004" title="ChristensenH , LauterleinJJ , SørensenPD , PetersenERB , MadsenJS , BrandslundI . Home management of oral anticoagulation via telemedicine versus conventional hospital-based treatment. Telemedicine and e-Health2011;17(3):169-76. ">Christensen 2011</a>; <a href="./references#CD003839-bbs2-0011" title="GardinerC , WilliamsK , LongairI , MackieIJ , MachinSJ , CohenH . A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing.. British Journal of Haematolgy2006;132(5):598-603. GardinerC , WilliamsK , MackieIJ , MachinSJ , CohenH . Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. British Journal of Haematology2005;128(2):242-7. ">Gardiner 2005</a>; <a href="./references#CD003839-bbs2-0013" title="HorstkotteD , PiperC , WiemerM . Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. Journal of Thrombosis and Thrombolysis1998;5 Suppl 1(3):19-24. ">Horstkotte 1998</a>; <a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a>; <a href="./references#CD003839-bbs2-0015" title="KhanTI , KamaliF , KestevenP , AveryP , WynneH . The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology2004;126(4):557-64. ">Khan 2004</a>; <a href="./references#CD003839-bbs2-0017" title="MatcharDB , DolorR , JacobsonA , LoveS , EdsonR , UyedaL . More frequent self-testing of prothrombin time results in improved time in target range. Circulation2012;126:21 Suppl. MatcharDB , JacobsonA , DolorR , EdsonR , UyedaL , PhibbsCS , et al, THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. New England Journal of Medicine2010;363(17):1608-20. ">Matchar 2010</a>; <a href="./references#CD003839-bbs2-0019" title="RasmussenRS , CorellP , MadsenP , OvergaardK . Effects of computer-assisted oral anticoagulant therapy. Thrombosis Journal2012;10(1):17. ">Rasmussen 2012</a>; <a href="./references#CD003839-bbs2-0020" title="RyanF , ByrneS , O'SheaS . Randomized controlled trial of supervised patient self-testing of warfarin therapy using an internet-based expert system. Journal of Thrombosis and Haemostasis : JTH2007;7(8):1284-90. ">Ryan 2009</a>; <a href="./references#CD003839-bbs2-0026" title="ThompsonJL , BurkhartHM , DalyRC , DearaniJA , JoyceLD , SuriRM , et al. Anticoagulation early after mechanical valve replacement: improved management with patient self-testing. Journal of Thoracic and Cardiovascular Surgery2013;146:599-604. ">Thompson 2013</a>; <a href="./references#CD003839-bbs2-0029" title="WhiteRH , McCurdySA , vonMarensdorffH , Woodruff DE Jr, LeftgoffL . Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Annals of Internal Medicine1989;111(9):730-7. ">White 1989</a>). One further study (<a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>; <a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a>), reported information on both self‐management and self‐monitoring groups. Eleven trials used primary care for the control group (<a href="./references#CD003839-bbs2-0002" title="BeythRJ , QuinnL , LandefeldCS . A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Annals of Internal Medicine2000;133(9):687-95. ">Beyth 2000</a>; <a href="./references#CD003839-bbs2-0007" title="FitzmauriceDA , MurrayET , GeeKM , AllanTF , HobbsFD . A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology2002;55(11):845-9. McCahonD , MurrayET , MurrayK , HolderRL , FitzmauriceDA . Does self-management of oral anticoagulation therapy improve quality of life and anxiety?Family Practice2011;28(2):134-40. ">Fitzmaurice 2002</a>; <a href="./references#CD003839-bbs2-0012" title="GrunauBE , WiensMO , HarderKK . Patient self-management of warfarin therapy: pragmatic feasibility study in Canadian primary care. Canadian Family Physician Medecin de Famille Canadien2011;57(8):e292-8. ">Grunau 2011</a>; <a href="./references#CD003839-bbs2-0013" title="HorstkotteD , PiperC , WiemerM . Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. Journal of Thrombosis and Thrombolysis1998;5 Suppl 1(3):19-24. ">Horstkotte 1998</a>; <a href="./references#CD003839-bbs2-0016" title="EitzT , SchenkS , FritzscheD , BairaktarisA , WagnerO , KoertkeH , et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Annals of Thoracic Surgery2008;85(3):949-54. KörtkeH , KörferR . International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?Annals of Thoracic Surgery2001;72(1):44-8. KörtkeH , MinamiK , BreymannT , SeifertD , BaraktarisA , WagnerO , et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Zeitschrift fur Kardiologie2001;90 Suppl:6118-24. KoertkeH , MinamiK , BairaktarisA , WagnerO , KoerferR . INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis2000;9 Suppl 1:41-5. KoertkeH , MinamiK , BoethigD , BreymannTH , SeifertD , WagnerO , et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation2003;108(10 Suppl 1):II-75-II-78. KoertkeH , ZittermannA , MinamiK , TenderichG , WagnerO , El-ArousyM , et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Annals of Thoracic Surgery2005;79(6):1909-14. KoertkeH , ZittermannA , TenderichG , WagnerO , El-ArousyM , KrianA , et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. European Heart Journal2007;28(20):2479-84. KoertkeH , ZittermannA , WagnerO , EnnkerJ , SaggauW , SackFU , et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2010;90(5):1487-93. KoertkeH , ZittermannA , WagnerO , KoerferR . Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2007;83(1):24-9. ">Körtke 2001</a>; <a href="./references#CD003839-bbs2-0019" title="RasmussenRS , CorellP , MadsenP , OvergaardK . Effects of computer-assisted oral anticoagulant therapy. Thrombosis Journal2012;10(1):17. ">Rasmussen 2012</a>; <a href="./references#CD003839-bbs2-0021" title="SawickiPT , GlaserB , KleespiesC , StubbeJ , SchmitzN , KaiserT , et al. Long-term results of patients' self-management of oral anticoagulation. Journal of Clinical &amp; Basic Cardiology2003;6(1-4):59-62. SawickiPT . A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA1999;281(2):145-50. ">Sawicki 1999</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0025" title="SunderjiR , CampbellL , ShalanskyK , FungA , CarterC , GinK . Outpatient self-management of warfarin therapy: A pilot study. Pharmacotherapy1999;19(6):787-93. SunderjiR , GinK , ShalanskyK , CarterC , ChambersK , DaviesC , et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Canadian Journal of Cardiology2004;20(11):1117-23. ">Sunderji 2004</a>; <a href="./references#CD003839-bbs2-0026" title="ThompsonJL , BurkhartHM , DalyRC , DearaniJA , JoyceLD , SuriRM , et al. Anticoagulation early after mechanical valve replacement: improved management with patient self-testing. Journal of Thoracic and Cardiovascular Surgery2013;146:599-604. ">Thompson 2013</a>; <a href="./references#CD003839-bbs2-0028" title="VöllerH , GlatzJ , TaborskiU , BernardoA , DovifatC , HeidingerK . Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Zeitschrift fur Kardiologie2005;94(3):182-6. ">Voller 2005</a>); 13 studies used specialist anticoagulation clinics (<a href="./references#CD003839-bbs2-0004" title="ChristensenH , LauterleinJJ , SørensenPD , PetersenERB , MadsenJS , BrandslundI . Home management of oral anticoagulation via telemedicine versus conventional hospital-based treatment. Telemedicine and e-Health2011;17(3):169-76. ">Christensen 2011</a>; <a href="./references#CD003839-bbs2-0005" title="CromheeckeME , LeviM , CollyLP , deMolBJ , PrinsMH , HuttenBA , et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet2000;356(9224):97-102. ">Cromheecke 2000</a>; <a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a>; <a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>; <a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a>; <a href="./references#CD003839-bbs2-0011" title="GardinerC , WilliamsK , LongairI , MackieIJ , MachinSJ , CohenH . A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing.. British Journal of Haematolgy2006;132(5):598-603. GardinerC , WilliamsK , MackieIJ , MachinSJ , CohenH . Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. British Journal of Haematology2005;128(2):242-7. ">Gardiner 2005</a>; <a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a>; <a href="./references#CD003839-bbs2-0015" title="KhanTI , KamaliF , KestevenP , AveryP , WynneH . The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology2004;126(4):557-64. ">Khan 2004</a>; <a href="./references#CD003839-bbs2-0017" title="MatcharDB , DolorR , JacobsonA , LoveS , EdsonR , UyedaL . More frequent self-testing of prothrombin time results in improved time in target range. Circulation2012;126:21 Suppl. MatcharDB , JacobsonA , DolorR , EdsonR , UyedaL , PhibbsCS , et al, THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. New England Journal of Medicine2010;363(17):1608-20. ">Matchar 2010</a>; <a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>; <a href="./references#CD003839-bbs2-0020" title="RyanF , ByrneS , O'SheaS . Randomized controlled trial of supervised patient self-testing of warfarin therapy using an internet-based expert system. Journal of Thrombosis and Haemostasis : JTH2007;7(8):1284-90. ">Ryan 2009</a>; <a href="./references#CD003839-bbs2-0024" title="Soliman HamadMA , vanEekelenE , vanAgtT , vanStratenAH . Self-management program improves anticoagulation control and quality of life: a prospective randomized study. European Journal of Cardiothoracic Surgery2009;35(2):265-9. ">Soliman Hamad 2009</a>; <a href="./references#CD003839-bbs2-0027" title="VerretL , CouturierJ , RozonA , Saudrais-JanecekS , St-OngeA , NguyenA , et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy2012;32(10):871-9. ">Verret 2012</a>; <a href="./references#CD003839-bbs2-0029" title="WhiteRH , McCurdySA , vonMarensdorffH , Woodruff DE Jr, LeftgoffL . Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Annals of Internal Medicine1989;111(9):730-7. ">White 1989</a>); and one trial (<a href="./references#CD003839-bbs2-0001" title="AzarnoushK , CamilleriL , Aublet-CuvelierB , GeoffroyE , DauphinC , DubrayC , et al. Results of the first randomized French study evaluating self-testing of the International Normalized Ratio. Journal of Heart Valve Disease2011;20(5):518-25. DauphinC , LegaultB , JaffeuxP , MotreffP , AzarnoushK , JolyH , et al. Comparison of INR stability between self-monitoring and standard laboratory method: preliminary results of a prospective study in 67 mechanical heart valve patients. Archives of Cardiovascular Diseases2008;101(11-12):753-61. ">Azarnoush 2009</a>) used a medical analysis laboratory. In the three remaining trials participants in the control group could use either primary care or specialist clinics (<a href="./references#CD003839-bbs2-0003" title="ChristensenTD , MaegaardM , SørensenHT , HjortdalVE , HasenkamJM . Self-management versus conventional management of oral anticoagulant therapy: A randomized, controlled trial. European Journal of Internal Medicine2006;17(4):260-6. ">Christensen 2006</a>; <a href="./references#CD003839-bbs2-0006" title="DignanR , KeechAC , GebskiVJ , MannKP , HughesCF , Warfarin SMART Investigators. Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial. International Journal of Cardiology2013;168(6):5378-84. ">Dignan 2013</a>; <a href="./references#CD003839-bbs2-0023" title="SiebenhoferA , HemkensLG , RakovacI , SpatS , DidjurgeitU , SPOG 60+ Study Group. Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thrombosis Research2012;130:e60-e6. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thrombosis and Haemostasis2007;97(3):408-16. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thrombosis &amp; Haemostasis2008;100(6):1089-98. ">Siebenhofer 2007</a>). Duration of studies varied from two months (<a href="./references#CD003839-bbs2-0029" title="WhiteRH , McCurdySA , vonMarensdorffH , Woodruff DE Jr, LeftgoffL . Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Annals of Internal Medicine1989;111(9):730-7. ">White 1989</a>) to more than 24 months (<a href="./references#CD003839-bbs2-0016" title="EitzT , SchenkS , FritzscheD , BairaktarisA , WagnerO , KoertkeH , et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Annals of Thoracic Surgery2008;85(3):949-54. KörtkeH , KörferR . International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?Annals of Thoracic Surgery2001;72(1):44-8. KörtkeH , MinamiK , BreymannT , SeifertD , BaraktarisA , WagnerO , et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Zeitschrift fur Kardiologie2001;90 Suppl:6118-24. KoertkeH , MinamiK , BairaktarisA , WagnerO , KoerferR . INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis2000;9 Suppl 1:41-5. KoertkeH , MinamiK , BoethigD , BreymannTH , SeifertD , WagnerO , et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation2003;108(10 Suppl 1):II-75-II-78. KoertkeH , ZittermannA , MinamiK , TenderichG , WagnerO , El-ArousyM , et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Annals of Thoracic Surgery2005;79(6):1909-14. KoertkeH , ZittermannA , TenderichG , WagnerO , El-ArousyM , KrianA , et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. European Heart Journal2007;28(20):2479-84. KoertkeH , ZittermannA , WagnerO , EnnkerJ , SaggauW , SackFU , et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2010;90(5):1487-93. KoertkeH , ZittermannA , WagnerO , KoerferR . Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2007;83(1):24-9. ">Körtke 2001</a>; <a href="./references#CD003839-bbs2-0017" title="MatcharDB , DolorR , JacobsonA , LoveS , EdsonR , UyedaL . More frequent self-testing of prothrombin time results in improved time in target range. Circulation2012;126:21 Suppl. MatcharDB , JacobsonA , DolorR , EdsonR , UyedaL , PhibbsCS , et al, THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. New England Journal of Medicine2010;363(17):1608-20. ">Matchar 2010</a>); the mean duration was 12 months. </p> <p>Analysis of publication bias using funnel plots of major haemorrhage and thromboembolic events showed no evidence of asymmetry (<a href="#CD003839-fig-0002">Figure 2</a>, <a href="#CD003839-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD003839-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Major haemorrhage, outcome" data-id="CD003839-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Major haemorrhage, outcome</p> </div> </div> </div> <div class="figure" id="CD003839-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 2 Thromboembolic events" data-id="CD003839-fig-0003" src="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 2 Thromboembolic events</p> </div> </div> </div> </section> </section> <section id="CD003839-sec-0035"> <h3 class="title">Risk of bias in included studies</h3> <p>The reported risk of bias was generally low to moderate. The nature of the intervention made blinding of the allocation of intervention to the participants impossible, although blinding of study staff and outcome assessment was possible. We contacted nine authors of the 27 included trials for additional details of randomisation process, concealment of allocation, and blinding. The additional information provided generally raised our ratings of the quality of the trial, indicating that authors had met methodological criteria. We also obtained valuable validity information from the ACP Journal Club structured reviews on two occasions. ACP reviews contact study authors when needed and are a valuable source of additional information for validity issues. </p> <p>After the addition of extra information supplied by authors, 11 trials were judged to be of high risk of bias (<a href="./references#CD003839-bbs2-0001" title="AzarnoushK , CamilleriL , Aublet-CuvelierB , GeoffroyE , DauphinC , DubrayC , et al. Results of the first randomized French study evaluating self-testing of the International Normalized Ratio. Journal of Heart Valve Disease2011;20(5):518-25. DauphinC , LegaultB , JaffeuxP , MotreffP , AzarnoushK , JolyH , et al. Comparison of INR stability between self-monitoring and standard laboratory method: preliminary results of a prospective study in 67 mechanical heart valve patients. Archives of Cardiovascular Diseases2008;101(11-12):753-61. ">Azarnoush 2009</a>; <a href="./references#CD003839-bbs2-0004" title="ChristensenH , LauterleinJJ , SørensenPD , PetersenERB , MadsenJS , BrandslundI . Home management of oral anticoagulation via telemedicine versus conventional hospital-based treatment. Telemedicine and e-Health2011;17(3):169-76. ">Christensen 2011</a>; <a href="./references#CD003839-bbs2-0011" title="GardinerC , WilliamsK , LongairI , MackieIJ , MachinSJ , CohenH . A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing.. British Journal of Haematolgy2006;132(5):598-603. GardinerC , WilliamsK , MackieIJ , MachinSJ , CohenH . Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. British Journal of Haematology2005;128(2):242-7. ">Gardiner 2005</a>; <a href="./references#CD003839-bbs2-0015" title="KhanTI , KamaliF , KestevenP , AveryP , WynneH . The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology2004;126(4):557-64. ">Khan 2004</a>; <a href="./references#CD003839-bbs2-0017" title="MatcharDB , DolorR , JacobsonA , LoveS , EdsonR , UyedaL . More frequent self-testing of prothrombin time results in improved time in target range. Circulation2012;126:21 Suppl. MatcharDB , JacobsonA , DolorR , EdsonR , UyedaL , PhibbsCS , et al, THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. New England Journal of Medicine2010;363(17):1608-20. ">Matchar 2010</a>; <a href="./references#CD003839-bbs2-0019" title="RasmussenRS , CorellP , MadsenP , OvergaardK . Effects of computer-assisted oral anticoagulant therapy. Thrombosis Journal2012;10(1):17. ">Rasmussen 2012</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0024" title="Soliman HamadMA , vanEekelenE , vanAgtT , vanStratenAH . Self-management program improves anticoagulation control and quality of life: a prospective randomized study. European Journal of Cardiothoracic Surgery2009;35(2):265-9. ">Soliman Hamad 2009</a>; <a href="./references#CD003839-bbs2-0026" title="ThompsonJL , BurkhartHM , DalyRC , DearaniJA , JoyceLD , SuriRM , et al. Anticoagulation early after mechanical valve replacement: improved management with patient self-testing. Journal of Thoracic and Cardiovascular Surgery2013;146:599-604. ">Thompson 2013</a>; <a href="./references#CD003839-bbs2-0027" title="VerretL , CouturierJ , RozonA , Saudrais-JanecekS , St-OngeA , NguyenA , et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy2012;32(10):871-9. ">Verret 2012</a>; <a href="./references#CD003839-bbs2-0029" title="WhiteRH , McCurdySA , vonMarensdorffH , Woodruff DE Jr, LeftgoffL . Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Annals of Internal Medicine1989;111(9):730-7. ">White 1989</a>) and were removed in the sensitivity analysis. These 11 trials did not perform intention‐to‐treat analyses and randomisation and/or allocation concealment was unclear. Overall, the available evidence was judged to be moderate according to the GRADE Working Group grades of evidence (<a href="./full#CD003839-tbl-0001">summary of findings Table 1</a>). This was due to flaws in study design; most commonly there was an absence of information about the allocation concealment procedure or blinding and the number of events was less than 300 for the primary outcomes (<a href="./references#CD003839-sec-0084" title="">Characteristics of included studies</a>). The overall risk of bias graph and summary table are shown in <a href="#CD003839-fig-0004">Figure 4</a> and <a href="#CD003839-fig-0005">Figure 5</a>. </p> <div class="figure" id="CD003839-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD003839-fig-0004" src="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD003839-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD003839-fig-0005" src="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-FIG-05.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD003839-sec-0036"> <h4 class="title">Randomisation and allocation concealment</h4> <p>Twenty‐one trials reported adequate information about the randomisation process (<a href="./references#CD003839-bbs2-0003" title="ChristensenTD , MaegaardM , SørensenHT , HjortdalVE , HasenkamJM . Self-management versus conventional management of oral anticoagulant therapy: A randomized, controlled trial. European Journal of Internal Medicine2006;17(4):260-6. ">Christensen 2006</a>; <a href="./references#CD003839-bbs2-0004" title="ChristensenH , LauterleinJJ , SørensenPD , PetersenERB , MadsenJS , BrandslundI . Home management of oral anticoagulation via telemedicine versus conventional hospital-based treatment. Telemedicine and e-Health2011;17(3):169-76. ">Christensen 2011</a>; <a href="./references#CD003839-bbs2-0005" title="CromheeckeME , LeviM , CollyLP , deMolBJ , PrinsMH , HuttenBA , et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet2000;356(9224):97-102. ">Cromheecke 2000</a>; <a href="./references#CD003839-bbs2-0006" title="DignanR , KeechAC , GebskiVJ , MannKP , HughesCF , Warfarin SMART Investigators. Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial. International Journal of Cardiology2013;168(6):5378-84. ">Dignan 2013</a>; <a href="./references#CD003839-bbs2-0007" title="FitzmauriceDA , MurrayET , GeeKM , AllanTF , HobbsFD . A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology2002;55(11):845-9. McCahonD , MurrayET , MurrayK , HolderRL , FitzmauriceDA . Does self-management of oral anticoagulation therapy improve quality of life and anxiety?Family Practice2011;28(2):134-40. ">Fitzmaurice 2002</a>; <a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a>; <a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>; <a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a>; <a href="./references#CD003839-bbs2-0012" title="GrunauBE , WiensMO , HarderKK . Patient self-management of warfarin therapy: pragmatic feasibility study in Canadian primary care. Canadian Family Physician Medecin de Famille Canadien2011;57(8):e292-8. ">Grunau 2011</a>; <a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a>; <a href="./references#CD003839-bbs2-0015" title="KhanTI , KamaliF , KestevenP , AveryP , WynneH . The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology2004;126(4):557-64. ">Khan 2004</a>; <a href="./references#CD003839-bbs2-0016" title="EitzT , SchenkS , FritzscheD , BairaktarisA , WagnerO , KoertkeH , et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Annals of Thoracic Surgery2008;85(3):949-54. KörtkeH , KörferR . International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?Annals of Thoracic Surgery2001;72(1):44-8. KörtkeH , MinamiK , BreymannT , SeifertD , BaraktarisA , WagnerO , et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Zeitschrift fur Kardiologie2001;90 Suppl:6118-24. KoertkeH , MinamiK , BairaktarisA , WagnerO , KoerferR . INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis2000;9 Suppl 1:41-5. KoertkeH , MinamiK , BoethigD , BreymannTH , SeifertD , WagnerO , et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation2003;108(10 Suppl 1):II-75-II-78. KoertkeH , ZittermannA , MinamiK , TenderichG , WagnerO , El-ArousyM , et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Annals of Thoracic Surgery2005;79(6):1909-14. KoertkeH , ZittermannA , TenderichG , WagnerO , El-ArousyM , KrianA , et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. European Heart Journal2007;28(20):2479-84. KoertkeH , ZittermannA , WagnerO , EnnkerJ , SaggauW , SackFU , et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2010;90(5):1487-93. KoertkeH , ZittermannA , WagnerO , KoerferR . Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2007;83(1):24-9. ">Körtke 2001</a>; <a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>; <a href="./references#CD003839-bbs2-0019" title="RasmussenRS , CorellP , MadsenP , OvergaardK . Effects of computer-assisted oral anticoagulant therapy. Thrombosis Journal2012;10(1):17. ">Rasmussen 2012</a>; <a href="./references#CD003839-bbs2-0020" title="RyanF , ByrneS , O'SheaS . Randomized controlled trial of supervised patient self-testing of warfarin therapy using an internet-based expert system. Journal of Thrombosis and Haemostasis : JTH2007;7(8):1284-90. ">Ryan 2009</a>; <a href="./references#CD003839-bbs2-0021" title="SawickiPT , GlaserB , KleespiesC , StubbeJ , SchmitzN , KaiserT , et al. Long-term results of patients' self-management of oral anticoagulation. Journal of Clinical &amp; Basic Cardiology2003;6(1-4):59-62. SawickiPT . A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA1999;281(2):145-50. ">Sawicki 1999</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0023" title="SiebenhoferA , HemkensLG , RakovacI , SpatS , DidjurgeitU , SPOG 60+ Study Group. Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thrombosis Research2012;130:e60-e6. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thrombosis and Haemostasis2007;97(3):408-16. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thrombosis &amp; Haemostasis2008;100(6):1089-98. ">Siebenhofer 2007</a>; <a href="./references#CD003839-bbs2-0025" title="SunderjiR , CampbellL , ShalanskyK , FungA , CarterC , GinK . Outpatient self-management of warfarin therapy: A pilot study. Pharmacotherapy1999;19(6):787-93. SunderjiR , GinK , ShalanskyK , CarterC , ChambersK , DaviesC , et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Canadian Journal of Cardiology2004;20(11):1117-23. ">Sunderji 2004</a>; <a href="./references#CD003839-bbs2-0028" title="VöllerH , GlatzJ , TaborskiU , BernardoA , DovifatC , HeidingerK . Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Zeitschrift fur Kardiologie2005;94(3):182-6. ">Voller 2005</a>; <a href="./references#CD003839-bbs2-0029" title="WhiteRH , McCurdySA , vonMarensdorffH , Woodruff DE Jr, LeftgoffL . Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Annals of Internal Medicine1989;111(9):730-7. ">White 1989</a>) and were therefore judged to be of low risk of bias in this domain. </p> <p>However, the method of allocation concealment was generally not reported in the published papers. After contacting authors for additional information, 14 of the 28 trials had an appropriate method of concealment (<a href="./references#CD003839-bbs2-0002" title="BeythRJ , QuinnL , LandefeldCS . A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Annals of Internal Medicine2000;133(9):687-95. ">Beyth 2000</a>; <a href="./references#CD003839-bbs2-0003" title="ChristensenTD , MaegaardM , SørensenHT , HjortdalVE , HasenkamJM . Self-management versus conventional management of oral anticoagulant therapy: A randomized, controlled trial. European Journal of Internal Medicine2006;17(4):260-6. ">Christensen 2006</a>; <a href="./references#CD003839-bbs2-0005" title="CromheeckeME , LeviM , CollyLP , deMolBJ , PrinsMH , HuttenBA , et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet2000;356(9224):97-102. ">Cromheecke 2000</a>; <a href="./references#CD003839-bbs2-0007" title="FitzmauriceDA , MurrayET , GeeKM , AllanTF , HobbsFD . A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology2002;55(11):845-9. McCahonD , MurrayET , MurrayK , HolderRL , FitzmauriceDA . Does self-management of oral anticoagulation therapy improve quality of life and anxiety?Family Practice2011;28(2):134-40. ">Fitzmaurice 2002</a>; <a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a>; <a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>; <a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a>; <a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a>; <a href="./references#CD003839-bbs2-0016" title="EitzT , SchenkS , FritzscheD , BairaktarisA , WagnerO , KoertkeH , et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Annals of Thoracic Surgery2008;85(3):949-54. KörtkeH , KörferR . International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?Annals of Thoracic Surgery2001;72(1):44-8. KörtkeH , MinamiK , BreymannT , SeifertD , BaraktarisA , WagnerO , et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Zeitschrift fur Kardiologie2001;90 Suppl:6118-24. KoertkeH , MinamiK , BairaktarisA , WagnerO , KoerferR . INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis2000;9 Suppl 1:41-5. KoertkeH , MinamiK , BoethigD , BreymannTH , SeifertD , WagnerO , et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation2003;108(10 Suppl 1):II-75-II-78. KoertkeH , ZittermannA , MinamiK , TenderichG , WagnerO , El-ArousyM , et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Annals of Thoracic Surgery2005;79(6):1909-14. KoertkeH , ZittermannA , TenderichG , WagnerO , El-ArousyM , KrianA , et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. European Heart Journal2007;28(20):2479-84. KoertkeH , ZittermannA , WagnerO , EnnkerJ , SaggauW , SackFU , et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2010;90(5):1487-93. KoertkeH , ZittermannA , WagnerO , KoerferR . Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2007;83(1):24-9. ">Körtke 2001</a>; <a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>; <a href="./references#CD003839-bbs2-0020" title="RyanF , ByrneS , O'SheaS . Randomized controlled trial of supervised patient self-testing of warfarin therapy using an internet-based expert system. Journal of Thrombosis and Haemostasis : JTH2007;7(8):1284-90. ">Ryan 2009</a>; <a href="./references#CD003839-bbs2-0023" title="SiebenhoferA , HemkensLG , RakovacI , SpatS , DidjurgeitU , SPOG 60+ Study Group. Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thrombosis Research2012;130:e60-e6. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thrombosis and Haemostasis2007;97(3):408-16. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thrombosis &amp; Haemostasis2008;100(6):1089-98. ">Siebenhofer 2007</a>; <a href="./references#CD003839-bbs2-0025" title="SunderjiR , CampbellL , ShalanskyK , FungA , CarterC , GinK . Outpatient self-management of warfarin therapy: A pilot study. Pharmacotherapy1999;19(6):787-93. SunderjiR , GinK , ShalanskyK , CarterC , ChambersK , DaviesC , et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Canadian Journal of Cardiology2004;20(11):1117-23. ">Sunderji 2004</a>; <a href="./references#CD003839-bbs2-0028" title="VöllerH , GlatzJ , TaborskiU , BernardoA , DovifatC , HeidingerK . Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Zeitschrift fur Kardiologie2005;94(3):182-6. ">Voller 2005</a>). Four studies used both concealment of allocation and intention‐to‐treat (<a href="./references#CD003839-bbs2-0003" title="ChristensenTD , MaegaardM , SørensenHT , HjortdalVE , HasenkamJM . Self-management versus conventional management of oral anticoagulant therapy: A randomized, controlled trial. European Journal of Internal Medicine2006;17(4):260-6. ">Christensen 2006</a>; <a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a>; <a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>; <a href="./references#CD003839-bbs2-0023" title="SiebenhoferA , HemkensLG , RakovacI , SpatS , DidjurgeitU , SPOG 60+ Study Group. Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thrombosis Research2012;130:e60-e6. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thrombosis and Haemostasis2007;97(3):408-16. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thrombosis &amp; Haemostasis2008;100(6):1089-98. ">Siebenhofer 2007</a>) (see <a href="#CD003839-fig-0004">Figure 4</a> and <a href="#CD003839-fig-0005">Figure 5</a>). </p> </section> <section id="CD003839-sec-0037"> <h4 class="title">Blinding</h4> <p>Participant blinding was not possible due to the nature of the intervention. Seven studies included information about blinding. Two trials blinded data collectors (<a href="./references#CD003839-bbs2-0002" title="BeythRJ , QuinnL , LandefeldCS . A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Annals of Internal Medicine2000;133(9):687-95. ">Beyth 2000</a>; <a href="./references#CD003839-bbs2-0021" title="SawickiPT , GlaserB , KleespiesC , StubbeJ , SchmitzN , KaiserT , et al. Long-term results of patients' self-management of oral anticoagulation. Journal of Clinical &amp; Basic Cardiology2003;6(1-4):59-62. SawickiPT . A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA1999;281(2):145-50. ">Sawicki 1999</a>), three blinded healthcare providers (<a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>; <a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a>; <a href="./references#CD003839-bbs2-0019" title="RasmussenRS , CorellP , MadsenP , OvergaardK . Effects of computer-assisted oral anticoagulant therapy. Thrombosis Journal2012;10(1):17. ">Rasmussen 2012</a>), and six trials blinded outcome assessors (<a href="./references#CD003839-bbs2-0005" title="CromheeckeME , LeviM , CollyLP , deMolBJ , PrinsMH , HuttenBA , et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet2000;356(9224):97-102. ">Cromheecke 2000</a>; <a href="./references#CD003839-bbs2-0006" title="DignanR , KeechAC , GebskiVJ , MannKP , HughesCF , Warfarin SMART Investigators. Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial. International Journal of Cardiology2013;168(6):5378-84. ">Dignan 2013</a>; <a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a>; <a href="./references#CD003839-bbs2-0012" title="GrunauBE , WiensMO , HarderKK . Patient self-management of warfarin therapy: pragmatic feasibility study in Canadian primary care. Canadian Family Physician Medecin de Famille Canadien2011;57(8):e292-8. ">Grunau 2011</a>; <a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>; <a href="./references#CD003839-bbs2-0023" title="SiebenhoferA , HemkensLG , RakovacI , SpatS , DidjurgeitU , SPOG 60+ Study Group. Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thrombosis Research2012;130:e60-e6. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thrombosis and Haemostasis2007;97(3):408-16. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thrombosis &amp; Haemostasis2008;100(6):1089-98. ">Siebenhofer 2007</a>) (see <a href="#CD003839-fig-0004">Figure 4</a> and <a href="#CD003839-fig-0005">Figure 5</a>). </p> </section> <section id="CD003839-sec-0038"> <h4 class="title">Follow‐up</h4> <p>Of those assigned to the intervention, 25% (range 0% to 57%) stopped self‐monitoring or self‐management by the end of the trial. Nine trials used an intention‐to‐treat analysis (<a href="./references#CD003839-bbs2-0002" title="BeythRJ , QuinnL , LandefeldCS . A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Annals of Internal Medicine2000;133(9):687-95. ">Beyth 2000</a>; <a href="./references#CD003839-bbs2-0006" title="DignanR , KeechAC , GebskiVJ , MannKP , HughesCF , Warfarin SMART Investigators. Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial. International Journal of Cardiology2013;168(6):5378-84. ">Dignan 2013</a>; <a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a>; <a href="./references#CD003839-bbs2-0012" title="GrunauBE , WiensMO , HarderKK . Patient self-management of warfarin therapy: pragmatic feasibility study in Canadian primary care. Canadian Family Physician Medecin de Famille Canadien2011;57(8):e292-8. ">Grunau 2011</a>; <a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a>; <a href="./references#CD003839-bbs2-0017" title="MatcharDB , DolorR , JacobsonA , LoveS , EdsonR , UyedaL . More frequent self-testing of prothrombin time results in improved time in target range. Circulation2012;126:21 Suppl. MatcharDB , JacobsonA , DolorR , EdsonR , UyedaL , PhibbsCS , et al, THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. New England Journal of Medicine2010;363(17):1608-20. ">Matchar 2010</a>; <a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>; <a href="./references#CD003839-bbs2-0021" title="SawickiPT , GlaserB , KleespiesC , StubbeJ , SchmitzN , KaiserT , et al. Long-term results of patients' self-management of oral anticoagulation. Journal of Clinical &amp; Basic Cardiology2003;6(1-4):59-62. SawickiPT . A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA1999;281(2):145-50. ">Sawicki 1999</a>; <a href="./references#CD003839-bbs2-0025" title="SunderjiR , CampbellL , ShalanskyK , FungA , CarterC , GinK . Outpatient self-management of warfarin therapy: A pilot study. Pharmacotherapy1999;19(6):787-93. SunderjiR , GinK , ShalanskyK , CarterC , ChambersK , DaviesC , et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Canadian Journal of Cardiology2004;20(11):1117-23. ">Sunderji 2004</a>). All included studies described appropriate participant follow‐up (see <a href="#CD003839-fig-0004">Figure 4</a> and <a href="#CD003839-fig-0005">Figure 5</a>). </p> </section> <section id="CD003839-sec-0039"> <h4 class="title">Financial support</h4> <p>Eight studies (<a href="./references#CD003839-bbs2-0002" title="BeythRJ , QuinnL , LandefeldCS . A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Annals of Internal Medicine2000;133(9):687-95. ">Beyth 2000</a>; <a href="./references#CD003839-bbs2-0005" title="CromheeckeME , LeviM , CollyLP , deMolBJ , PrinsMH , HuttenBA , et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet2000;356(9224):97-102. ">Cromheecke 2000</a>; <a href="./references#CD003839-bbs2-0012" title="GrunauBE , WiensMO , HarderKK . Patient self-management of warfarin therapy: pragmatic feasibility study in Canadian primary care. Canadian Family Physician Medecin de Famille Canadien2011;57(8):e292-8. ">Grunau 2011</a>; <a href="./references#CD003839-bbs2-0013" title="HorstkotteD , PiperC , WiemerM . Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. Journal of Thrombosis and Thrombolysis1998;5 Suppl 1(3):19-24. ">Horstkotte 1998</a>; <a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a>; <a href="./references#CD003839-bbs2-0016" title="EitzT , SchenkS , FritzscheD , BairaktarisA , WagnerO , KoertkeH , et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Annals of Thoracic Surgery2008;85(3):949-54. KörtkeH , KörferR . International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?Annals of Thoracic Surgery2001;72(1):44-8. KörtkeH , MinamiK , BreymannT , SeifertD , BaraktarisA , WagnerO , et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Zeitschrift fur Kardiologie2001;90 Suppl:6118-24. KoertkeH , MinamiK , BairaktarisA , WagnerO , KoerferR . INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis2000;9 Suppl 1:41-5. KoertkeH , MinamiK , BoethigD , BreymannTH , SeifertD , WagnerO , et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation2003;108(10 Suppl 1):II-75-II-78. KoertkeH , ZittermannA , MinamiK , TenderichG , WagnerO , El-ArousyM , et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Annals of Thoracic Surgery2005;79(6):1909-14. KoertkeH , ZittermannA , TenderichG , WagnerO , El-ArousyM , KrianA , et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. European Heart Journal2007;28(20):2479-84. KoertkeH , ZittermannA , WagnerO , EnnkerJ , SaggauW , SackFU , et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2010;90(5):1487-93. KoertkeH , ZittermannA , WagnerO , KoerferR . Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2007;83(1):24-9. ">Körtke 2001</a>; <a href="./references#CD003839-bbs2-0024" title="Soliman HamadMA , vanEekelenE , vanAgtT , vanStratenAH . Self-management program improves anticoagulation control and quality of life: a prospective randomized study. European Journal of Cardiothoracic Surgery2009;35(2):265-9. ">Soliman Hamad 2009</a>; <a href="./references#CD003839-bbs2-0026" title="ThompsonJL , BurkhartHM , DalyRC , DearaniJA , JoyceLD , SuriRM , et al. Anticoagulation early after mechanical valve replacement: improved management with patient self-testing. Journal of Thoracic and Cardiovascular Surgery2013;146:599-604. ">Thompson 2013</a>) did not describe financial support. Six studies were supported by grants from professional associations or national agencies (<a href="./references#CD003839-bbs2-0003" title="ChristensenTD , MaegaardM , SørensenHT , HjortdalVE , HasenkamJM . Self-management versus conventional management of oral anticoagulant therapy: A randomized, controlled trial. European Journal of Internal Medicine2006;17(4):260-6. ">Christensen 2006</a>; <a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a>; <a href="./references#CD003839-bbs2-0015" title="KhanTI , KamaliF , KestevenP , AveryP , WynneH . The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology2004;126(4):557-64. ">Khan 2004</a>; <a href="./references#CD003839-bbs2-0017" title="MatcharDB , DolorR , JacobsonA , LoveS , EdsonR , UyedaL . More frequent self-testing of prothrombin time results in improved time in target range. Circulation2012;126:21 Suppl. MatcharDB , JacobsonA , DolorR , EdsonR , UyedaL , PhibbsCS , et al, THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. New England Journal of Medicine2010;363(17):1608-20. ">Matchar 2010</a>; <a href="./references#CD003839-bbs2-0025" title="SunderjiR , CampbellL , ShalanskyK , FungA , CarterC , GinK . Outpatient self-management of warfarin therapy: A pilot study. Pharmacotherapy1999;19(6):787-93. SunderjiR , GinK , ShalanskyK , CarterC , ChambersK , DaviesC , et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Canadian Journal of Cardiology2004;20(11):1117-23. ">Sunderji 2004</a>; <a href="./references#CD003839-bbs2-0029" title="WhiteRH , McCurdySA , vonMarensdorffH , Woodruff DE Jr, LeftgoffL . Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Annals of Internal Medicine1989;111(9):730-7. ">White 1989</a>). Twelve studies (<a href="./references#CD003839-bbs2-0001" title="AzarnoushK , CamilleriL , Aublet-CuvelierB , GeoffroyE , DauphinC , DubrayC , et al. Results of the first randomized French study evaluating self-testing of the International Normalized Ratio. Journal of Heart Valve Disease2011;20(5):518-25. DauphinC , LegaultB , JaffeuxP , MotreffP , AzarnoushK , JolyH , et al. Comparison of INR stability between self-monitoring and standard laboratory method: preliminary results of a prospective study in 67 mechanical heart valve patients. Archives of Cardiovascular Diseases2008;101(11-12):753-61. ">Azarnoush 2009</a>; <a href="./references#CD003839-bbs2-0007" title="FitzmauriceDA , MurrayET , GeeKM , AllanTF , HobbsFD . A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology2002;55(11):845-9. McCahonD , MurrayET , MurrayK , HolderRL , FitzmauriceDA . Does self-management of oral anticoagulation therapy improve quality of life and anxiety?Family Practice2011;28(2):134-40. ">Fitzmaurice 2002</a>; <a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>; <a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a>; <a href="./references#CD003839-bbs2-0011" title="GardinerC , WilliamsK , LongairI , MackieIJ , MachinSJ , CohenH . A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing.. British Journal of Haematolgy2006;132(5):598-603. GardinerC , WilliamsK , MackieIJ , MachinSJ , CohenH . Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. British Journal of Haematology2005;128(2):242-7. ">Gardiner 2005</a>; <a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>; <a href="./references#CD003839-bbs2-0020" title="RyanF , ByrneS , O'SheaS . Randomized controlled trial of supervised patient self-testing of warfarin therapy using an internet-based expert system. Journal of Thrombosis and Haemostasis : JTH2007;7(8):1284-90. ">Ryan 2009</a>; <a href="./references#CD003839-bbs2-0021" title="SawickiPT , GlaserB , KleespiesC , StubbeJ , SchmitzN , KaiserT , et al. Long-term results of patients' self-management of oral anticoagulation. Journal of Clinical &amp; Basic Cardiology2003;6(1-4):59-62. SawickiPT . A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA1999;281(2):145-50. ">Sawicki 1999</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0023" title="SiebenhoferA , HemkensLG , RakovacI , SpatS , DidjurgeitU , SPOG 60+ Study Group. Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thrombosis Research2012;130:e60-e6. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thrombosis and Haemostasis2007;97(3):408-16. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thrombosis &amp; Haemostasis2008;100(6):1089-98. ">Siebenhofer 2007</a>; <a href="./references#CD003839-bbs2-0027" title="VerretL , CouturierJ , RozonA , Saudrais-JanecekS , St-OngeA , NguyenA , et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy2012;32(10):871-9. ">Verret 2012</a>; <a href="./references#CD003839-bbs2-0028" title="VöllerH , GlatzJ , TaborskiU , BernardoA , DovifatC , HeidingerK . Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Zeitschrift fur Kardiologie2005;94(3):182-6. ">Voller 2005</a>) were part funded by an unrestricted research grant from industry or received the coagulometer and strips for utilisation during the study. One study was funded by a private hospital (<a href="./references#CD003839-bbs2-0004" title="ChristensenH , LauterleinJJ , SørensenPD , PetersenERB , MadsenJS , BrandslundI . Home management of oral anticoagulation via telemedicine versus conventional hospital-based treatment. Telemedicine and e-Health2011;17(3):169-76. ">Christensen 2011</a>); and two by a combination of government and private agencies (<a href="./references#CD003839-bbs2-0006" title="DignanR , KeechAC , GebskiVJ , MannKP , HughesCF , Warfarin SMART Investigators. Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial. International Journal of Cardiology2013;168(6):5378-84. ">Dignan 2013</a>; <a href="./references#CD003839-bbs2-0019" title="RasmussenRS , CorellP , MadsenP , OvergaardK . Effects of computer-assisted oral anticoagulant therapy. Thrombosis Journal2012;10(1):17. ">Rasmussen 2012</a>). </p> </section> </section> <section id="CD003839-sec-0040"> <h3 class="title" id="CD003839-sec-0040">Effects of interventions</h3> <p>See: <a href="./full#CD003839-tbl-0001"><b>Summary of findings 1</b> Self‐monitoring or self‐management of oral anticoagulation vs. standard care</a>; <a href="./full#CD003839-tbl-0002"><b>Summary of findings 2</b> Self‐monitoring of oral anticoagulation vs. standard care</a>; <a href="./full#CD003839-tbl-0003"><b>Summary of findings 3</b> self‐management of oral anticoagulation vs. standard care</a> </p> <section id="CD003839-sec-0041"> <h4 class="title">Primary endpoints</h4> <section id="CD003839-sec-0042"> <h5 class="title">Thromboembolic events</h5> <p>Twenty‐six trials reported thromboembolic outcomes; however, eight trials showed no events in either the intervention or control arm (<a href="./references#CD003839-bbs2-0003" title="ChristensenTD , MaegaardM , SørensenHT , HjortdalVE , HasenkamJM . Self-management versus conventional management of oral anticoagulant therapy: A randomized, controlled trial. European Journal of Internal Medicine2006;17(4):260-6. ">Christensen 2006</a>; <a href="./references#CD003839-bbs2-0006" title="DignanR , KeechAC , GebskiVJ , MannKP , HughesCF , Warfarin SMART Investigators. Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial. International Journal of Cardiology2013;168(6):5378-84. ">Dignan 2013</a>; <a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>; <a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a>; <a href="./references#CD003839-bbs2-0011" title="GardinerC , WilliamsK , LongairI , MackieIJ , MachinSJ , CohenH . A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing.. British Journal of Haematolgy2006;132(5):598-603. GardinerC , WilliamsK , MackieIJ , MachinSJ , CohenH . Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. British Journal of Haematology2005;128(2):242-7. ">Gardiner 2005</a>; <a href="./references#CD003839-bbs2-0012" title="GrunauBE , WiensMO , HarderKK . Patient self-management of warfarin therapy: pragmatic feasibility study in Canadian primary care. Canadian Family Physician Medecin de Famille Canadien2011;57(8):e292-8. ">Grunau 2011</a>; <a href="./references#CD003839-bbs2-0015" title="KhanTI , KamaliF , KestevenP , AveryP , WynneH . The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology2004;126(4):557-64. ">Khan 2004</a>; <a href="./references#CD003839-bbs2-0027" title="VerretL , CouturierJ , RozonA , Saudrais-JanecekS , St-OngeA , NguyenA , et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy2012;32(10):871-9. ">Verret 2012</a>), and were therefore not included in the pooled analysis (chapter 16.9.3, <a href="./references#CD003839-bbs2-0089" title="HigginsJPT , DeeksJJ , Altman DG (editors). Chapter 16: Special topics in statistics. In: HigginsJPT , GreenS , editors(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). Eighteen trials provided the information to calculate the overall effect size (<a href="./references#CD003839-bbs2-0001" title="AzarnoushK , CamilleriL , Aublet-CuvelierB , GeoffroyE , DauphinC , DubrayC , et al. Results of the first randomized French study evaluating self-testing of the International Normalized Ratio. Journal of Heart Valve Disease2011;20(5):518-25. DauphinC , LegaultB , JaffeuxP , MotreffP , AzarnoushK , JolyH , et al. Comparison of INR stability between self-monitoring and standard laboratory method: preliminary results of a prospective study in 67 mechanical heart valve patients. Archives of Cardiovascular Diseases2008;101(11-12):753-61. ">Azarnoush 2009</a>; <a href="./references#CD003839-bbs2-0002" title="BeythRJ , QuinnL , LandefeldCS . A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Annals of Internal Medicine2000;133(9):687-95. ">Beyth 2000</a>; <a href="./references#CD003839-bbs2-0005" title="CromheeckeME , LeviM , CollyLP , deMolBJ , PrinsMH , HuttenBA , et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet2000;356(9224):97-102. ">Cromheecke 2000</a>; <a href="./references#CD003839-bbs2-0006" title="DignanR , KeechAC , GebskiVJ , MannKP , HughesCF , Warfarin SMART Investigators. Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial. International Journal of Cardiology2013;168(6):5378-84. ">Dignan 2013</a>; <a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a>; <a href="./references#CD003839-bbs2-0013" title="HorstkotteD , PiperC , WiemerM . Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. Journal of Thrombosis and Thrombolysis1998;5 Suppl 1(3):19-24. ">Horstkotte 1998</a>; <a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a>; <a href="./references#CD003839-bbs2-0016" title="EitzT , SchenkS , FritzscheD , BairaktarisA , WagnerO , KoertkeH , et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Annals of Thoracic Surgery2008;85(3):949-54. KörtkeH , KörferR . International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?Annals of Thoracic Surgery2001;72(1):44-8. KörtkeH , MinamiK , BreymannT , SeifertD , BaraktarisA , WagnerO , et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Zeitschrift fur Kardiologie2001;90 Suppl:6118-24. KoertkeH , MinamiK , BairaktarisA , WagnerO , KoerferR . INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis2000;9 Suppl 1:41-5. KoertkeH , MinamiK , BoethigD , BreymannTH , SeifertD , WagnerO , et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation2003;108(10 Suppl 1):II-75-II-78. KoertkeH , ZittermannA , MinamiK , TenderichG , WagnerO , El-ArousyM , et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Annals of Thoracic Surgery2005;79(6):1909-14. KoertkeH , ZittermannA , TenderichG , WagnerO , El-ArousyM , KrianA , et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. European Heart Journal2007;28(20):2479-84. KoertkeH , ZittermannA , WagnerO , EnnkerJ , SaggauW , SackFU , et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2010;90(5):1487-93. KoertkeH , ZittermannA , WagnerO , KoerferR . Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2007;83(1):24-9. ">Körtke 2001</a>; <a href="./references#CD003839-bbs2-0017" title="MatcharDB , DolorR , JacobsonA , LoveS , EdsonR , UyedaL . More frequent self-testing of prothrombin time results in improved time in target range. Circulation2012;126:21 Suppl. MatcharDB , JacobsonA , DolorR , EdsonR , UyedaL , PhibbsCS , et al, THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. New England Journal of Medicine2010;363(17):1608-20. ">Matchar 2010</a>; <a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>; <a href="./references#CD003839-bbs2-0020" title="RyanF , ByrneS , O'SheaS . Randomized controlled trial of supervised patient self-testing of warfarin therapy using an internet-based expert system. Journal of Thrombosis and Haemostasis : JTH2007;7(8):1284-90. ">Ryan 2009</a>; <a href="./references#CD003839-bbs2-0021" title="SawickiPT , GlaserB , KleespiesC , StubbeJ , SchmitzN , KaiserT , et al. Long-term results of patients' self-management of oral anticoagulation. Journal of Clinical &amp; Basic Cardiology2003;6(1-4):59-62. SawickiPT . A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA1999;281(2):145-50. ">Sawicki 1999</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0023" title="SiebenhoferA , HemkensLG , RakovacI , SpatS , DidjurgeitU , SPOG 60+ Study Group. Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thrombosis Research2012;130:e60-e6. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thrombosis and Haemostasis2007;97(3):408-16. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thrombosis &amp; Haemostasis2008;100(6):1089-98. ">Siebenhofer 2007</a>; <a href="./references#CD003839-bbs2-0024" title="Soliman HamadMA , vanEekelenE , vanAgtT , vanStratenAH . Self-management program improves anticoagulation control and quality of life: a prospective randomized study. European Journal of Cardiothoracic Surgery2009;35(2):265-9. ">Soliman Hamad 2009</a>; <a href="./references#CD003839-bbs2-0025" title="SunderjiR , CampbellL , ShalanskyK , FungA , CarterC , GinK . Outpatient self-management of warfarin therapy: A pilot study. Pharmacotherapy1999;19(6):787-93. SunderjiR , GinK , ShalanskyK , CarterC , ChambersK , DaviesC , et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Canadian Journal of Cardiology2004;20(11):1117-23. ">Sunderji 2004</a>; <a href="./references#CD003839-bbs2-0028" title="VöllerH , GlatzJ , TaborskiU , BernardoA , DovifatC , HeidingerK . Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Zeitschrift fur Kardiologie2005;94(3):182-6. ">Voller 2005</a>; <a href="./references#CD003839-bbs2-0029" title="WhiteRH , McCurdySA , vonMarensdorffH , Woodruff DE Jr, LeftgoffL . Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Annals of Internal Medicine1989;111(9):730-7. ">White 1989</a>). </p> <p>Compared to standard therapy, self‐monitoring or self‐management reduced thromboembolic events (risk ratio (RR) 0.58, 95% confidence interval (CI) 0.45 to 0.75; participants = 7594; studies = 18) (<a href="./references#CD003839-fig-0006" title="">Analysis 1.1</a>). The overall quality of evidence was downgraded from high to moderate because of serious risk of bias (<a href="./full#CD003839-tbl-0001">summary of findings Table 1</a>). The findings were not affected by the removal of the five trials deemed to have high risk of bias (RR 0.50, 95% CI 0.36 to 0.69; participants = 4558; studies = 13) (<a href="./references#CD003839-fig-0008" title="">Analysis 1.3</a>). </p> <p>In those groups that self‐managed (<a href="./references#CD003839-bbs2-0005" title="CromheeckeME , LeviM , CollyLP , deMolBJ , PrinsMH , HuttenBA , et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet2000;356(9224):97-102. ">Cromheecke 2000</a>; <a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a>; <a href="./references#CD003839-bbs2-0016" title="EitzT , SchenkS , FritzscheD , BairaktarisA , WagnerO , KoertkeH , et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Annals of Thoracic Surgery2008;85(3):949-54. KörtkeH , KörferR . International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?Annals of Thoracic Surgery2001;72(1):44-8. KörtkeH , MinamiK , BreymannT , SeifertD , BaraktarisA , WagnerO , et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Zeitschrift fur Kardiologie2001;90 Suppl:6118-24. KoertkeH , MinamiK , BairaktarisA , WagnerO , KoerferR . INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis2000;9 Suppl 1:41-5. KoertkeH , MinamiK , BoethigD , BreymannTH , SeifertD , WagnerO , et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation2003;108(10 Suppl 1):II-75-II-78. KoertkeH , ZittermannA , MinamiK , TenderichG , WagnerO , El-ArousyM , et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Annals of Thoracic Surgery2005;79(6):1909-14. KoertkeH , ZittermannA , TenderichG , WagnerO , El-ArousyM , KrianA , et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. European Heart Journal2007;28(20):2479-84. KoertkeH , ZittermannA , WagnerO , EnnkerJ , SaggauW , SackFU , et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2010;90(5):1487-93. KoertkeH , ZittermannA , WagnerO , KoerferR . Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2007;83(1):24-9. ">Körtke 2001</a>; <a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>; <a href="./references#CD003839-bbs2-0021" title="SawickiPT , GlaserB , KleespiesC , StubbeJ , SchmitzN , KaiserT , et al. Long-term results of patients' self-management of oral anticoagulation. Journal of Clinical &amp; Basic Cardiology2003;6(1-4):59-62. SawickiPT . A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA1999;281(2):145-50. ">Sawicki 1999</a>; <a href="./references#CD003839-bbs2-0024" title="Soliman HamadMA , vanEekelenE , vanAgtT , vanStratenAH . Self-management program improves anticoagulation control and quality of life: a prospective randomized study. European Journal of Cardiothoracic Surgery2009;35(2):265-9. ">Soliman Hamad 2009</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0023" title="SiebenhoferA , HemkensLG , RakovacI , SpatS , DidjurgeitU , SPOG 60+ Study Group. Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thrombosis Research2012;130:e60-e6. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thrombosis and Haemostasis2007;97(3):408-16. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thrombosis &amp; Haemostasis2008;100(6):1089-98. ">Siebenhofer 2007</a>; <a href="./references#CD003839-bbs2-0025" title="SunderjiR , CampbellL , ShalanskyK , FungA , CarterC , GinK . Outpatient self-management of warfarin therapy: A pilot study. Pharmacotherapy1999;19(6):787-93. SunderjiR , GinK , ShalanskyK , CarterC , ChambersK , DaviesC , et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Canadian Journal of Cardiology2004;20(11):1117-23. ">Sunderji 2004</a>; <a href="./references#CD003839-bbs2-0027" title="VerretL , CouturierJ , RozonA , Saudrais-JanecekS , St-OngeA , NguyenA , et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy2012;32(10):871-9. ">Verret 2012</a>; <a href="./references#CD003839-bbs2-0028" title="VöllerH , GlatzJ , TaborskiU , BernardoA , DovifatC , HeidingerK . Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Zeitschrift fur Kardiologie2005;94(3):182-6. ">Voller 2005</a>), the effect was larger (RR 0.47, 95% CI 0.31 to 0.70; participants = 3497; studies = 11; <a href="./full#CD003839-tbl-0003">summary of findings Table 3</a>) than in the groups that self‐monitored (RR 0.69, 95% CI 0.49 to 0.97; participants = 4097; studies = 7); <a href="./full#CD003839-tbl-0002">summary of findings Table 2</a>) (<a href="./references#CD003839-bbs2-0001" title="AzarnoushK , CamilleriL , Aublet-CuvelierB , GeoffroyE , DauphinC , DubrayC , et al. Results of the first randomized French study evaluating self-testing of the International Normalized Ratio. Journal of Heart Valve Disease2011;20(5):518-25. DauphinC , LegaultB , JaffeuxP , MotreffP , AzarnoushK , JolyH , et al. Comparison of INR stability between self-monitoring and standard laboratory method: preliminary results of a prospective study in 67 mechanical heart valve patients. Archives of Cardiovascular Diseases2008;101(11-12):753-61. ">Azarnoush 2009</a>; <a href="./references#CD003839-bbs2-0002" title="BeythRJ , QuinnL , LandefeldCS . A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Annals of Internal Medicine2000;133(9):687-95. ">Beyth 2000</a>; <a href="./references#CD003839-bbs2-0013" title="HorstkotteD , PiperC , WiemerM . Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. Journal of Thrombosis and Thrombolysis1998;5 Suppl 1(3):19-24. ">Horstkotte 1998</a>; <a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a>; <a href="./references#CD003839-bbs2-0017" title="MatcharDB , DolorR , JacobsonA , LoveS , EdsonR , UyedaL . More frequent self-testing of prothrombin time results in improved time in target range. Circulation2012;126:21 Suppl. MatcharDB , JacobsonA , DolorR , EdsonR , UyedaL , PhibbsCS , et al, THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. New England Journal of Medicine2010;363(17):1608-20. ">Matchar 2010</a>; <a href="./references#CD003839-bbs2-0020" title="RyanF , ByrneS , O'SheaS . Randomized controlled trial of supervised patient self-testing of warfarin therapy using an internet-based expert system. Journal of Thrombosis and Haemostasis : JTH2007;7(8):1284-90. ">Ryan 2009</a>; <a href="./references#CD003839-bbs2-0029" title="WhiteRH , McCurdySA , vonMarensdorffH , Woodruff DE Jr, LeftgoffL . Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Annals of Internal Medicine1989;111(9):730-7. ">White 1989</a>). In either group, the quality of the evidence was downgraded from high to moderate because of serious risk of bias. However, the subgroup interaction was non‐significant (P = 0.66). </p> <p>Compared to standard therapy, self‐monitoring or self‐management in patients with mechanical valves (<a href="./references#CD003839-bbs2-0001" title="AzarnoushK , CamilleriL , Aublet-CuvelierB , GeoffroyE , DauphinC , DubrayC , et al. Results of the first randomized French study evaluating self-testing of the International Normalized Ratio. Journal of Heart Valve Disease2011;20(5):518-25. DauphinC , LegaultB , JaffeuxP , MotreffP , AzarnoushK , JolyH , et al. Comparison of INR stability between self-monitoring and standard laboratory method: preliminary results of a prospective study in 67 mechanical heart valve patients. Archives of Cardiovascular Diseases2008;101(11-12):753-61. ">Azarnoush 2009</a>; <a href="./references#CD003839-bbs2-0013" title="HorstkotteD , PiperC , WiemerM . Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. Journal of Thrombosis and Thrombolysis1998;5 Suppl 1(3):19-24. ">Horstkotte 1998</a>; <a href="./references#CD003839-bbs2-0016" title="EitzT , SchenkS , FritzscheD , BairaktarisA , WagnerO , KoertkeH , et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Annals of Thoracic Surgery2008;85(3):949-54. KörtkeH , KörferR . International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?Annals of Thoracic Surgery2001;72(1):44-8. KörtkeH , MinamiK , BreymannT , SeifertD , BaraktarisA , WagnerO , et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Zeitschrift fur Kardiologie2001;90 Suppl:6118-24. KoertkeH , MinamiK , BairaktarisA , WagnerO , KoerferR . INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis2000;9 Suppl 1:41-5. KoertkeH , MinamiK , BoethigD , BreymannTH , SeifertD , WagnerO , et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation2003;108(10 Suppl 1):II-75-II-78. KoertkeH , ZittermannA , MinamiK , TenderichG , WagnerO , El-ArousyM , et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Annals of Thoracic Surgery2005;79(6):1909-14. KoertkeH , ZittermannA , TenderichG , WagnerO , El-ArousyM , KrianA , et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. European Heart Journal2007;28(20):2479-84. KoertkeH , ZittermannA , WagnerO , EnnkerJ , SaggauW , SackFU , et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2010;90(5):1487-93. KoertkeH , ZittermannA , WagnerO , KoerferR . Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2007;83(1):24-9. ">Körtke 2001</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0024" title="Soliman HamadMA , vanEekelenE , vanAgtT , vanStratenAH . Self-management program improves anticoagulation control and quality of life: a prospective randomized study. European Journal of Cardiothoracic Surgery2009;35(2):265-9. ">Soliman Hamad 2009</a>; <a href="./references#CD003839-bbs2-0026" title="ThompsonJL , BurkhartHM , DalyRC , DearaniJA , JoyceLD , SuriRM , et al. Anticoagulation early after mechanical valve replacement: improved management with patient self-testing. Journal of Thoracic and Cardiovascular Surgery2013;146:599-604. ">Thompson 2013</a>) resulted in a significant effect on thromboembolic events (RR 0.53, 95% CI 0.32 to 0.90; participants = 1816; studies = 6) (<a href="./references#CD003839-fig-0007" title="">Analysis 1.2</a>). The post‐hoc subgroup analysis for specialised care (RR 0.63, 95% CI 0.44 to 0.90; participants = 4947; studies = 8) and family physician care (RR 0.56, 95% CI 0.38 to 0.84; participants = 2397; studies = 8) (<a href="./references#CD003839-fig-0009" title="">Analysis 1.4</a>) showed both to be significant (subgroup interaction P = 0.33). </p> </section> <section id="CD003839-sec-0043"> <h5 class="title">All‐cause mortality</h5> <p>Twenty‐two trials reported information on mortality; 11 trials did not report any deaths in the intervention and control groups and are therefore excluded form the pooled analysis (<a href="./references#CD003839-bbs2-0001" title="AzarnoushK , CamilleriL , Aublet-CuvelierB , GeoffroyE , DauphinC , DubrayC , et al. Results of the first randomized French study evaluating self-testing of the International Normalized Ratio. Journal of Heart Valve Disease2011;20(5):518-25. DauphinC , LegaultB , JaffeuxP , MotreffP , AzarnoushK , JolyH , et al. Comparison of INR stability between self-monitoring and standard laboratory method: preliminary results of a prospective study in 67 mechanical heart valve patients. Archives of Cardiovascular Diseases2008;101(11-12):753-61. ">Azarnoush 2009</a>; <a href="./references#CD003839-bbs2-0003" title="ChristensenTD , MaegaardM , SørensenHT , HjortdalVE , HasenkamJM . Self-management versus conventional management of oral anticoagulant therapy: A randomized, controlled trial. European Journal of Internal Medicine2006;17(4):260-6. ">Christensen 2006</a>; <a href="./references#CD003839-bbs2-0004" title="ChristensenH , LauterleinJJ , SørensenPD , PetersenERB , MadsenJS , BrandslundI . Home management of oral anticoagulation via telemedicine versus conventional hospital-based treatment. Telemedicine and e-Health2011;17(3):169-76. ">Christensen 2011</a>; <a href="./references#CD003839-bbs2-0006" title="DignanR , KeechAC , GebskiVJ , MannKP , HughesCF , Warfarin SMART Investigators. Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial. International Journal of Cardiology2013;168(6):5378-84. ">Dignan 2013</a>; <a href="./references#CD003839-bbs2-0013" title="HorstkotteD , PiperC , WiemerM . Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. Journal of Thrombosis and Thrombolysis1998;5 Suppl 1(3):19-24. ">Horstkotte 1998</a>; <a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a>; <a href="./references#CD003839-bbs2-0015" title="KhanTI , KamaliF , KestevenP , AveryP , WynneH . The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology2004;126(4):557-64. ">Khan 2004</a>; <a href="./references#CD003839-bbs2-0025" title="SunderjiR , CampbellL , ShalanskyK , FungA , CarterC , GinK . Outpatient self-management of warfarin therapy: A pilot study. Pharmacotherapy1999;19(6):787-93. SunderjiR , GinK , ShalanskyK , CarterC , ChambersK , DaviesC , et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Canadian Journal of Cardiology2004;20(11):1117-23. ">Sunderji 2004</a>; <a href="./references#CD003839-bbs2-0027" title="VerretL , CouturierJ , RozonA , Saudrais-JanecekS , St-OngeA , NguyenA , et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy2012;32(10):871-9. ">Verret 2012</a>; <a href="./references#CD003839-bbs2-0028" title="VöllerH , GlatzJ , TaborskiU , BernardoA , DovifatC , HeidingerK . Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Zeitschrift fur Kardiologie2005;94(3):182-6. ">Voller 2005</a>; <a href="./references#CD003839-bbs2-0029" title="WhiteRH , McCurdySA , vonMarensdorffH , Woodruff DE Jr, LeftgoffL . Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Annals of Internal Medicine1989;111(9):730-7. ">White 1989</a>) (chapter 16.9.3, <a href="./references#CD003839-bbs2-0089" title="HigginsJPT , DeeksJJ , Altman DG (editors). Chapter 16: Special topics in statistics. In: HigginsJPT , GreenS , editors(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). Eleven trials (<a href="./references#CD003839-bbs2-0002" title="BeythRJ , QuinnL , LandefeldCS . A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Annals of Internal Medicine2000;133(9):687-95. ">Beyth 2000</a>; <a href="./references#CD003839-bbs2-0007" title="FitzmauriceDA , MurrayET , GeeKM , AllanTF , HobbsFD . A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology2002;55(11):845-9. McCahonD , MurrayET , MurrayK , HolderRL , FitzmauriceDA . Does self-management of oral anticoagulation therapy improve quality of life and anxiety?Family Practice2011;28(2):134-40. ">Fitzmaurice 2002</a>; <a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a>; <a href="./references#CD003839-bbs2-0011" title="GardinerC , WilliamsK , LongairI , MackieIJ , MachinSJ , CohenH . A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing.. British Journal of Haematolgy2006;132(5):598-603. GardinerC , WilliamsK , MackieIJ , MachinSJ , CohenH . Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. British Journal of Haematology2005;128(2):242-7. ">Gardiner 2005</a>; <a href="./references#CD003839-bbs2-0016" title="EitzT , SchenkS , FritzscheD , BairaktarisA , WagnerO , KoertkeH , et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Annals of Thoracic Surgery2008;85(3):949-54. KörtkeH , KörferR . International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?Annals of Thoracic Surgery2001;72(1):44-8. KörtkeH , MinamiK , BreymannT , SeifertD , BaraktarisA , WagnerO , et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Zeitschrift fur Kardiologie2001;90 Suppl:6118-24. KoertkeH , MinamiK , BairaktarisA , WagnerO , KoerferR . INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis2000;9 Suppl 1:41-5. KoertkeH , MinamiK , BoethigD , BreymannTH , SeifertD , WagnerO , et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation2003;108(10 Suppl 1):II-75-II-78. KoertkeH , ZittermannA , MinamiK , TenderichG , WagnerO , El-ArousyM , et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Annals of Thoracic Surgery2005;79(6):1909-14. KoertkeH , ZittermannA , TenderichG , WagnerO , El-ArousyM , KrianA , et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. European Heart Journal2007;28(20):2479-84. KoertkeH , ZittermannA , WagnerO , EnnkerJ , SaggauW , SackFU , et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2010;90(5):1487-93. KoertkeH , ZittermannA , WagnerO , KoerferR . Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2007;83(1):24-9. ">Körtke 2001</a>; <a href="./references#CD003839-bbs2-0017" title="MatcharDB , DolorR , JacobsonA , LoveS , EdsonR , UyedaL . More frequent self-testing of prothrombin time results in improved time in target range. Circulation2012;126:21 Suppl. MatcharDB , JacobsonA , DolorR , EdsonR , UyedaL , PhibbsCS , et al, THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. New England Journal of Medicine2010;363(17):1608-20. ">Matchar 2010</a>; <a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>; <a href="./references#CD003839-bbs2-0021" title="SawickiPT , GlaserB , KleespiesC , StubbeJ , SchmitzN , KaiserT , et al. Long-term results of patients' self-management of oral anticoagulation. Journal of Clinical &amp; Basic Cardiology2003;6(1-4):59-62. SawickiPT . A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA1999;281(2):145-50. ">Sawicki 1999</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0023" title="SiebenhoferA , HemkensLG , RakovacI , SpatS , DidjurgeitU , SPOG 60+ Study Group. Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thrombosis Research2012;130:e60-e6. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thrombosis and Haemostasis2007;97(3):408-16. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thrombosis &amp; Haemostasis2008;100(6):1089-98. ">Siebenhofer 2007</a>; <a href="./references#CD003839-bbs2-0024" title="Soliman HamadMA , vanEekelenE , vanAgtT , vanStratenAH . Self-management program improves anticoagulation control and quality of life: a prospective randomized study. European Journal of Cardiothoracic Surgery2009;35(2):265-9. ">Soliman Hamad 2009</a>) reported all‐cause mortality events. No reduction in all‐cause mortality was found (RR 0.85, 95% CI 0.71 to 1.01; participants = 6358; studies = 11) (<a href="./references#CD003839-fig-0010" title="">Analysis 2.1</a>). The overall quality of evidence was downgraded from high to moderate because of serious risk of bias (<a href="./full#CD003839-tbl-0001">summary of findings Table 1</a>). Removal of three studies deemed to have high risk of bias resulted in no difference of the effect (RR 0.85, 95% CI 0.71 to 1.02; participants = 6160; studies = 8) (<a href="./references#CD003839-fig-0012" title="">Analysis 2.3</a>). In three studies of participants with mechanical valves (<a href="./references#CD003839-bbs2-0016" title="EitzT , SchenkS , FritzscheD , BairaktarisA , WagnerO , KoertkeH , et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Annals of Thoracic Surgery2008;85(3):949-54. KörtkeH , KörferR . International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?Annals of Thoracic Surgery2001;72(1):44-8. KörtkeH , MinamiK , BreymannT , SeifertD , BaraktarisA , WagnerO , et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Zeitschrift fur Kardiologie2001;90 Suppl:6118-24. KoertkeH , MinamiK , BairaktarisA , WagnerO , KoerferR . INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis2000;9 Suppl 1:41-5. KoertkeH , MinamiK , BoethigD , BreymannTH , SeifertD , WagnerO , et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation2003;108(10 Suppl 1):II-75-II-78. KoertkeH , ZittermannA , MinamiK , TenderichG , WagnerO , El-ArousyM , et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Annals of Thoracic Surgery2005;79(6):1909-14. KoertkeH , ZittermannA , TenderichG , WagnerO , El-ArousyM , KrianA , et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. European Heart Journal2007;28(20):2479-84. KoertkeH , ZittermannA , WagnerO , EnnkerJ , SaggauW , SackFU , et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2010;90(5):1487-93. KoertkeH , ZittermannA , WagnerO , KoerferR . Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2007;83(1):24-9. ">Körtke 2001</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0024" title="Soliman HamadMA , vanEekelenE , vanAgtT , vanStratenAH . Self-management program improves anticoagulation control and quality of life: a prospective randomized study. European Journal of Cardiothoracic Surgery2009;35(2):265-9. ">Soliman Hamad 2009</a>) self‐monitoring or self‐management showed a significant reduction in mortality (RR 0.50, 95% CI 0.29 to 0.86; participants = 1295; studies = 3) (<a href="./references#CD003839-fig-0011" title="">Analysis 2.2</a>). </p> <p>Two studies (<a href="./references#CD003839-bbs2-0015" title="KhanTI , KamaliF , KestevenP , AveryP , WynneH . The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology2004;126(4):557-64. ">Khan 2004</a>; <a href="./references#CD003839-bbs2-0028" title="VöllerH , GlatzJ , TaborskiU , BernardoA , DovifatC , HeidingerK . Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Zeitschrift fur Kardiologie2005;94(3):182-6. ">Voller 2005</a>) reported on participants with atrial fibrillation, no deaths were reported. A reduction in mortality occurred in participants who self‐managed (<a href="./references#CD003839-bbs2-0007" title="FitzmauriceDA , MurrayET , GeeKM , AllanTF , HobbsFD . A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology2002;55(11):845-9. McCahonD , MurrayET , MurrayK , HolderRL , FitzmauriceDA . Does self-management of oral anticoagulation therapy improve quality of life and anxiety?Family Practice2011;28(2):134-40. ">Fitzmaurice 2002</a>; <a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a>; <a href="./references#CD003839-bbs2-0016" title="EitzT , SchenkS , FritzscheD , BairaktarisA , WagnerO , KoertkeH , et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Annals of Thoracic Surgery2008;85(3):949-54. KörtkeH , KörferR . International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?Annals of Thoracic Surgery2001;72(1):44-8. KörtkeH , MinamiK , BreymannT , SeifertD , BaraktarisA , WagnerO , et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Zeitschrift fur Kardiologie2001;90 Suppl:6118-24. KoertkeH , MinamiK , BairaktarisA , WagnerO , KoerferR . INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis2000;9 Suppl 1:41-5. KoertkeH , MinamiK , BoethigD , BreymannTH , SeifertD , WagnerO , et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation2003;108(10 Suppl 1):II-75-II-78. KoertkeH , ZittermannA , MinamiK , TenderichG , WagnerO , El-ArousyM , et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Annals of Thoracic Surgery2005;79(6):1909-14. KoertkeH , ZittermannA , TenderichG , WagnerO , El-ArousyM , KrianA , et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. European Heart Journal2007;28(20):2479-84. KoertkeH , ZittermannA , WagnerO , EnnkerJ , SaggauW , SackFU , et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2010;90(5):1487-93. KoertkeH , ZittermannA , WagnerO , KoerferR . Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2007;83(1):24-9. ">Körtke 2001</a>; <a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>; <a href="./references#CD003839-bbs2-0021" title="SawickiPT , GlaserB , KleespiesC , StubbeJ , SchmitzN , KaiserT , et al. Long-term results of patients' self-management of oral anticoagulation. Journal of Clinical &amp; Basic Cardiology2003;6(1-4):59-62. SawickiPT . A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA1999;281(2):145-50. ">Sawicki 1999</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0023" title="SiebenhoferA , HemkensLG , RakovacI , SpatS , DidjurgeitU , SPOG 60+ Study Group. Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thrombosis Research2012;130:e60-e6. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thrombosis and Haemostasis2007;97(3):408-16. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thrombosis &amp; Haemostasis2008;100(6):1089-98. ">Siebenhofer 2007</a>; <a href="./references#CD003839-bbs2-0024" title="Soliman HamadMA , vanEekelenE , vanAgtT , vanStratenAH . Self-management program improves anticoagulation control and quality of life: a prospective randomized study. European Journal of Cardiothoracic Surgery2009;35(2):265-9. ">Soliman Hamad 2009</a>) compared to standard therapy (RR 0.55, 95% CI 0.36 to 0.84; participants = 3058; studies = 8) (<a href="./references#CD003839-fig-0010" title="">Analysis 2.1</a>). The overall quality of evidence was downgraded from high to moderate because of serious risk of bias (<a href="./full#CD003839-tbl-0003">summary of findings Table 3</a>). No effect was found for the self‐monitoring only trials (<a href="./references#CD003839-bbs2-0002" title="BeythRJ , QuinnL , LandefeldCS . A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Annals of Internal Medicine2000;133(9):687-95. ">Beyth 2000</a>; <a href="./references#CD003839-bbs2-0011" title="GardinerC , WilliamsK , LongairI , MackieIJ , MachinSJ , CohenH . A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing.. British Journal of Haematolgy2006;132(5):598-603. GardinerC , WilliamsK , MackieIJ , MachinSJ , CohenH . Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. British Journal of Haematology2005;128(2):242-7. ">Gardiner 2005</a>; <a href="./references#CD003839-bbs2-0017" title="MatcharDB , DolorR , JacobsonA , LoveS , EdsonR , UyedaL . More frequent self-testing of prothrombin time results in improved time in target range. Circulation2012;126:21 Suppl. MatcharDB , JacobsonA , DolorR , EdsonR , UyedaL , PhibbsCS , et al, THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. New England Journal of Medicine2010;363(17):1608-20. ">Matchar 2010</a>) (RR 0.94, 95% CI 0.78 to 1.15; participants = 3300; studies = 3) (<a href="./references#CD003839-fig-0010" title="">Analysis 2.1</a>); The overall quality of evidence was downgraded from high to moderate because of serious risk of bias (<a href="./full#CD003839-tbl-0002">summary of findings Table 2</a>). The subgroup interaction was significant (P = 0.02). The post‐hoc subgroup analysis for specialised care (RR 0.92, 95% CI 0.75 to 1.13; participants = 4387; studies = 5) and family physician care (RR 0.62, 95% CI 0.43 to 0.90; participants = 1776; studies = 5) (<a href="./references#CD003839-fig-0013" title="">Analysis 2.4</a>) showed only family physician care to be significant; however the subgroup interaction was not significant (P = 0.06). </p> </section> <section id="CD003839-sec-0044"> <h5 class="title">Major haemorrhage</h5> <p>Twenty‐four trials reported major haemorrhage outcomes, four of which did not report any events (<a href="./references#CD003839-bbs2-0003" title="ChristensenTD , MaegaardM , SørensenHT , HjortdalVE , HasenkamJM . Self-management versus conventional management of oral anticoagulant therapy: A randomized, controlled trial. European Journal of Internal Medicine2006;17(4):260-6. ">Christensen 2006</a>; <a href="./references#CD003839-bbs2-0005" title="CromheeckeME , LeviM , CollyLP , deMolBJ , PrinsMH , HuttenBA , et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet2000;356(9224):97-102. ">Cromheecke 2000</a>; <a href="./references#CD003839-bbs2-0011" title="GardinerC , WilliamsK , LongairI , MackieIJ , MachinSJ , CohenH . A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing.. British Journal of Haematolgy2006;132(5):598-603. GardinerC , WilliamsK , MackieIJ , MachinSJ , CohenH . Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. British Journal of Haematology2005;128(2):242-7. ">Gardiner 2005</a>; <a href="./references#CD003839-bbs2-0029" title="WhiteRH , McCurdySA , vonMarensdorffH , Woodruff DE Jr, LeftgoffL . Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Annals of Internal Medicine1989;111(9):730-7. ">White 1989</a>). Twenty trials provided the information to calculate the overall effect size (<a href="./references#CD003839-bbs2-0001" title="AzarnoushK , CamilleriL , Aublet-CuvelierB , GeoffroyE , DauphinC , DubrayC , et al. Results of the first randomized French study evaluating self-testing of the International Normalized Ratio. Journal of Heart Valve Disease2011;20(5):518-25. DauphinC , LegaultB , JaffeuxP , MotreffP , AzarnoushK , JolyH , et al. Comparison of INR stability between self-monitoring and standard laboratory method: preliminary results of a prospective study in 67 mechanical heart valve patients. Archives of Cardiovascular Diseases2008;101(11-12):753-61. ">Azarnoush 2009</a>; <a href="./references#CD003839-bbs2-0002" title="BeythRJ , QuinnL , LandefeldCS . A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Annals of Internal Medicine2000;133(9):687-95. ">Beyth 2000</a>; <a href="./references#CD003839-bbs2-0006" title="DignanR , KeechAC , GebskiVJ , MannKP , HughesCF , Warfarin SMART Investigators. Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial. International Journal of Cardiology2013;168(6):5378-84. ">Dignan 2013</a>; <a href="./references#CD003839-bbs2-0007" title="FitzmauriceDA , MurrayET , GeeKM , AllanTF , HobbsFD . A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology2002;55(11):845-9. McCahonD , MurrayET , MurrayK , HolderRL , FitzmauriceDA . Does self-management of oral anticoagulation therapy improve quality of life and anxiety?Family Practice2011;28(2):134-40. ">Fitzmaurice 2002</a>; <a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a>; <a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>; <a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a>; <a href="./references#CD003839-bbs2-0013" title="HorstkotteD , PiperC , WiemerM . Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. Journal of Thrombosis and Thrombolysis1998;5 Suppl 1(3):19-24. ">Horstkotte 1998</a>; <a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a>; <a href="./references#CD003839-bbs2-0015" title="KhanTI , KamaliF , KestevenP , AveryP , WynneH . The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology2004;126(4):557-64. ">Khan 2004</a>; <a href="./references#CD003839-bbs2-0016" title="EitzT , SchenkS , FritzscheD , BairaktarisA , WagnerO , KoertkeH , et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Annals of Thoracic Surgery2008;85(3):949-54. KörtkeH , KörferR . International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?Annals of Thoracic Surgery2001;72(1):44-8. KörtkeH , MinamiK , BreymannT , SeifertD , BaraktarisA , WagnerO , et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Zeitschrift fur Kardiologie2001;90 Suppl:6118-24. KoertkeH , MinamiK , BairaktarisA , WagnerO , KoerferR . INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis2000;9 Suppl 1:41-5. KoertkeH , MinamiK , BoethigD , BreymannTH , SeifertD , WagnerO , et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation2003;108(10 Suppl 1):II-75-II-78. KoertkeH , ZittermannA , MinamiK , TenderichG , WagnerO , El-ArousyM , et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Annals of Thoracic Surgery2005;79(6):1909-14. KoertkeH , ZittermannA , TenderichG , WagnerO , El-ArousyM , KrianA , et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. European Heart Journal2007;28(20):2479-84. KoertkeH , ZittermannA , WagnerO , EnnkerJ , SaggauW , SackFU , et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2010;90(5):1487-93. KoertkeH , ZittermannA , WagnerO , KoerferR . Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2007;83(1):24-9. ">Körtke 2001</a>; <a href="./references#CD003839-bbs2-0017" title="MatcharDB , DolorR , JacobsonA , LoveS , EdsonR , UyedaL . More frequent self-testing of prothrombin time results in improved time in target range. Circulation2012;126:21 Suppl. MatcharDB , JacobsonA , DolorR , EdsonR , UyedaL , PhibbsCS , et al, THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. New England Journal of Medicine2010;363(17):1608-20. ">Matchar 2010</a>; <a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>; <a href="./references#CD003839-bbs2-0021" title="SawickiPT , GlaserB , KleespiesC , StubbeJ , SchmitzN , KaiserT , et al. Long-term results of patients' self-management of oral anticoagulation. Journal of Clinical &amp; Basic Cardiology2003;6(1-4):59-62. SawickiPT . A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA1999;281(2):145-50. ">Sawicki 1999</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0023" title="SiebenhoferA , HemkensLG , RakovacI , SpatS , DidjurgeitU , SPOG 60+ Study Group. Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thrombosis Research2012;130:e60-e6. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thrombosis and Haemostasis2007;97(3):408-16. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thrombosis &amp; Haemostasis2008;100(6):1089-98. ">Siebenhofer 2007</a>; <a href="./references#CD003839-bbs2-0024" title="Soliman HamadMA , vanEekelenE , vanAgtT , vanStratenAH . Self-management program improves anticoagulation control and quality of life: a prospective randomized study. European Journal of Cardiothoracic Surgery2009;35(2):265-9. ">Soliman Hamad 2009</a>; <a href="./references#CD003839-bbs2-0025" title="SunderjiR , CampbellL , ShalanskyK , FungA , CarterC , GinK . Outpatient self-management of warfarin therapy: A pilot study. Pharmacotherapy1999;19(6):787-93. SunderjiR , GinK , ShalanskyK , CarterC , ChambersK , DaviesC , et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Canadian Journal of Cardiology2004;20(11):1117-23. ">Sunderji 2004</a>; <a href="./references#CD003839-bbs2-0027" title="VerretL , CouturierJ , RozonA , Saudrais-JanecekS , St-OngeA , NguyenA , et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy2012;32(10):871-9. ">Verret 2012</a>; <a href="./references#CD003839-bbs2-0028" title="VöllerH , GlatzJ , TaborskiU , BernardoA , DovifatC , HeidingerK . Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Zeitschrift fur Kardiologie2005;94(3):182-6. ">Voller 2005</a>). Compared to standard therapy, self‐monitoring or self‐management were associated with no reduction in major haemorrhage (RR 0.95, 95% CI 0.80 to 1.12; participants = 8018; studies = 20) (<a href="./references#CD003839-fig-0014" title="">Analysis 3.1</a>). The overall quality of evidence was downgraded from high to moderate because of serious risk of bias (<a href="./full#CD003839-tbl-0001">summary of findings Table 1</a>). After removal of the six studies deemed to have high risk of bias, the result remained similar (RR 0.96, 95% CI 0.81 to 1.14; participants = 7337; studies = 14) (<a href="./references#CD003839-fig-0016" title="">Analysis 3.3</a>). In terms of clinical condition, four studies (<a href="./references#CD003839-bbs2-0013" title="HorstkotteD , PiperC , WiemerM . Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. Journal of Thrombosis and Thrombolysis1998;5 Suppl 1(3):19-24. ">Horstkotte 1998</a>; <a href="./references#CD003839-bbs2-0016" title="EitzT , SchenkS , FritzscheD , BairaktarisA , WagnerO , KoertkeH , et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Annals of Thoracic Surgery2008;85(3):949-54. KörtkeH , KörferR . International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?Annals of Thoracic Surgery2001;72(1):44-8. KörtkeH , MinamiK , BreymannT , SeifertD , BaraktarisA , WagnerO , et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Zeitschrift fur Kardiologie2001;90 Suppl:6118-24. KoertkeH , MinamiK , BairaktarisA , WagnerO , KoerferR . INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis2000;9 Suppl 1:41-5. KoertkeH , MinamiK , BoethigD , BreymannTH , SeifertD , WagnerO , et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation2003;108(10 Suppl 1):II-75-II-78. KoertkeH , ZittermannA , MinamiK , TenderichG , WagnerO , El-ArousyM , et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Annals of Thoracic Surgery2005;79(6):1909-14. KoertkeH , ZittermannA , TenderichG , WagnerO , El-ArousyM , KrianA , et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. European Heart Journal2007;28(20):2479-84. KoertkeH , ZittermannA , WagnerO , EnnkerJ , SaggauW , SackFU , et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2010;90(5):1487-93. KoertkeH , ZittermannA , WagnerO , KoerferR . Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2007;83(1):24-9. ">Körtke 2001</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0024" title="Soliman HamadMA , vanEekelenE , vanAgtT , vanStratenAH . Self-management program improves anticoagulation control and quality of life: a prospective randomized study. European Journal of Cardiothoracic Surgery2009;35(2):265-9. ">Soliman Hamad 2009</a>) included participants with mechanical valves only and two studies (<a href="./references#CD003839-bbs2-0015" title="KhanTI , KamaliF , KestevenP , AveryP , WynneH . The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology2004;126(4):557-64. ">Khan 2004</a>; <a href="./references#CD003839-bbs2-0028" title="VöllerH , GlatzJ , TaborskiU , BernardoA , DovifatC , HeidingerK . Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Zeitschrift fur Kardiologie2005;94(3):182-6. ">Voller 2005</a>) reported on participants with atrial fibrillation. No significant differences were found.The inability to distinguish between the two conditions in the remaining trials meant there was insufficient power to determine significance by clinical condition (<a href="./references#CD003839-fig-0015" title="">Analysis 3.2</a>). </p> <p>In those who self‐monitored (<a href="./references#CD003839-bbs2-0001" title="AzarnoushK , CamilleriL , Aublet-CuvelierB , GeoffroyE , DauphinC , DubrayC , et al. Results of the first randomized French study evaluating self-testing of the International Normalized Ratio. Journal of Heart Valve Disease2011;20(5):518-25. DauphinC , LegaultB , JaffeuxP , MotreffP , AzarnoushK , JolyH , et al. Comparison of INR stability between self-monitoring and standard laboratory method: preliminary results of a prospective study in 67 mechanical heart valve patients. Archives of Cardiovascular Diseases2008;101(11-12):753-61. ">Azarnoush 2009</a>; <a href="./references#CD003839-bbs2-0002" title="BeythRJ , QuinnL , LandefeldCS . A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Annals of Internal Medicine2000;133(9):687-95. ">Beyth 2000</a>; <a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>; <a href="./references#CD003839-bbs2-0013" title="HorstkotteD , PiperC , WiemerM . Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. Journal of Thrombosis and Thrombolysis1998;5 Suppl 1(3):19-24. ">Horstkotte 1998</a>; <a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a>; <a href="./references#CD003839-bbs2-0015" title="KhanTI , KamaliF , KestevenP , AveryP , WynneH . The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology2004;126(4):557-64. ">Khan 2004</a>; <a href="./references#CD003839-bbs2-0017" title="MatcharDB , DolorR , JacobsonA , LoveS , EdsonR , UyedaL . More frequent self-testing of prothrombin time results in improved time in target range. Circulation2012;126:21 Suppl. MatcharDB , JacobsonA , DolorR , EdsonR , UyedaL , PhibbsCS , et al, THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. New England Journal of Medicine2010;363(17):1608-20. ">Matchar 2010</a>), there was no significant reduction in the number of events that occurred compared to standard therapy (RR 0.90, 95% CI 0.74 to 1.09; participants = 4038; studies = 7). The quality of the evidence was downgraded from high to low because of serious risk of bias and strong suspicion of publication bias (<a href="./full#CD003839-tbl-0002">summary of findings Table 2</a>). Self‐management (<a href="./references#CD003839-bbs2-0006" title="DignanR , KeechAC , GebskiVJ , MannKP , HughesCF , Warfarin SMART Investigators. Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial. International Journal of Cardiology2013;168(6):5378-84. ">Dignan 2013</a>; <a href="./references#CD003839-bbs2-0007" title="FitzmauriceDA , MurrayET , GeeKM , AllanTF , HobbsFD . A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology2002;55(11):845-9. McCahonD , MurrayET , MurrayK , HolderRL , FitzmauriceDA . Does self-management of oral anticoagulation therapy improve quality of life and anxiety?Family Practice2011;28(2):134-40. ">Fitzmaurice 2002</a>; <a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a>; <a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a>; <a href="./references#CD003839-bbs2-0016" title="EitzT , SchenkS , FritzscheD , BairaktarisA , WagnerO , KoertkeH , et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Annals of Thoracic Surgery2008;85(3):949-54. KörtkeH , KörferR . International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?Annals of Thoracic Surgery2001;72(1):44-8. KörtkeH , MinamiK , BreymannT , SeifertD , BaraktarisA , WagnerO , et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Zeitschrift fur Kardiologie2001;90 Suppl:6118-24. KoertkeH , MinamiK , BairaktarisA , WagnerO , KoerferR . INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis2000;9 Suppl 1:41-5. KoertkeH , MinamiK , BoethigD , BreymannTH , SeifertD , WagnerO , et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation2003;108(10 Suppl 1):II-75-II-78. KoertkeH , ZittermannA , MinamiK , TenderichG , WagnerO , El-ArousyM , et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Annals of Thoracic Surgery2005;79(6):1909-14. KoertkeH , ZittermannA , TenderichG , WagnerO , El-ArousyM , KrianA , et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. European Heart Journal2007;28(20):2479-84. KoertkeH , ZittermannA , WagnerO , EnnkerJ , SaggauW , SackFU , et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2010;90(5):1487-93. KoertkeH , ZittermannA , WagnerO , KoerferR . Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2007;83(1):24-9. ">Körtke 2001</a>; <a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>; <a href="./references#CD003839-bbs2-0021" title="SawickiPT , GlaserB , KleespiesC , StubbeJ , SchmitzN , KaiserT , et al. Long-term results of patients' self-management of oral anticoagulation. Journal of Clinical &amp; Basic Cardiology2003;6(1-4):59-62. SawickiPT . A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA1999;281(2):145-50. ">Sawicki 1999</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0023" title="SiebenhoferA , HemkensLG , RakovacI , SpatS , DidjurgeitU , SPOG 60+ Study Group. Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thrombosis Research2012;130:e60-e6. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thrombosis and Haemostasis2007;97(3):408-16. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thrombosis &amp; Haemostasis2008;100(6):1089-98. ">Siebenhofer 2007</a>; <a href="./references#CD003839-bbs2-0024" title="Soliman HamadMA , vanEekelenE , vanAgtT , vanStratenAH . Self-management program improves anticoagulation control and quality of life: a prospective randomized study. European Journal of Cardiothoracic Surgery2009;35(2):265-9. ">Soliman Hamad 2009</a>; <a href="./references#CD003839-bbs2-0025" title="SunderjiR , CampbellL , ShalanskyK , FungA , CarterC , GinK . Outpatient self-management of warfarin therapy: A pilot study. Pharmacotherapy1999;19(6):787-93. SunderjiR , GinK , ShalanskyK , CarterC , ChambersK , DaviesC , et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Canadian Journal of Cardiology2004;20(11):1117-23. ">Sunderji 2004</a>; <a href="./references#CD003839-bbs2-0027" title="VerretL , CouturierJ , RozonA , Saudrais-JanecekS , St-OngeA , NguyenA , et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy2012;32(10):871-9. ">Verret 2012</a>; <a href="./references#CD003839-bbs2-0028" title="VöllerH , GlatzJ , TaborskiU , BernardoA , DovifatC , HeidingerK . Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Zeitschrift fur Kardiologie2005;94(3):182-6. ">Voller 2005</a>) was comparable with standard therapy (RR 1.08, 95% CI 0.79 to 1.47; participants = 3980; studies = 13) (<a href="./references#CD003839-fig-0014" title="">Analysis 3.1</a>). The subgroup interaction for this outcome, between the two groups, was not significant (P = 0.32). The quality of the evidence was downgraded from high to low because of serious risk of bias and imprecision of effect estimate (<a href="./full#CD003839-tbl-0003">summary of findings Table 3</a>). The post‐hoc subgroup analysis for specialised care (RR 0.98, 95% CI 0.80 to 1.19; participants = 5054; studies = 9) and family physician care (RR 0.93, 95% CI 0.66 to 1.30; participants = 2267; studies = 8) showed no effect (subgroup interaction P = 0.79). </p> </section> <section id="CD003839-sec-0045"> <h5 class="title">Tests in range</h5> <p>Sixteen trials reported results of mean international normalized ratio (INR) within target range (<a href="./references#CD003839-bbs2-0005" title="CromheeckeME , LeviM , CollyLP , deMolBJ , PrinsMH , HuttenBA , et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet2000;356(9224):97-102. ">Cromheecke 2000</a>; <a href="./references#CD003839-bbs2-0007" title="FitzmauriceDA , MurrayET , GeeKM , AllanTF , HobbsFD . A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology2002;55(11):845-9. McCahonD , MurrayET , MurrayK , HolderRL , FitzmauriceDA . Does self-management of oral anticoagulation therapy improve quality of life and anxiety?Family Practice2011;28(2):134-40. ">Fitzmaurice 2002</a>; <a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>; <a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a>; <a href="./references#CD003839-bbs2-0012" title="GrunauBE , WiensMO , HarderKK . Patient self-management of warfarin therapy: pragmatic feasibility study in Canadian primary care. Canadian Family Physician Medecin de Famille Canadien2011;57(8):e292-8. ">Grunau 2011</a>; <a href="./references#CD003839-bbs2-0013" title="HorstkotteD , PiperC , WiemerM . Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. Journal of Thrombosis and Thrombolysis1998;5 Suppl 1(3):19-24. ">Horstkotte 1998</a>; <a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a>; <a href="./references#CD003839-bbs2-0016" title="EitzT , SchenkS , FritzscheD , BairaktarisA , WagnerO , KoertkeH , et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Annals of Thoracic Surgery2008;85(3):949-54. KörtkeH , KörferR . International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?Annals of Thoracic Surgery2001;72(1):44-8. KörtkeH , MinamiK , BreymannT , SeifertD , BaraktarisA , WagnerO , et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Zeitschrift fur Kardiologie2001;90 Suppl:6118-24. KoertkeH , MinamiK , BairaktarisA , WagnerO , KoerferR . INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis2000;9 Suppl 1:41-5. KoertkeH , MinamiK , BoethigD , BreymannTH , SeifertD , WagnerO , et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation2003;108(10 Suppl 1):II-75-II-78. KoertkeH , ZittermannA , MinamiK , TenderichG , WagnerO , El-ArousyM , et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Annals of Thoracic Surgery2005;79(6):1909-14. KoertkeH , ZittermannA , TenderichG , WagnerO , El-ArousyM , KrianA , et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. European Heart Journal2007;28(20):2479-84. KoertkeH , ZittermannA , WagnerO , EnnkerJ , SaggauW , SackFU , et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2010;90(5):1487-93. KoertkeH , ZittermannA , WagnerO , KoerferR . Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2007;83(1):24-9. ">Körtke 2001</a>; <a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>; <a href="./references#CD003839-bbs2-0021" title="SawickiPT , GlaserB , KleespiesC , StubbeJ , SchmitzN , KaiserT , et al. Long-term results of patients' self-management of oral anticoagulation. Journal of Clinical &amp; Basic Cardiology2003;6(1-4):59-62. SawickiPT . A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA1999;281(2):145-50. ">Sawicki 1999</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0023" title="SiebenhoferA , HemkensLG , RakovacI , SpatS , DidjurgeitU , SPOG 60+ Study Group. Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thrombosis Research2012;130:e60-e6. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thrombosis and Haemostasis2007;97(3):408-16. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thrombosis &amp; Haemostasis2008;100(6):1089-98. ">Siebenhofer 2007</a>; <a href="./references#CD003839-bbs2-0024" title="Soliman HamadMA , vanEekelenE , vanAgtT , vanStratenAH . Self-management program improves anticoagulation control and quality of life: a prospective randomized study. European Journal of Cardiothoracic Surgery2009;35(2):265-9. ">Soliman Hamad 2009</a>; <a href="./references#CD003839-bbs2-0025" title="SunderjiR , CampbellL , ShalanskyK , FungA , CarterC , GinK . Outpatient self-management of warfarin therapy: A pilot study. Pharmacotherapy1999;19(6):787-93. SunderjiR , GinK , ShalanskyK , CarterC , ChambersK , DaviesC , et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Canadian Journal of Cardiology2004;20(11):1117-23. ">Sunderji 2004</a>; <a href="./references#CD003839-bbs2-0028" title="VöllerH , GlatzJ , TaborskiU , BernardoA , DovifatC , HeidingerK . Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Zeitschrift fur Kardiologie2005;94(3):182-6. ">Voller 2005</a>; <a href="./references#CD003839-bbs2-0029" title="WhiteRH , McCurdySA , vonMarensdorffH , Woodruff DE Jr, LeftgoffL . Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Annals of Internal Medicine1989;111(9):730-7. ">White 1989</a>). All studies but one (<a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a>), reported improvements in the self‐monitoring or self‐management groups; six were statistically significant (<a href="./references#CD003839-bbs2-0013" title="HorstkotteD , PiperC , WiemerM . Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. Journal of Thrombosis and Thrombolysis1998;5 Suppl 1(3):19-24. ">Horstkotte 1998</a>; <a href="./references#CD003839-bbs2-0016" title="EitzT , SchenkS , FritzscheD , BairaktarisA , WagnerO , KoertkeH , et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Annals of Thoracic Surgery2008;85(3):949-54. KörtkeH , KörferR . International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?Annals of Thoracic Surgery2001;72(1):44-8. KörtkeH , MinamiK , BreymannT , SeifertD , BaraktarisA , WagnerO , et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Zeitschrift fur Kardiologie2001;90 Suppl:6118-24. KoertkeH , MinamiK , BairaktarisA , WagnerO , KoerferR . INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis2000;9 Suppl 1:41-5. KoertkeH , MinamiK , BoethigD , BreymannTH , SeifertD , WagnerO , et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation2003;108(10 Suppl 1):II-75-II-78. KoertkeH , ZittermannA , MinamiK , TenderichG , WagnerO , El-ArousyM , et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Annals of Thoracic Surgery2005;79(6):1909-14. KoertkeH , ZittermannA , TenderichG , WagnerO , El-ArousyM , KrianA , et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. European Heart Journal2007;28(20):2479-84. KoertkeH , ZittermannA , WagnerO , EnnkerJ , SaggauW , SackFU , et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2010;90(5):1487-93. KoertkeH , ZittermannA , WagnerO , KoerferR . Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2007;83(1):24-9. ">Körtke 2001</a>; <a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0028" title="VöllerH , GlatzJ , TaborskiU , BernardoA , DovifatC , HeidingerK . Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Zeitschrift fur Kardiologie2005;94(3):182-6. ">Voller 2005</a>; <a href="./references#CD003839-bbs2-0029" title="WhiteRH , McCurdySA , vonMarensdorffH , Woodruff DE Jr, LeftgoffL . Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Annals of Internal Medicine1989;111(9):730-7. ">White 1989</a>). Pooling of the mean percentage of tests in range was not possible as information was collected in two different ways: as the percentage of overall tests in range (<a href="./references#CD003839-bbs2-0005" title="CromheeckeME , LeviM , CollyLP , deMolBJ , PrinsMH , HuttenBA , et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet2000;356(9224):97-102. ">Cromheecke 2000</a>; <a href="./references#CD003839-bbs2-0007" title="FitzmauriceDA , MurrayET , GeeKM , AllanTF , HobbsFD . A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology2002;55(11):845-9. McCahonD , MurrayET , MurrayK , HolderRL , FitzmauriceDA . Does self-management of oral anticoagulation therapy improve quality of life and anxiety?Family Practice2011;28(2):134-40. ">Fitzmaurice 2002</a>; <a href="./references#CD003839-bbs2-0013" title="HorstkotteD , PiperC , WiemerM . Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. Journal of Thrombosis and Thrombolysis1998;5 Suppl 1(3):19-24. ">Horstkotte 1998</a>; <a href="./references#CD003839-bbs2-0016" title="EitzT , SchenkS , FritzscheD , BairaktarisA , WagnerO , KoertkeH , et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Annals of Thoracic Surgery2008;85(3):949-54. KörtkeH , KörferR . International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?Annals of Thoracic Surgery2001;72(1):44-8. KörtkeH , MinamiK , BreymannT , SeifertD , BaraktarisA , WagnerO , et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Zeitschrift fur Kardiologie2001;90 Suppl:6118-24. KoertkeH , MinamiK , BairaktarisA , WagnerO , KoerferR . INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis2000;9 Suppl 1:41-5. KoertkeH , MinamiK , BoethigD , BreymannTH , SeifertD , WagnerO , et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation2003;108(10 Suppl 1):II-75-II-78. KoertkeH , ZittermannA , MinamiK , TenderichG , WagnerO , El-ArousyM , et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Annals of Thoracic Surgery2005;79(6):1909-14. KoertkeH , ZittermannA , TenderichG , WagnerO , El-ArousyM , KrianA , et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. European Heart Journal2007;28(20):2479-84. KoertkeH , ZittermannA , WagnerO , EnnkerJ , SaggauW , SackFU , et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2010;90(5):1487-93. KoertkeH , ZittermannA , WagnerO , KoerferR . Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2007;83(1):24-9. ">Körtke 2001</a>; <a href="./references#CD003839-bbs2-0021" title="SawickiPT , GlaserB , KleespiesC , StubbeJ , SchmitzN , KaiserT , et al. Long-term results of patients' self-management of oral anticoagulation. Journal of Clinical &amp; Basic Cardiology2003;6(1-4):59-62. SawickiPT . A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA1999;281(2):145-50. ">Sawicki 1999</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0025" title="SunderjiR , CampbellL , ShalanskyK , FungA , CarterC , GinK . Outpatient self-management of warfarin therapy: A pilot study. Pharmacotherapy1999;19(6):787-93. SunderjiR , GinK , ShalanskyK , CarterC , ChambersK , DaviesC , et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Canadian Journal of Cardiology2004;20(11):1117-23. ">Sunderji 2004</a>; <a href="./references#CD003839-bbs2-0028" title="VöllerH , GlatzJ , TaborskiU , BernardoA , DovifatC , HeidingerK . Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Zeitschrift fur Kardiologie2005;94(3):182-6. ">Voller 2005</a>; <a href="./references#CD003839-bbs2-0029" title="WhiteRH , McCurdySA , vonMarensdorffH , Woodruff DE Jr, LeftgoffL . Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Annals of Internal Medicine1989;111(9):730-7. ">White 1989</a>), and the percentage of tests for each individual in range (<a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>; <a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a>; <a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>; <a href="./references#CD003839-bbs2-0020" title="RyanF , ByrneS , O'SheaS . Randomized controlled trial of supervised patient self-testing of warfarin therapy using an internet-based expert system. Journal of Thrombosis and Haemostasis : JTH2007;7(8):1284-90. ">Ryan 2009</a>). Improvements ranged from 3% to 21%. Eighteen trials reported the percentage time within range (<a href="./references#CD003839-bbs2-0001" title="AzarnoushK , CamilleriL , Aublet-CuvelierB , GeoffroyE , DauphinC , DubrayC , et al. Results of the first randomized French study evaluating self-testing of the International Normalized Ratio. Journal of Heart Valve Disease2011;20(5):518-25. DauphinC , LegaultB , JaffeuxP , MotreffP , AzarnoushK , JolyH , et al. Comparison of INR stability between self-monitoring and standard laboratory method: preliminary results of a prospective study in 67 mechanical heart valve patients. Archives of Cardiovascular Diseases2008;101(11-12):753-61. ">Azarnoush 2009</a>; <a href="./references#CD003839-bbs2-0002" title="BeythRJ , QuinnL , LandefeldCS . A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Annals of Internal Medicine2000;133(9):687-95. ">Beyth 2000</a>; <a href="./references#CD003839-bbs2-0003" title="ChristensenTD , MaegaardM , SørensenHT , HjortdalVE , HasenkamJM . Self-management versus conventional management of oral anticoagulant therapy: A randomized, controlled trial. European Journal of Internal Medicine2006;17(4):260-6. ">Christensen 2006</a>; <a href="./references#CD003839-bbs2-0004" title="ChristensenH , LauterleinJJ , SørensenPD , PetersenERB , MadsenJS , BrandslundI . Home management of oral anticoagulation via telemedicine versus conventional hospital-based treatment. Telemedicine and e-Health2011;17(3):169-76. ">Christensen 2011</a>; <a href="./references#CD003839-bbs2-0007" title="FitzmauriceDA , MurrayET , GeeKM , AllanTF , HobbsFD . A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology2002;55(11):845-9. McCahonD , MurrayET , MurrayK , HolderRL , FitzmauriceDA . Does self-management of oral anticoagulation therapy improve quality of life and anxiety?Family Practice2011;28(2):134-40. ">Fitzmaurice 2002</a>; <a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a>; <a href="./references#CD003839-bbs2-0011" title="GardinerC , WilliamsK , LongairI , MackieIJ , MachinSJ , CohenH . A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing.. British Journal of Haematolgy2006;132(5):598-603. GardinerC , WilliamsK , MackieIJ , MachinSJ , CohenH . Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. British Journal of Haematology2005;128(2):242-7. ">Gardiner 2005</a>; <a href="./references#CD003839-bbs2-0012" title="GrunauBE , WiensMO , HarderKK . Patient self-management of warfarin therapy: pragmatic feasibility study in Canadian primary care. Canadian Family Physician Medecin de Famille Canadien2011;57(8):e292-8. ">Grunau 2011</a>; <a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a>; <a href="./references#CD003839-bbs2-0015" title="KhanTI , KamaliF , KestevenP , AveryP , WynneH . The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology2004;126(4):557-64. ">Khan 2004</a>; <a href="./references#CD003839-bbs2-0017" title="MatcharDB , DolorR , JacobsonA , LoveS , EdsonR , UyedaL . More frequent self-testing of prothrombin time results in improved time in target range. Circulation2012;126:21 Suppl. MatcharDB , JacobsonA , DolorR , EdsonR , UyedaL , PhibbsCS , et al, THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. New England Journal of Medicine2010;363(17):1608-20. ">Matchar 2010</a>; <a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>; <a href="./references#CD003839-bbs2-0019" title="RasmussenRS , CorellP , MadsenP , OvergaardK . Effects of computer-assisted oral anticoagulant therapy. Thrombosis Journal2012;10(1):17. ">Rasmussen 2012</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0023" title="SiebenhoferA , HemkensLG , RakovacI , SpatS , DidjurgeitU , SPOG 60+ Study Group. Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thrombosis Research2012;130:e60-e6. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thrombosis and Haemostasis2007;97(3):408-16. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thrombosis &amp; Haemostasis2008;100(6):1089-98. ">Siebenhofer 2007</a>; <a href="./references#CD003839-bbs2-0025" title="SunderjiR , CampbellL , ShalanskyK , FungA , CarterC , GinK . Outpatient self-management of warfarin therapy: A pilot study. Pharmacotherapy1999;19(6):787-93. SunderjiR , GinK , ShalanskyK , CarterC , ChambersK , DaviesC , et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Canadian Journal of Cardiology2004;20(11):1117-23. ">Sunderji 2004</a>; <a href="./references#CD003839-bbs2-0026" title="ThompsonJL , BurkhartHM , DalyRC , DearaniJA , JoyceLD , SuriRM , et al. Anticoagulation early after mechanical valve replacement: improved management with patient self-testing. Journal of Thoracic and Cardiovascular Surgery2013;146:599-604. ">Thompson 2013</a>; <a href="./references#CD003839-bbs2-0027" title="VerretL , CouturierJ , RozonA , Saudrais-JanecekS , St-OngeA , NguyenA , et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy2012;32(10):871-9. ">Verret 2012</a>). Seven studies (<a href="./references#CD003839-bbs2-0001" title="AzarnoushK , CamilleriL , Aublet-CuvelierB , GeoffroyE , DauphinC , DubrayC , et al. Results of the first randomized French study evaluating self-testing of the International Normalized Ratio. Journal of Heart Valve Disease2011;20(5):518-25. DauphinC , LegaultB , JaffeuxP , MotreffP , AzarnoushK , JolyH , et al. Comparison of INR stability between self-monitoring and standard laboratory method: preliminary results of a prospective study in 67 mechanical heart valve patients. Archives of Cardiovascular Diseases2008;101(11-12):753-61. ">Azarnoush 2009</a>; <a href="./references#CD003839-bbs2-0002" title="BeythRJ , QuinnL , LandefeldCS . A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Annals of Internal Medicine2000;133(9):687-95. ">Beyth 2000</a>; <a href="./references#CD003839-bbs2-0004" title="ChristensenH , LauterleinJJ , SørensenPD , PetersenERB , MadsenJS , BrandslundI . Home management of oral anticoagulation via telemedicine versus conventional hospital-based treatment. Telemedicine and e-Health2011;17(3):169-76. ">Christensen 2011</a>; <a href="./references#CD003839-bbs2-0017" title="MatcharDB , DolorR , JacobsonA , LoveS , EdsonR , UyedaL . More frequent self-testing of prothrombin time results in improved time in target range. Circulation2012;126:21 Suppl. MatcharDB , JacobsonA , DolorR , EdsonR , UyedaL , PhibbsCS , et al, THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. New England Journal of Medicine2010;363(17):1608-20. ">Matchar 2010</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0023" title="SiebenhoferA , HemkensLG , RakovacI , SpatS , DidjurgeitU , SPOG 60+ Study Group. Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thrombosis Research2012;130:e60-e6. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thrombosis and Haemostasis2007;97(3):408-16. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thrombosis &amp; Haemostasis2008;100(6):1089-98. ">Siebenhofer 2007</a>; <a href="./references#CD003839-bbs2-0026" title="ThompsonJL , BurkhartHM , DalyRC , DearaniJA , JoyceLD , SuriRM , et al. Anticoagulation early after mechanical valve replacement: improved management with patient self-testing. Journal of Thoracic and Cardiovascular Surgery2013;146:599-604. ">Thompson 2013</a>) reported a significant improvement in the time in therapeutic range in the self‐monitoring or self‐management groups (see additional tables, <a href="#CD003839-tbl-0004">Table 1</a>). </p> <div class="table" id="CD003839-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Tests in range</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Mean INR within target range, %</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>TIme within range, %</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Source</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P value</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0029" title="WhiteRH , McCurdySA , vonMarensdorffH , Woodruff DE Jr, LeftgoffL . Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Annals of Internal Medicine1989;111(9):730-7. ">White 1989</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>87</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.001</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0013" title="HorstkotteD , PiperC , WiemerM . Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. Journal of Thrombosis and Thrombolysis1998;5 Suppl 1(3):19-24. ">Horstkotte 1998</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22.3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43.2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.001</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> ‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0021" title="SawickiPT , GlaserB , KleespiesC , StubbeJ , SchmitzN , KaiserT , et al. Long-term results of patients' self-management of oral anticoagulation. Journal of Clinical &amp; Basic Cardiology2003;6(1-4):59-62. SawickiPT . A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA1999;281(2):145-50. ">Sawicki 1999</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43.2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.22</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> ‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0002" title="BeythRJ , QuinnL , LandefeldCS . A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Annals of Internal Medicine2000;133(9):687-95. ">Beyth 2000</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>‐</i> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>‐</i> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐ </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0005" title="CromheeckeME , LeviM , CollyLP , deMolBJ , PrinsMH , HuttenBA , et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet2000;356(9224):97-102. ">Cromheecke 2000</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.06</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> ‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67.60</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.0001</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63.8</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76.5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.0001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0007" title="FitzmauriceDA , MurrayET , GeeKM , AllanTF , HobbsFD . A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology2002;55(11):845-9. McCahonD , MurrayET , MurrayK , HolderRL , FitzmauriceDA . Does self-management of oral anticoagulation therapy improve quality of life and anxiety?Family Practice2011;28(2):134-40. ">Fitzmaurice 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66 (61‐71)*</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72 (65‐80)*</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77 (67‐86)*</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74 (67‐81)*</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>; <a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61.3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐ </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0011" title="GardinerC , WilliamsK , LongairI , MackieIJ , MachinSJ , CohenH . A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing.. British Journal of Haematolgy2006;132(5):598-603. GardinerC , WilliamsK , MackieIJ , MachinSJ , CohenH . Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. British Journal of Haematology2005;128(2):242-7. ">Gardiner 2005</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>‐</i> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>‐</i> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> ‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64 (26)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61 (20)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.6</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.05</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66.9</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63.5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.127</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0025" title="SunderjiR , CampbellL , ShalanskyK , FungA , CarterC , GinK . Outpatient self-management of warfarin therapy: A pilot study. Pharmacotherapy1999;19(6):787-93. SunderjiR , GinK , ShalanskyK , CarterC , ChambersK , DaviesC , et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Canadian Journal of Cardiology2004;20(11):1117-23. ">Sunderji 2004</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58.7 (5.8)**</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.8 (5.9)**</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.23</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63.2 (5.8)**</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71.8 (5.5)**</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0015" title="KhanTI , KamaliF , KestevenP , AveryP , WynneH . The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology2004;126(4):557-64. ">Khan 2004</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>‐</i> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>‐</i> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐ </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70.4 (24.5)**</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71.1 (14.5)**</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0016" title="EitzT , SchenkS , FritzscheD , BairaktarisA , WagnerO , KoertkeH , et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Annals of Thoracic Surgery2008;85(3):949-54. KörtkeH , KörferR . International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?Annals of Thoracic Surgery2001;72(1):44-8. KörtkeH , MinamiK , BreymannT , SeifertD , BaraktarisA , WagnerO , et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Zeitschrift fur Kardiologie2001;90 Suppl:6118-24. KoertkeH , MinamiK , BairaktarisA , WagnerO , KoerferR . INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis2000;9 Suppl 1:41-5. KoertkeH , MinamiK , BoethigD , BreymannTH , SeifertD , WagnerO , et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation2003;108(10 Suppl 1):II-75-II-78. KoertkeH , ZittermannA , MinamiK , TenderichG , WagnerO , El-ArousyM , et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Annals of Thoracic Surgery2005;79(6):1909-14. KoertkeH , ZittermannA , TenderichG , WagnerO , El-ArousyM , KrianA , et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. European Heart Journal2007;28(20):2479-84. KoertkeH , ZittermannA , WagnerO , EnnkerJ , SaggauW , SackFU , et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2010;90(5):1487-93. KoertkeH , ZittermannA , WagnerO , KoerferR . Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2007;83(1):24-9. ">Körtke 2001</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60.5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>78.3</i> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.001</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> ‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0028" title="VöllerH , GlatzJ , TaborskiU , BernardoA , DovifatC , HeidingerK . Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Zeitschrift fur Kardiologie2005;94(3):182-6. ">Voller 2005</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58.5 (19.8)**</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67.8 (17.6)**</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.0061</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55.6 (19.6)**</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58.6% (14.3)**</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.02</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.9 (19.9)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.3 (14.3)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>‐</i> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>‐</i> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐ </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68 (65.2‐70.6)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70 (68.1‐72.4)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0003" title="ChristensenTD , MaegaardM , SørensenHT , HjortdalVE , HasenkamJM . Self-management versus conventional management of oral anticoagulant therapy: A randomized, controlled trial. European Journal of Internal Medicine2006;17(4):260-6. ">Christensen 2006</a>, Denmark </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>‐</i> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>‐</i> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> ‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68.9 (59.3‐78.2)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78.7 (69.2‐81.0)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0023" title="SiebenhoferA , HemkensLG , RakovacI , SpatS , DidjurgeitU , SPOG 60+ Study Group. Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thrombosis Research2012;130:e60-e6. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thrombosis and Haemostasis2007;97(3):408-16. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thrombosis &amp; Haemostasis2008;100(6):1089-98. ">Siebenhofer 2007</a>, Austria<sup>†</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57.1 (40.4‐72.4)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72.4 (53.5‐79.4)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.001</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66.5 (47.1‐81.5)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75.4 (59.4‐85.0)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.029</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0001" title="AzarnoushK , CamilleriL , Aublet-CuvelierB , GeoffroyE , DauphinC , DubrayC , et al. Results of the first randomized French study evaluating self-testing of the International Normalized Ratio. Journal of Heart Valve Disease2011;20(5):518-25. DauphinC , LegaultB , JaffeuxP , MotreffP , AzarnoushK , JolyH , et al. Comparison of INR stability between self-monitoring and standard laboratory method: preliminary results of a prospective study in 67 mechanical heart valve patients. Archives of Cardiovascular Diseases2008;101(11-12):753-61. ">Azarnoush 2009</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61.5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55.5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.0343</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0004" title="ChristensenH , LauterleinJJ , SørensenPD , PetersenERB , MadsenJS , BrandslundI . Home management of oral anticoagulation via telemedicine versus conventional hospital-based treatment. Telemedicine and e-Health2011;17(3):169-76. ">Christensen 2011</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79.9</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72.7</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.0001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0012" title="GrunauBE , WiensMO , HarderKK . Patient self-management of warfarin therapy: pragmatic feasibility study in Canadian primary care. Canadian Family Physician Medecin de Famille Canadien2011;57(8):e292-8. ">Grunau 2011</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82.4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80.2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.82</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82.2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>89.7</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.76</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0017" title="MatcharDB , DolorR , JacobsonA , LoveS , EdsonR , UyedaL . More frequent self-testing of prothrombin time results in improved time in target range. Circulation2012;126:21 Suppl. MatcharDB , JacobsonA , DolorR , EdsonR , UyedaL , PhibbsCS , et al, THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. New England Journal of Medicine2010;363(17):1608-20. ">Matchar 2010</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66.2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62.4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0019" title="RasmussenRS , CorellP , MadsenP , OvergaardK . Effects of computer-assisted oral anticoagulant therapy. Thrombosis Journal2012;10(1):17. ">Rasmussen 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention A 49</p> <p>Intervention B 55</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0024" title="Soliman HamadMA , vanEekelenE , vanAgtT , vanStratenAH . Self-management program improves anticoagulation control and quality of life: a prospective randomized study. European Journal of Cardiothoracic Surgery2009;35(2):265-9. ">Soliman Hamad 2009</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72.9</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53.9</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.01</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0026" title="ThompsonJL , BurkhartHM , DalyRC , DearaniJA , JoyceLD , SuriRM , et al. Anticoagulation early after mechanical valve replacement: improved management with patient self-testing. Journal of Thoracic and Cardiovascular Surgery2013;146:599-604. ">Thompson 2013</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.05</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0027" title="VerretL , CouturierJ , RozonA , Saudrais-JanecekS , St-OngeA , NguyenA , et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy2012;32(10):871-9. ">Verret 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75.5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.79</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>* 95% Confidence intervals</p> <p>** Standard Deviations</p> <p><sup>†</sup> Used median not mean </p> </div> </div> <p>The method used to estimate the time within therapeutic INR target range in 16 studies was linear interpolation (<a href="./references#CD003839-bbs2-0002" title="BeythRJ , QuinnL , LandefeldCS . A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Annals of Internal Medicine2000;133(9):687-95. ">Beyth 2000</a>; <a href="./references#CD003839-bbs2-0003" title="ChristensenTD , MaegaardM , SørensenHT , HjortdalVE , HasenkamJM . Self-management versus conventional management of oral anticoagulant therapy: A randomized, controlled trial. European Journal of Internal Medicine2006;17(4):260-6. ">Christensen 2006</a>; <a href="./references#CD003839-bbs2-0007" title="FitzmauriceDA , MurrayET , GeeKM , AllanTF , HobbsFD . A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology2002;55(11):845-9. McCahonD , MurrayET , MurrayK , HolderRL , FitzmauriceDA . Does self-management of oral anticoagulation therapy improve quality of life and anxiety?Family Practice2011;28(2):134-40. ">Fitzmaurice 2002</a>; <a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a>; <a href="./references#CD003839-bbs2-0011" title="GardinerC , WilliamsK , LongairI , MackieIJ , MachinSJ , CohenH . A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing.. British Journal of Haematolgy2006;132(5):598-603. GardinerC , WilliamsK , MackieIJ , MachinSJ , CohenH . Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. British Journal of Haematology2005;128(2):242-7. ">Gardiner 2005</a>; <a href="./references#CD003839-bbs2-0012" title="GrunauBE , WiensMO , HarderKK . Patient self-management of warfarin therapy: pragmatic feasibility study in Canadian primary care. Canadian Family Physician Medecin de Famille Canadien2011;57(8):e292-8. ">Grunau 2011</a>; <a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a>; <a href="./references#CD003839-bbs2-0015" title="KhanTI , KamaliF , KestevenP , AveryP , WynneH . The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology2004;126(4):557-64. ">Khan 2004</a>; <a href="./references#CD003839-bbs2-0017" title="MatcharDB , DolorR , JacobsonA , LoveS , EdsonR , UyedaL . More frequent self-testing of prothrombin time results in improved time in target range. Circulation2012;126:21 Suppl. MatcharDB , JacobsonA , DolorR , EdsonR , UyedaL , PhibbsCS , et al, THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. New England Journal of Medicine2010;363(17):1608-20. ">Matchar 2010</a>; <a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>; <a href="./references#CD003839-bbs2-0019" title="RasmussenRS , CorellP , MadsenP , OvergaardK . Effects of computer-assisted oral anticoagulant therapy. Thrombosis Journal2012;10(1):17. ">Rasmussen 2012</a>; <a href="./references#CD003839-bbs2-0020" title="RyanF , ByrneS , O'SheaS . Randomized controlled trial of supervised patient self-testing of warfarin therapy using an internet-based expert system. Journal of Thrombosis and Haemostasis : JTH2007;7(8):1284-90. ">Ryan 2009</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0023" title="SiebenhoferA , HemkensLG , RakovacI , SpatS , DidjurgeitU , SPOG 60+ Study Group. Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thrombosis Research2012;130:e60-e6. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thrombosis and Haemostasis2007;97(3):408-16. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thrombosis &amp; Haemostasis2008;100(6):1089-98. ">Siebenhofer 2007</a>; <a href="./references#CD003839-bbs2-0025" title="SunderjiR , CampbellL , ShalanskyK , FungA , CarterC , GinK . Outpatient self-management of warfarin therapy: A pilot study. Pharmacotherapy1999;19(6):787-93. SunderjiR , GinK , ShalanskyK , CarterC , ChambersK , DaviesC , et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Canadian Journal of Cardiology2004;20(11):1117-23. ">Sunderji 2004</a>; <a href="./references#CD003839-bbs2-0027" title="VerretL , CouturierJ , RozonA , Saudrais-JanecekS , St-OngeA , NguyenA , et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy2012;32(10):871-9. ">Verret 2012</a>). </p> </section> </section> <section id="CD003839-sec-0046"> <h4 class="title">Secondary endpoints</h4> <section id="CD003839-sec-0047"> <h5 class="title">Minor haemorrhage</h5> <p>Eighteen trials reported minor haemorrhage outcomes, with 13 reporting events (<a href="./references#CD003839-bbs2-0001" title="AzarnoushK , CamilleriL , Aublet-CuvelierB , GeoffroyE , DauphinC , DubrayC , et al. Results of the first randomized French study evaluating self-testing of the International Normalized Ratio. Journal of Heart Valve Disease2011;20(5):518-25. DauphinC , LegaultB , JaffeuxP , MotreffP , AzarnoushK , JolyH , et al. Comparison of INR stability between self-monitoring and standard laboratory method: preliminary results of a prospective study in 67 mechanical heart valve patients. Archives of Cardiovascular Diseases2008;101(11-12):753-61. ">Azarnoush 2009</a>; <a href="./references#CD003839-bbs2-0005" title="CromheeckeME , LeviM , CollyLP , deMolBJ , PrinsMH , HuttenBA , et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet2000;356(9224):97-102. ">Cromheecke 2000</a>; <a href="./references#CD003839-bbs2-0007" title="FitzmauriceDA , MurrayET , GeeKM , AllanTF , HobbsFD . A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology2002;55(11):845-9. McCahonD , MurrayET , MurrayK , HolderRL , FitzmauriceDA . Does self-management of oral anticoagulation therapy improve quality of life and anxiety?Family Practice2011;28(2):134-40. ">Fitzmaurice 2002</a>; <a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a>; <a href="./references#CD003839-bbs2-0011" title="GardinerC , WilliamsK , LongairI , MackieIJ , MachinSJ , CohenH . A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing.. British Journal of Haematolgy2006;132(5):598-603. GardinerC , WilliamsK , MackieIJ , MachinSJ , CohenH . Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. British Journal of Haematology2005;128(2):242-7. ">Gardiner 2005</a>; <a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a>; <a href="./references#CD003839-bbs2-0015" title="KhanTI , KamaliF , KestevenP , AveryP , WynneH . The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology2004;126(4):557-64. ">Khan 2004</a>; <a href="./references#CD003839-bbs2-0017" title="MatcharDB , DolorR , JacobsonA , LoveS , EdsonR , UyedaL . More frequent self-testing of prothrombin time results in improved time in target range. Circulation2012;126:21 Suppl. MatcharDB , JacobsonA , DolorR , EdsonR , UyedaL , PhibbsCS , et al, THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. New England Journal of Medicine2010;363(17):1608-20. ">Matchar 2010</a>; <a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>; <a href="./references#CD003839-bbs2-0021" title="SawickiPT , GlaserB , KleespiesC , StubbeJ , SchmitzN , KaiserT , et al. Long-term results of patients' self-management of oral anticoagulation. Journal of Clinical &amp; Basic Cardiology2003;6(1-4):59-62. SawickiPT . A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA1999;281(2):145-50. ">Sawicki 1999</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0027" title="VerretL , CouturierJ , RozonA , Saudrais-JanecekS , St-OngeA , NguyenA , et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy2012;32(10):871-9. ">Verret 2012</a>; <a href="./references#CD003839-bbs2-0029" title="WhiteRH , McCurdySA , vonMarensdorffH , Woodruff DE Jr, LeftgoffL . Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Annals of Internal Medicine1989;111(9):730-7. ">White 1989</a>). Compared to standard therapy, self‐monitoring or self‐management there was no difference in minor haemorrhage (RR 0.97, 95% CI 0.67 to 1.41; participants = 5365; studies = 13) (<a href="./references#CD003839-fig-0018" title="">Analysis 4.1</a>), but results varied considerably (I<sup>2</sup> = 82%). The overall quality of evidence was downgraded from high to low because of serious risk of bias and substantial heterogeneity (<a href="./full#CD003839-tbl-0001">summary of findings Table 1</a>). </p> <p>There was no reduction in minor haemorrhage with self‐management (RR 0.91, 95% CI 0.47 to 1.76; participants = 1862; studies = 7), or with self‐monitoring (RR 1.16, 95% CI 0.95 to 1.42; participants = 3503; studies = 6) (<a href="./references#CD003839-fig-0018" title="">Analysis 4.1</a>). The quality of the evidence for self‐monitoring was downgraded from high to moderate because of serious risk of bias (<a href="./full#CD003839-tbl-0002">summary of findings Table 2</a>). The quality of evidence for self‐management was downgraded from high to low because of serious risk of bias and high heterogeneity (82%) (<a href="./full#CD003839-tbl-0003">summary of findings Table 3</a>). Only one trial (<a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>) showed a significant effect on minor haemorrhage with self‐management (RR 0.41, 95% CI 0.31 to 0.54). </p> </section> <section id="CD003839-sec-0048"> <h5 class="title">Frequency of testing</h5> <p>Fourteen studies reported on the total number of tests performed throughout the study (<a href="./references#CD003839-bbs2-0007" title="FitzmauriceDA , MurrayET , GeeKM , AllanTF , HobbsFD . A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology2002;55(11):845-9. McCahonD , MurrayET , MurrayK , HolderRL , FitzmauriceDA . Does self-management of oral anticoagulation therapy improve quality of life and anxiety?Family Practice2011;28(2):134-40. ">Fitzmaurice 2002</a>; <a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>; <a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a>; <a href="./references#CD003839-bbs2-0013" title="HorstkotteD , PiperC , WiemerM . Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. Journal of Thrombosis and Thrombolysis1998;5 Suppl 1(3):19-24. ">Horstkotte 1998</a>; <a href="./references#CD003839-bbs2-0016" title="EitzT , SchenkS , FritzscheD , BairaktarisA , WagnerO , KoertkeH , et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Annals of Thoracic Surgery2008;85(3):949-54. KörtkeH , KörferR . International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?Annals of Thoracic Surgery2001;72(1):44-8. KörtkeH , MinamiK , BreymannT , SeifertD , BaraktarisA , WagnerO , et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Zeitschrift fur Kardiologie2001;90 Suppl:6118-24. KoertkeH , MinamiK , BairaktarisA , WagnerO , KoerferR . INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis2000;9 Suppl 1:41-5. KoertkeH , MinamiK , BoethigD , BreymannTH , SeifertD , WagnerO , et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation2003;108(10 Suppl 1):II-75-II-78. KoertkeH , ZittermannA , MinamiK , TenderichG , WagnerO , El-ArousyM , et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Annals of Thoracic Surgery2005;79(6):1909-14. KoertkeH , ZittermannA , TenderichG , WagnerO , El-ArousyM , KrianA , et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. European Heart Journal2007;28(20):2479-84. KoertkeH , ZittermannA , WagnerO , EnnkerJ , SaggauW , SackFU , et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2010;90(5):1487-93. KoertkeH , ZittermannA , WagnerO , KoerferR . Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2007;83(1):24-9. ">Körtke 2001</a>; <a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0023" title="SiebenhoferA , HemkensLG , RakovacI , SpatS , DidjurgeitU , SPOG 60+ Study Group. Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thrombosis Research2012;130:e60-e6. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thrombosis and Haemostasis2007;97(3):408-16. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thrombosis &amp; Haemostasis2008;100(6):1089-98. ">Siebenhofer 2007</a>; <a href="./references#CD003839-bbs2-0024" title="Soliman HamadMA , vanEekelenE , vanAgtT , vanStratenAH . Self-management program improves anticoagulation control and quality of life: a prospective randomized study. European Journal of Cardiothoracic Surgery2009;35(2):265-9. ">Soliman Hamad 2009</a>; <a href="./references#CD003839-bbs2-0025" title="SunderjiR , CampbellL , ShalanskyK , FungA , CarterC , GinK . Outpatient self-management of warfarin therapy: A pilot study. Pharmacotherapy1999;19(6):787-93. SunderjiR , GinK , ShalanskyK , CarterC , ChambersK , DaviesC , et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Canadian Journal of Cardiology2004;20(11):1117-23. ">Sunderji 2004</a>; <a href="./references#CD003839-bbs2-0026" title="ThompsonJL , BurkhartHM , DalyRC , DearaniJA , JoyceLD , SuriRM , et al. Anticoagulation early after mechanical valve replacement: improved management with patient self-testing. Journal of Thoracic and Cardiovascular Surgery2013;146:599-604. ">Thompson 2013</a>; <a href="./references#CD003839-bbs2-0027" title="VerretL , CouturierJ , RozonA , Saudrais-JanecekS , St-OngeA , NguyenA , et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy2012;32(10):871-9. ">Verret 2012</a>; <a href="./references#CD003839-bbs2-0028" title="VöllerH , GlatzJ , TaborskiU , BernardoA , DovifatC , HeidingerK . Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Zeitschrift fur Kardiologie2005;94(3):182-6. ">Voller 2005</a>; <a href="./references#CD003839-bbs2-0029" title="WhiteRH , McCurdySA , vonMarensdorffH , Woodruff DE Jr, LeftgoffL . Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Annals of Internal Medicine1989;111(9):730-7. ">White 1989</a>). Maximum test frequency occurred in the study with the shortest duration (<a href="./references#CD003839-bbs2-0029" title="WhiteRH , McCurdySA , vonMarensdorffH , Woodruff DE Jr, LeftgoffL . Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Annals of Internal Medicine1989;111(9):730-7. ">White 1989</a>). The ratio of tests in the self‐monitoring or self‐management groups compared to the control groups ranged from 1.00 to 4.98; this ratio increased with duration of study (test for linear trend P &lt; 0.002). Due to inadequate data, we were unable to rate the quality of the evidence. </p> </section> <section id="CD003839-sec-0049"> <h5 class="title">Feasibility of testing</h5> <p>A population of 11,738 was sampled in 15 trials (<a href="./references#CD003839-bbs2-0002" title="BeythRJ , QuinnL , LandefeldCS . A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Annals of Internal Medicine2000;133(9):687-95. ">Beyth 2000</a>; <a href="./references#CD003839-bbs2-0003" title="ChristensenTD , MaegaardM , SørensenHT , HjortdalVE , HasenkamJM . Self-management versus conventional management of oral anticoagulant therapy: A randomized, controlled trial. European Journal of Internal Medicine2006;17(4):260-6. ">Christensen 2006</a>; <a href="./references#CD003839-bbs2-0007" title="FitzmauriceDA , MurrayET , GeeKM , AllanTF , HobbsFD . A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology2002;55(11):845-9. McCahonD , MurrayET , MurrayK , HolderRL , FitzmauriceDA . Does self-management of oral anticoagulation therapy improve quality of life and anxiety?Family Practice2011;28(2):134-40. ">Fitzmaurice 2002</a>; <a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a>; <a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>; <a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a>; <a href="./references#CD003839-bbs2-0011" title="GardinerC , WilliamsK , LongairI , MackieIJ , MachinSJ , CohenH . A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing.. British Journal of Haematolgy2006;132(5):598-603. GardinerC , WilliamsK , MackieIJ , MachinSJ , CohenH . Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. British Journal of Haematology2005;128(2):242-7. ">Gardiner 2005</a>; <a href="./references#CD003839-bbs2-0015" title="KhanTI , KamaliF , KestevenP , AveryP , WynneH . The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology2004;126(4):557-64. ">Khan 2004</a>; <a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a>; <a href="./references#CD003839-bbs2-0016" title="EitzT , SchenkS , FritzscheD , BairaktarisA , WagnerO , KoertkeH , et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Annals of Thoracic Surgery2008;85(3):949-54. KörtkeH , KörferR . International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?Annals of Thoracic Surgery2001;72(1):44-8. KörtkeH , MinamiK , BreymannT , SeifertD , BaraktarisA , WagnerO , et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Zeitschrift fur Kardiologie2001;90 Suppl:6118-24. KoertkeH , MinamiK , BairaktarisA , WagnerO , KoerferR . INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis2000;9 Suppl 1:41-5. KoertkeH , MinamiK , BoethigD , BreymannTH , SeifertD , WagnerO , et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation2003;108(10 Suppl 1):II-75-II-78. KoertkeH , ZittermannA , MinamiK , TenderichG , WagnerO , El-ArousyM , et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Annals of Thoracic Surgery2005;79(6):1909-14. KoertkeH , ZittermannA , TenderichG , WagnerO , El-ArousyM , KrianA , et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. European Heart Journal2007;28(20):2479-84. KoertkeH , ZittermannA , WagnerO , EnnkerJ , SaggauW , SackFU , et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2010;90(5):1487-93. KoertkeH , ZittermannA , WagnerO , KoerferR . Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2007;83(1):24-9. ">Körtke 2001</a>; <a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>; <a href="./references#CD003839-bbs2-0021" title="SawickiPT , GlaserB , KleespiesC , StubbeJ , SchmitzN , KaiserT , et al. Long-term results of patients' self-management of oral anticoagulation. Journal of Clinical &amp; Basic Cardiology2003;6(1-4):59-62. SawickiPT . A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA1999;281(2):145-50. ">Sawicki 1999</a>; <a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a>; <a href="./references#CD003839-bbs2-0025" title="SunderjiR , CampbellL , ShalanskyK , FungA , CarterC , GinK . Outpatient self-management of warfarin therapy: A pilot study. Pharmacotherapy1999;19(6):787-93. SunderjiR , GinK , ShalanskyK , CarterC , ChambersK , DaviesC , et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Canadian Journal of Cardiology2004;20(11):1117-23. ">Sunderji 2004</a>; <a href="./references#CD003839-bbs2-0023" title="SiebenhoferA , HemkensLG , RakovacI , SpatS , DidjurgeitU , SPOG 60+ Study Group. Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thrombosis Research2012;130:e60-e6. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thrombosis and Haemostasis2007;97(3):408-16. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thrombosis &amp; Haemostasis2008;100(6):1089-98. ">Siebenhofer 2007</a>). Of that population, 7974 were either excluded or decided not to take part. The average proportion of people that could not (or would not) take part in the trials was 68% (range 31% to 88%). In trials which included older populations (<a href="./references#CD003839-bbs2-0002" title="BeythRJ , QuinnL , LandefeldCS . A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Annals of Internal Medicine2000;133(9):687-95. ">Beyth 2000</a>; <a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a>), the exclusion rates were much higher. Of the participants assigned to the intervention 24.9% (range 0% to 57.3%) were unable to complete self‐monitoring or self‐management. The main reasons for the dropouts were: problems with the device, physical limitations preventing self‐testing and problems with attending the training assessments or failing the assessment. Due to inadequate data, we were unable to rate the quality of the evidence. </p> </section> <section id="CD003839-sec-0050"> <h5 class="title">Other outcomes</h5> <p>Thirteen studies evaluated quality of life outcomes. These included ease of use (<a href="./references#CD003839-bbs2-0011" title="GardinerC , WilliamsK , LongairI , MackieIJ , MachinSJ , CohenH . A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing.. British Journal of Haematolgy2006;132(5):598-603. GardinerC , WilliamsK , MackieIJ , MachinSJ , CohenH . Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. British Journal of Haematology2005;128(2):242-7. ">Gardiner 2005</a>), anxiety caused by testing (<a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a>), beliefs specific to warfarin (<a href="./references#CD003839-bbs2-0015" title="KhanTI , KamaliF , KestevenP , AveryP , WynneH . The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology2004;126(4):557-64. ">Khan 2004</a>), and quality of life (<a href="./references#CD003839-bbs2-0005" title="CromheeckeME , LeviM , CollyLP , deMolBJ , PrinsMH , HuttenBA , et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet2000;356(9224):97-102. ">Cromheecke 2000</a>; <a href="./references#CD003839-bbs2-0007" title="FitzmauriceDA , MurrayET , GeeKM , AllanTF , HobbsFD . A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology2002;55(11):845-9. McCahonD , MurrayET , MurrayK , HolderRL , FitzmauriceDA . Does self-management of oral anticoagulation therapy improve quality of life and anxiety?Family Practice2011;28(2):134-40. ">Fitzmaurice 2002</a>; <a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a>; <a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>; <a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a>; <a href="./references#CD003839-bbs2-0012" title="GrunauBE , WiensMO , HarderKK . Patient self-management of warfarin therapy: pragmatic feasibility study in Canadian primary care. Canadian Family Physician Medecin de Famille Canadien2011;57(8):e292-8. ">Grunau 2011</a>; <a href="./references#CD003839-bbs2-0015" title="KhanTI , KamaliF , KestevenP , AveryP , WynneH . The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology2004;126(4):557-64. ">Khan 2004</a>; <a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a>; <a href="./references#CD003839-bbs2-0017" title="MatcharDB , DolorR , JacobsonA , LoveS , EdsonR , UyedaL . More frequent self-testing of prothrombin time results in improved time in target range. Circulation2012;126:21 Suppl. MatcharDB , JacobsonA , DolorR , EdsonR , UyedaL , PhibbsCS , et al, THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. New England Journal of Medicine2010;363(17):1608-20. ">Matchar 2010</a>; <a href="./references#CD003839-bbs2-0021" title="SawickiPT , GlaserB , KleespiesC , StubbeJ , SchmitzN , KaiserT , et al. Long-term results of patients' self-management of oral anticoagulation. Journal of Clinical &amp; Basic Cardiology2003;6(1-4):59-62. SawickiPT . A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA1999;281(2):145-50. ">Sawicki 1999</a>; <a href="./references#CD003839-bbs2-0024" title="Soliman HamadMA , vanEekelenE , vanAgtT , vanStratenAH . Self-management program improves anticoagulation control and quality of life: a prospective randomized study. European Journal of Cardiothoracic Surgery2009;35(2):265-9. ">Soliman Hamad 2009</a>; <a href="./references#CD003839-bbs2-0027" title="VerretL , CouturierJ , RozonA , Saudrais-JanecekS , St-OngeA , NguyenA , et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy2012;32(10):871-9. ">Verret 2012</a> ). <a href="./references#CD003839-bbs2-0015" title="KhanTI , KamaliF , KestevenP , AveryP , WynneH . The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology2004;126(4):557-64. ">Khan 2004</a> evaluated health status and quality of life using a validated tool, the 36‐item United Kingdom Short Form Health Survey (UKSF‐36) and the European Quality of Life questionnaire (Euroqol). <a href="./references#CD003839-bbs2-0007" title="FitzmauriceDA , MurrayET , GeeKM , AllanTF , HobbsFD . A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology2002;55(11):845-9. McCahonD , MurrayET , MurrayK , HolderRL , FitzmauriceDA . Does self-management of oral anticoagulation therapy improve quality of life and anxiety?Family Practice2011;28(2):134-40. ">Fitzmaurice 2002</a> used the individual quality of life (SEIQoL) tool for estimating quality of life and reported on results of participant interviews (<a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a>). <a href="./references#CD003839-bbs2-0012" title="GrunauBE , WiensMO , HarderKK . Patient self-management of warfarin therapy: pragmatic feasibility study in Canadian primary care. Canadian Family Physician Medecin de Famille Canadien2011;57(8):e292-8. ">Grunau 2011</a> used a treatment‐related satisfaction survey measuring five categories; <a href="./references#CD003839-bbs2-0017" title="MatcharDB , DolorR , JacobsonA , LoveS , EdsonR , UyedaL . More frequent self-testing of prothrombin time results in improved time in target range. Circulation2012;126:21 Suppl. MatcharDB , JacobsonA , DolorR , EdsonR , UyedaL , PhibbsCS , et al, THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. New England Journal of Medicine2010;363(17):1608-20. ">Matchar 2010</a> used the Health Utilities Index Mark; <a href="./references#CD003839-bbs2-0024" title="Soliman HamadMA , vanEekelenE , vanAgtT , vanStratenAH . Self-management program improves anticoagulation control and quality of life: a prospective randomized study. European Journal of Cardiothoracic Surgery2009;35(2):265-9. ">Soliman Hamad 2009</a> used the SF‐36v2 questionnaire; and <a href="./references#CD003839-bbs2-0027" title="VerretL , CouturierJ , RozonA , Saudrais-JanecekS , St-OngeA , NguyenA , et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy2012;32(10):871-9. ">Verret 2012</a> used a validated questionnaire including 32 statements covering five socio‐psychological topics: general treatment satisfaction, self‐efficacy, daily hassles, psychological distress, and strained social network. Four trials (<a href="./references#CD003839-bbs2-0005" title="CromheeckeME , LeviM , CollyLP , deMolBJ , PrinsMH , HuttenBA , et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet2000;356(9224):97-102. ">Cromheecke 2000</a>; <a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>; <a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a>; <a href="./references#CD003839-bbs2-0021" title="SawickiPT , GlaserB , KleespiesC , StubbeJ , SchmitzN , KaiserT , et al. Long-term results of patients' self-management of oral anticoagulation. Journal of Clinical &amp; Basic Cardiology2003;6(1-4):59-62. SawickiPT . A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA1999;281(2):145-50. ">Sawicki 1999</a>) used a questionnaire designed by Sawicki on patients' feelings towards anticoagulation therapy. Six studies (<a href="./references#CD003839-bbs2-0005" title="CromheeckeME , LeviM , CollyLP , deMolBJ , PrinsMH , HuttenBA , et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet2000;356(9224):97-102. ">Cromheecke 2000</a>; <a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>; <a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a>; <a href="./references#CD003839-bbs2-0017" title="MatcharDB , DolorR , JacobsonA , LoveS , EdsonR , UyedaL . More frequent self-testing of prothrombin time results in improved time in target range. Circulation2012;126:21 Suppl. MatcharDB , JacobsonA , DolorR , EdsonR , UyedaL , PhibbsCS , et al, THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. New England Journal of Medicine2010;363(17):1608-20. ">Matchar 2010</a>; <a href="./references#CD003839-bbs2-0021" title="SawickiPT , GlaserB , KleespiesC , StubbeJ , SchmitzN , KaiserT , et al. Long-term results of patients' self-management of oral anticoagulation. Journal of Clinical &amp; Basic Cardiology2003;6(1-4):59-62. SawickiPT . A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA1999;281(2):145-50. ">Sawicki 1999</a>; <a href="./references#CD003839-bbs2-0027" title="VerretL , CouturierJ , RozonA , Saudrais-JanecekS , St-OngeA , NguyenA , et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy2012;32(10):871-9. ">Verret 2012</a>) showed a significant difference in treatment satisfaction. In addition, one study (<a href="./references#CD003839-bbs2-0080" title="GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91.">Gadisseur 2004</a>) (one of the articles from <a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>; <a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a>) reported quality of life outcomes showing greater treatment satisfaction in the self‐monitoring group compared to the self‐management group. One study (<a href="./references#CD003839-bbs2-0017" title="MatcharDB , DolorR , JacobsonA , LoveS , EdsonR , UyedaL . More frequent self-testing of prothrombin time results in improved time in target range. Circulation2012;126:21 Suppl. MatcharDB , JacobsonA , DolorR , EdsonR , UyedaL , PhibbsCS , et al, THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. New England Journal of Medicine2010;363(17):1608-20. ">Matchar 2010</a>), reported that there were no adverse events resulting from physical interaction with the testing device. Due to inadequate data, we were unable to rate the quality of the evidence for quality of life and satisfaction. </p> </section> <section id="CD003839-sec-0051"> <h5 class="title">Optimal information size</h5> <p>The calculated optimal information size needed for a reliable and conclusive treatment effect was 5150 in each arm. This assumed a 2% thromboembolic event rate in the control group, a 50% RR reduction, a power of 95%, and a two‐sided alpha = 0.01. The current meta‐analysis has approximately 4000 in each arm, which would give a 78% power using the same assumptions. </p> <p>One of the main trials included in the meta‐analysis showed a clear absence of correlation between the benefits observed and the degree of control (<a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a>). We therefore questioned the influence of this study by performing a post hoc sensitivity analysis that removed the trial; the beneficial effects observed for all the major outcomes remained similar. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD003839-sec-0052" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD003839-sec-0052"></div> <p>To our knowledge the present review is the most comprehensive review to date. We identified 28 randomised controlled trials (RCTs) trials (8950 participants). Self‐monitoring or self‐management of oral anticoagulation leads to a significant 50% reduction in thromboembolism but no reduction in all‐cause mortality. However, trials of self‐management led to a significant reduction in all‐cause mortality. Self‐management did not reduce major haemorrhages nor did self‐monitoring. </p> <section id="CD003839-sec-0053"> <h3 class="title" id="CD003839-sec-0053">Quality of the evidence</h3> <p>The GRADE approach was employed to interpret result findings and the GRADE profiler (GRADEPRO) allowed us to import data from Review Manager to create 'Summary of findings' tables. The overall quality of the evidence for the effect of self‐monitoring or self‐management of oral anticoagulation on major haemorrhage was moderate; the quality was downgraded because of serious risk of bias across the studies. The quality of the evidence for trials of self‐management was downgraded from high to low because of serious risk of bias and imprecision of effect estimate (i.e. large confidence intervals). The quality of the evidence for trials of self‐monitoring was downgraded from high to low because of serious risk of bias across the studies and strong suspicion of publication bias. </p> <p>The overall quality of the evidence for thromboembolic events was moderate; downgraded because of serious risk of bias across the included studies. The quality of the evidence for trials of either self‐monitoring or self‐management were downgraded from high to moderate because of serious risk of bias. The overall quality of the evidence for mortality was moderate; downgraded because of serious risk of bias across the included studies. The quality of the evidence for trials of either self‐monitoring or self‐management were downgraded from high to moderate because of serious risk of bias. </p> <p>The overall quality of the evidence for minor haemorrhage of the evidence was low; downgraded because of serious risk of bias and substantial heterogeneity in the meta‐analysis result. The quality of the evidence for trials of self‐management was downgraded from high to low because of serious risk of bias and substantial heterogeneity. The quality of the evidence for trials of self‐monitoring was downgraded from high to moderate because of serious risk of bias across the included studies. Due to inadequate data, we were unable to rate the quality of the evidence for the following outcomes: (i) Frequency of testing; (ii) Feasibility of testing; and (iii) Quality of life and satisfaction. </p> </section> <section id="CD003839-sec-0054"> <h3 class="title" id="CD003839-sec-0054">Comparison with other reviews</h3> <p>This systematic review provides information additional to a substantial body of evidence from previously published reviews of self‐monitoring or self‐management of oral anticoagulation (<a href="./references#CD003839-bbs2-0061" title="Bazian Ltd. Self-management of oral anticoagulation. Evidence-Based Healthcare and Public Health October 2005;9(5):334-40.">Bazian 2005</a>; <a href="./references#CD003839-bbs2-0062" title="BloomfieldHE , KrauseA , GreerN , TaylorBC , MacDonaldR , RutksI , et al. Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes. Annals of Internal Medicine2011;154(7):472-82.">Bloomfield 2011</a><a href="./references#CD003839-bbs2-0068" title="ChristensenTD , JohnsenSP , HjortdalVE , HasenkamJM . Self-management of oral anticoagulant therapy: a systematic review and meta-analysis. International Journal of Cardiology2007;118(1):54-61.">Christensen 2007</a>; <a href="./references#CD003839-bbs2-0070" title="ConnockM , StevensC , Fry-SmithA , JowettS , FitzmauriceD , MooreD , et al. Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling. Health Technology Assessment2007;11(38):ix-66.">Connock 2007</a>; <a href="./references#CD003839-bbs2-0073" title="deSolà-Morales SerraO , Elorza RicartJM . Portable coagulometers: a systematic review of the evidence on self-management of oral anticoagulant treatment. Medicina Clinica (Barc)2005;124(9):321-5.">de Solà‐Morales 2005</a>; <a href="./references#CD003839-bbs2-0085" title="HeneghanC , Alonso-CoelloP , Garcia-AlaminoJM , PereraR , MeatsE , GlasziouP . Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet2006;367(9508):404-11.">Heneghan 2006a</a>; <a href="./references#CD003839-bbs2-0109" title="ØdegaardKJ . Self-management in anticoagulation--a meta-analysis. Tidsskrift for den Norske Laegeforening2004;124(22):2900-3.">Ødegaard 2004</a>; <a href="./references#CD003839-bbs2-0105" title="SiebenhoferA , BergholdA , SawickiPT . Systematic review of studies of self-management of oral anticoagulation. Thrombosis and Haemostasis2004;91(2):225-32.">Siebenhofer 2004</a>) and a meta‐analysis of individual patient data (<a href="./references#CD003839-bbs2-0087" title="HeneghanC , WardA , PereraR , BankheadC , FullerA , StevensR , et al. Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet2012;379(9813):322-34.">Heneghan 2012</a>). </p> <p>The main results of this review are consistent with previous reviews. The <a href="./references#CD003839-bbs2-0068" title="ChristensenTD , JohnsenSP , HjortdalVE , HasenkamJM . Self-management of oral anticoagulant therapy: a systematic review and meta-analysis. International Journal of Cardiology2007;118(1):54-61.">Christensen 2007</a> review of 10 trials showed that self‐management was associated with a reduced risk of mortality and major complications with increased time being spent within the therapeutic INR target range. A 2004 review of eight trials (<a href="./references#CD003839-bbs2-0109" title="ØdegaardKJ . Self-management in anticoagulation--a meta-analysis. Tidsskrift for den Norske Laegeforening2004;124(22):2900-3.">Ødegaard 2004</a>) identified a significant reduction in major clinical events and a 2004 review of four trials (<a href="./references#CD003839-bbs2-0105" title="SiebenhoferA , BergholdA , SawickiPT . Systematic review of studies of self-management of oral anticoagulation. Thrombosis and Haemostasis2004;91(2):225-32.">Siebenhofer 2004</a>) concluded that patient self‐management is safe and can improve the quality of anticoagulation control. A 2005 review of 12 trials (seven RCTs and five quasi‐experimental trials) (<a href="./references#CD003839-bbs2-0073" title="deSolà-Morales SerraO , Elorza RicartJM . Portable coagulometers: a systematic review of the evidence on self-management of oral anticoagulant treatment. Medicina Clinica (Barc)2005;124(9):321-5.">de Solà‐Morales 2005</a>), reported no difference between participants undertaking self‐management and those receiving usual care in the time spent in the therapeutic range and in the incidence of adverse effects. Bazian's review (which was less comprehensive) also did not show a difference between self‐management and routine care (<a href="./references#CD003839-bbs2-0061" title="Bazian Ltd. Self-management of oral anticoagulation. Evidence-Based Healthcare and Public Health October 2005;9(5):334-40.">Bazian 2005</a>). In the <a href="./references#CD003839-bbs2-0062" title="BloomfieldHE , KrauseA , GreerN , TaylorBC , MacDonaldR , RutksI , et al. Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes. Annals of Internal Medicine2011;154(7):472-82.">Bloomfield 2011</a> review, patients assigned to self‐monitoring or self‐management had significantly lower total mortality, lower risk for major thromboembolism, and no increased risk in major haemorrhage. </p> <p>An individual patient data meta‐analysis (<a href="./references#CD003839-bbs2-0087" title="HeneghanC , WardA , PereraR , BankheadC , FullerA , StevensR , et al. Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet2012;379(9813):322-34.">Heneghan 2012</a>), which included 11 trials with data for 6417 participants and 12,800 person‐years of follow‐up, reported a significant reduction in thromboembolic events in the self‐monitoring group (Hazard Ratio (HR) 0.51; 95% CI 0.31 to 0.85), but not for major haemorrhagic events (HR 0.88, 95% CI, 0.74 to 1.06) or mortality (HR 0.82, 95% CI 0.62 to 1.09). In this review patients, younger than 55 years showed marked reductions in thrombotic events (HR 0.33, 95% CI 0.17 to 0.66), as did patients with mechanical heart valve (HR 0.52, 95% CI, 0.35 to 0.77). The greater reduction in mortality with self‐management compared with self‐monitoring observed in this review might be related to the higher frequency of thromboembolic events seen in the latter group. Also, reduced mortality might be affected by increased patient empowerment, whereby self‐management influences other aspects of a patient's lifestyle (i.e. adherence to treatments) as they take on more of a locus of control for their condition. </p> <p>A 2015 Health Technology Assesment (HTA) systematic review (<a href="./references#CD003839-bbs2-0104" title="SharmaP , ScotlandG , CruickshankM , TassieE , FraserC , BurtonC , et al. The clinical effectiveness and cost-effectiveness of point-of-care tests (CoaguChek system, INRatio2 PT/INR monitor and ProTime Microcoagulation system) for the self-monitoring of the coagulation status of people receiving long-term vitamin K antagonist therapy, compared with standard UK practice: systematic review and economic evaluation. Health Technology Assessment2015;19(48). [DOI: http://dx.doi.org/10.3310/hta19480]">Sharma 2015</a>) on the clinical effectiveness and cost‐effectiveness of point‐of‐care tests of people receiving long‐term vitamin K antagonist therapy reported that self‐monitoring significantly prevented thromboembolic events and reduced all‐cause mortality in people with artificial heart valves, and similarly to this current review, reported greater reductions in thromboembolic events and all‐cause in those self‐managing. In addition, the review reported net UK health and social care costs, which over a 10‐year period were equivalent to standard monitoring costs. </p> <p>Intrinsic limitations to self‐monitoring and self‐management include the reluctance of individuals to participate in self‐management and the extensive training required to do so. Self‐monitoring is not feasible for up to half of the patients requiring anticoagulation. Factors influencing patient participation within trials included problems with the device; physical limitations; attending training sessions; or failing the assessment. An additional problem with adoption in clinical practice will be the relatively high cost of the test strips. The reliability of self‐testing devices can affect test results; however, available devices give INR results which are comparable with those obtained in laboratory testing (<a href="./references#CD003839-bbs2-0056" title="AnsellJ , JacobsonA , LevyJ , VöllerH , HasenkamJM , International Self-Monitoring Association for Oral Anticoagulation. Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation. International Journal of Cardiology2005;99(1):37-45.">Ansell 2005</a>). Self‐monitoring and self‐management are also associated with a rate of testing that is higher than with usual care. In effect self‐managed warfarin dosing is analogous to self‐adjusted insulin dosing according to a pre‐specified sliding scale (<a href="./references#CD003839-bbs2-0053" title="AnsellJE , HughesR . Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management. American Heart Journal1996;132(5):1095-100.">Ansell 1996</a>). Such self‐managed treatment has been practiced for years by people with diabetes (<a href="./references#CD003839-bbs2-0053" title="AnsellJE , HughesR . Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management. American Heart Journal1996;132(5):1095-100.">Ansell 1996</a>), and the use of self‐monitoring or self‐management offers independence and freedom to travel for selected patients. </p> <p>Our review has some potential limitations. First, our search was comprehensive, making serious publication bias less likely, but it remains a concern. Therefore, the results may represent an overestimate of the true effect of treatment. Second, variability in the quality of care in the control groups can affect the rate of testing and hence the benefit and safety of standard anticoagulation monitoring. Specialist programmes may improve outcomes by the same mechanism as self‐monitoring or self‐management, that is improving the time in therapeutic range and lessening the frequency of adverse outcomes. However, our post hoc subgroup analysis did not verify this effect. A further modifying factor is education and training. The two trials in which patients consented to participate and received education alone had better results than did those patients allocated to routine care (<a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>; <a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a>; <a href="./references#CD003839-bbs2-0015" title="KhanTI , KamaliF , KestevenP , AveryP , WynneH . The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology2004;126(4):557-64. ">Khan 2004</a>). Third, for all the major outcomes of this review, limitations in the published reports led to an absence of information about the allocation concealment procedure or blinding. However, several authors were successfully contacted and the additional information that they provided generally raised the assessed quality of the trials. This finding is in agreement with recent empirical evidence suggesting that authors fail to report concealment of randomisation and blinding (<a href="./references#CD003839-bbs2-0075" title="DevereauxPJ , ChoiPT , El-DikaS , BhandariM , MontoriVM , SchünemannHJ , et al. An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. Journal of Clinical Epidemiology2004;57(12):1232-6.">Devereaux 2004</a>). Finally, for all the major outcomes there was a low numbers of events. Overestimates are likely in trials with fewer than 500 events and large overestimates of the effects are more likely in trials with fewer than 200 events. (<a href="./references#CD003839-bbs2-0060" title="BasslerD , BrielM , MontoriVM , LaneM , GlasziouP , ZhouQ , et al. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis.. JAMA2010;303(12):1180-7.">Bassler 2010</a>) </p> <p>Self‐monitoring or self‐management are likely to prevent thromboembolism to a greater extent than standard monitoring. The mechanism of effect is probably through increasing the number of INR values in range and therefore the longer time that patients are in the therapeutic range. Despite the limitations outlined above the apparent beneficial effects are large, and even smaller true underlying effects would probably justify widespread use of self‐monitoring and self‐management of oral anticoagulation in suitable candidates. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD003839-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/urn:x-wiley:14651858:media:CD003839:CD003839-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Flowchart showing the results of combined searches" data-id="CD003839-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_t/tCD003839-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Flowchart showing the results of combined searches</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/full#CD003839-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003839-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/urn:x-wiley:14651858:media:CD003839:CD003839-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Major haemorrhage, outcome" data-id="CD003839-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_t/tCD003839-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Major haemorrhage, outcome</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/full#CD003839-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003839-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/urn:x-wiley:14651858:media:CD003839:CD003839-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 2 Thromboembolic events" data-id="CD003839-fig-0003" src="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_t/tCD003839-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Funnel plot of comparison: 2 Thromboembolic events</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/full#CD003839-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003839-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/urn:x-wiley:14651858:media:CD003839:CD003839-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD003839-fig-0004" src="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_t/tCD003839-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/full#CD003839-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003839-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/urn:x-wiley:14651858:media:CD003839:CD003839-FIG-05" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD003839-fig-0005" src="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-FIG-05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_t/tCD003839-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/full#CD003839-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-FIG-05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003839-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/urn:x-wiley:14651858:media:CD003839:CD003839-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Thromboembolic events, Outcome 1: Self‐monitoring and self‐management" data-id="CD003839-fig-0006" src="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_t/tCD003839-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Thromboembolic events, Outcome 1: Self‐monitoring and self‐management</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/references#CD003839-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003839-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/urn:x-wiley:14651858:media:CD003839:CD003839-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Thromboembolic events, Outcome 2: Events by Clinical Condition" data-id="CD003839-fig-0007" src="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_t/tCD003839-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Thromboembolic events, Outcome 2: Events by Clinical Condition</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/references#CD003839-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003839-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/urn:x-wiley:14651858:media:CD003839:CD003839-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Thromboembolic events, Outcome 3: Events by Self‐management (sensitivity)" data-id="CD003839-fig-0008" src="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_t/tCD003839-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Thromboembolic events, Outcome 3: Events by Self‐management (sensitivity)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/references#CD003839-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003839-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/urn:x-wiley:14651858:media:CD003839:CD003839-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Thromboembolic events, Outcome 4: Events by specialty" data-id="CD003839-fig-0009" src="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_t/tCD003839-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Thromboembolic events, Outcome 4: Events by specialty</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/references#CD003839-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003839-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/urn:x-wiley:14651858:media:CD003839:CD003839-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: All‐cause mortality, Outcome 1: Events by Self‐management" data-id="CD003839-fig-0010" src="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_t/tCD003839-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: All‐cause mortality, Outcome 1: Events by Self‐management</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/references#CD003839-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003839-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/urn:x-wiley:14651858:media:CD003839:CD003839-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: All‐cause mortality, Outcome 2: Events by Clinical Condition" data-id="CD003839-fig-0011" src="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_t/tCD003839-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: All‐cause mortality, Outcome 2: Events by Clinical Condition</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/references#CD003839-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003839-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/urn:x-wiley:14651858:media:CD003839:CD003839-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: All‐cause mortality, Outcome 3: Events by Self‐management (sensitivity)" data-id="CD003839-fig-0012" src="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_t/tCD003839-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: All‐cause mortality, Outcome 3: Events by Self‐management (sensitivity)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/references#CD003839-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003839-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/urn:x-wiley:14651858:media:CD003839:CD003839-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: All‐cause mortality, Outcome 4: Events by specialty" data-id="CD003839-fig-0013" src="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_t/tCD003839-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: All‐cause mortality, Outcome 4: Events by specialty</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/references#CD003839-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003839-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/urn:x-wiley:14651858:media:CD003839:CD003839-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Major haemorrhage, Outcome 1: Events by Self‐management" data-id="CD003839-fig-0014" src="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_t/tCD003839-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Major haemorrhage, Outcome 1: Events by Self‐management</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/references#CD003839-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003839-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/urn:x-wiley:14651858:media:CD003839:CD003839-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Major haemorrhage, Outcome 2: Events by Clinical Condition" data-id="CD003839-fig-0015" src="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_t/tCD003839-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Major haemorrhage, Outcome 2: Events by Clinical Condition</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/references#CD003839-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003839-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/urn:x-wiley:14651858:media:CD003839:CD003839-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Major haemorrhage, Outcome 3: Events by Self‐management (sensitivity)" data-id="CD003839-fig-0016" src="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_t/tCD003839-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Major haemorrhage, Outcome 3: Events by Self‐management (sensitivity)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/references#CD003839-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003839-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/urn:x-wiley:14651858:media:CD003839:CD003839-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Major haemorrhage, Outcome 4: Events by specialty" data-id="CD003839-fig-0017" src="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_t/tCD003839-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Major haemorrhage, Outcome 4: Events by specialty</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/references#CD003839-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003839-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/urn:x-wiley:14651858:media:CD003839:CD003839-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Minor haemorrhage, Outcome 1: Events by Self‐management" data-id="CD003839-fig-0018" src="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_t/tCD003839-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Minor haemorrhage, Outcome 1: Events by Self‐management</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/references#CD003839-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/media/CDSR/CD003839/image_n/nCD003839-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD003839-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Self‐monitoring or self‐management of oral anticoagulation vs. standard care</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Self‐monitoring or self‐management of oral anticoagulation vs. standard care</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients on long‐term anticoagulant therapy (treatment duration longer than two months) irrespective of the indication for treatment </p> <p><b>Settings:</b> Primary care, specialist clinics (Europe, America, Canada) </p> <p><b>Intervention:</b> Self‐monitoring or self‐management </p> <p><b>Comparison:</b> Standard care </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Standard care</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Self‐monitoring or self‐management</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Thromboembolic events</b> </p> <p>Follow‐up: 3 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.58</b> </p> <p>(0.45 to 0.74)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>7594</p> <p>(18 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>35 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>21 per 1000</b> </p> <p>(16 to 26)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>22 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>12 per 1000</b> </p> <p>(10 to 16)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>All‐cause mortality</b> </p> <p>Follow‐up: 6 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.85</b><br/>(0.71 to 1.01) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>6358<br/>(11 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>64 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>54 per 1000</b><br/>(45 to 64) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Major haemorrhage</b> </p> <p>Follow‐up: 4 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.95</b> </p> <p>(0.80 to 1.12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>8018</p> <p>(20 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>62 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>59 per 1000</b> </p> <p>(50 to 69)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>17 per 1000</b> </p> <p>(14 to 20)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Minor haemorrhage</b> </p> <p>Follow‐up: 4 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.97</b><br/>(0.67 to 1.41) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>5365<br/>(13 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>217 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>210 per 1000</b><br/>(145 to 306) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>45 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>44 per 1000</b><br/>(30 to 63) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/><b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded from high to moderate because of serious risk of bias. </p> <p><sup>2</sup> Downgraded from high to low because of serious risk of bias and substantial heterogeneity. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Self‐monitoring or self‐management of oral anticoagulation vs. standard care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/full#CD003839-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD003839-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Self‐monitoring of oral anticoagulation vs. standard care</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Self‐monitoring of oral anticoagulation vs. standard care</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients on long‐term anticoagulant therapy (treatment duration longer than two months) irrespective of the indication for treatment </p> <p><b>Settings:</b> Primary care, specialist clinics (Europe, America, Canada) </p> <p><b>Intervention:</b> Self‐monitoring </p> <p><b>Comparison:</b> Standard care </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Standard care</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Self‐monitoring</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Thromboembolic events</b> </p> <p>Follow‐up: 3 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.69</b><br/>(0.49 to 0.97) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>4097<br/>(7 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>35 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>24 per 1000</b><br/>(17 to 34) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>34 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>23 per 1000</b><br/>(17 to 33) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>All‐cause mortality</b> </p> <p>Follow‐up: 6 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.94</b><br/>(0.78 to 1.15) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>3300<br/>(3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>90 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>85 per 1000</b><br/>(70 to 104) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Major haemorrhage</b> </p> <p>Follow‐up: 4 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.90</b><br/>(0.74 to 1.09) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>4038<br/>(7 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>91 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>82 per 1000</b><br/>(67 to 99) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>44 per 1000</b><br/>(36 to 53) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Minor haemorrhage</b> </p> <p>Follow‐up: 4 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.16</b><br/>(0.95 to 1.42) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>3503<br/>(6 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>275 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>319 per 1000</b><br/>(259 to 391) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>188 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>218 per 1000</b><br/>(177 to 267) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/><b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded from high to low because of serious risk of bias and strong suspicion of publication bias. </p> <p><sup>2</sup> Downgraded from high to moderate because of serious risk of bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Self‐monitoring of oral anticoagulation vs. standard care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/full#CD003839-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD003839-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">self‐management of oral anticoagulation vs. standard care</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Self‐management of oral anticoagulation vs. standard care</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients on long‐term anticoagulant therapy (treatment duration longer than two months) irrespective of the indication for treatment </p> <p><b>Settings:</b> Primary care, specialist clinics (Europe, America, Canada) </p> <p><b>Intervention:</b> Self‐management </p> <p><b>Comparison:</b> Standard care </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Standard care</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Self‐management</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Thromboembolic events</b> </p> <p>Follow‐up: 3 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.47</b><br/>(0.31 to 0.70) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>3497<br/>(11 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>36 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>17 per 1000</b><br/>(12 to 25) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>16 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>7 per 1000</b><br/>(5 to 11) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>All‐cause mortality</b> </p> <p>Follow‐up: 6 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.55</b><br/>(0.36 to 0.84) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>3058<br/>(8 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate<sup>2</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>33 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b><br/>(12 to 28) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>17 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>9 per 1000</b><br/>(6 to 14) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Major haemorrhage</b> </p> <p>Follow‐up:4 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.08</b><br/>(0.79 to 1.47) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>3980<br/>(13 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low<sup>1</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>33 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>36 per 1000</b><br/>(22 to 44) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>19 per 1000</b><br/>(14 to 26) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Minor haemorrhage</b> </p> <p>Follow‐up: 4 to 57 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 0.91</b><br/>(0.47 to 1.76) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1862<br/>(7 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low<sup>3</sup> </b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>137 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>125 per 1000</b><br/>(64 to 241) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate risk population</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>2 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>2 per 1000</b><br/>(1 to 4) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/><b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded from high to low because of serious risk of bias and imprecision of effect estimate. </p> <p><sup>2</sup> Downgraded from high to moderate because of serious risk of bias. </p> <p><sup>3</sup> Downgraded from high to low because of serious risk of bias and substantial heterogeneity. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">self‐management of oral anticoagulation vs. standard care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/full#CD003839-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003839-tbl-0004"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Tests in range</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Mean INR within target range, %</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>TIme within range, %</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Source</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P value</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0029" title="WhiteRH , McCurdySA , vonMarensdorffH , Woodruff DE Jr, LeftgoffL . Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Annals of Internal Medicine1989;111(9):730-7. ">White 1989</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>87</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.001</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0013" title="HorstkotteD , PiperC , WiemerM . Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. Journal of Thrombosis and Thrombolysis1998;5 Suppl 1(3):19-24. ">Horstkotte 1998</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22.3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43.2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.001</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> ‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0021" title="SawickiPT , GlaserB , KleespiesC , StubbeJ , SchmitzN , KaiserT , et al. Long-term results of patients' self-management of oral anticoagulation. Journal of Clinical &amp; Basic Cardiology2003;6(1-4):59-62. SawickiPT . A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA1999;281(2):145-50. ">Sawicki 1999</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43.2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.22</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> ‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0002" title="BeythRJ , QuinnL , LandefeldCS . A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Annals of Internal Medicine2000;133(9):687-95. ">Beyth 2000</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>‐</i> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>‐</i> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐ </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0005" title="CromheeckeME , LeviM , CollyLP , deMolBJ , PrinsMH , HuttenBA , et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet2000;356(9224):97-102. ">Cromheecke 2000</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.06</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> ‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0022" title="SidhuP , O'KaneHO . Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Annals of Thoracic Surgery2001;72(5):1523-7. ">Sidhu 2001</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67.60</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.0001</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63.8</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76.5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.0001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0007" title="FitzmauriceDA , MurrayET , GeeKM , AllanTF , HobbsFD . A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. Journal of Clinical Pathology2002;55(11):845-9. McCahonD , MurrayET , MurrayK , HolderRL , FitzmauriceDA . Does self-management of oral anticoagulation therapy improve quality of life and anxiety?Family Practice2011;28(2):134-40. ">Fitzmaurice 2002</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66 (61‐71)*</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72 (65‐80)*</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77 (67‐86)*</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74 (67‐81)*</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0009" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self mge</a>; <a href="./references#CD003839-bbs2-0010" title="GadisseurAP , Breukink-EngbersWG , van derMeerFJ , vanden BesselaarAM , SturkA , RosendaalFR . Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Archives of Internal Medicine2003;163(21):2639-46. GadisseurAP , KapteinAA , Breukink-EngbersWG , van derMeerFJ , RosendaalFR . Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life. Journal of Thrombosis and Haemostasis2004;2(4):584-91. ">Gadisseur 2003 Self monit</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61.3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐ </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0011" title="GardinerC , WilliamsK , LongairI , MackieIJ , MachinSJ , CohenH . A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing.. British Journal of Haematolgy2006;132(5):598-603. GardinerC , WilliamsK , MackieIJ , MachinSJ , CohenH . Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. British Journal of Haematology2005;128(2):242-7. ">Gardiner 2005</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>‐</i> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>‐</i> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> ‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64 (26)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61 (20)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0014" title="KaatzS , Elston-LafataJ , GooldyS . Anticoagulation therapy home and office monitoring evaluation study. Journal of Thrombosis and Thrombolysis2001;12:111. ">Kaatz Unpublished</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.6</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.05</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66.9</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63.5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.127</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0025" title="SunderjiR , CampbellL , ShalanskyK , FungA , CarterC , GinK . Outpatient self-management of warfarin therapy: A pilot study. Pharmacotherapy1999;19(6):787-93. SunderjiR , GinK , ShalanskyK , CarterC , ChambersK , DaviesC , et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Canadian Journal of Cardiology2004;20(11):1117-23. ">Sunderji 2004</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58.7 (5.8)**</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.8 (5.9)**</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.23</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63.2 (5.8)**</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71.8 (5.5)**</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0015" title="KhanTI , KamaliF , KestevenP , AveryP , WynneH . The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. British Journal of Haematology2004;126(4):557-64. ">Khan 2004</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>‐</i> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>‐</i> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐ </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70.4 (24.5)**</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71.1 (14.5)**</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0016" title="EitzT , SchenkS , FritzscheD , BairaktarisA , WagnerO , KoertkeH , et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Annals of Thoracic Surgery2008;85(3):949-54. KörtkeH , KörferR . International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?Annals of Thoracic Surgery2001;72(1):44-8. KörtkeH , MinamiK , BreymannT , SeifertD , BaraktarisA , WagnerO , et al. INR self-management after mechanical heart valve replacement: ESCAT (Early Self-Controlled Anticoagulation Trial). Zeitschrift fur Kardiologie2001;90 Suppl:6118-24. KoertkeH , MinamiK , BairaktarisA , WagnerO , KoerferR . INR self-management following mechanical heart valve replacement. Journal of Thrombosis and Thrombolysis2000;9 Suppl 1:41-5. KoertkeH , MinamiK , BoethigD , BreymannTH , SeifertD , WagnerO , et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation2003;108(10 Suppl 1):II-75-II-78. KoertkeH , ZittermannA , MinamiK , TenderichG , WagnerO , El-ArousyM , et al. Low-dose international normalized ratio self-management: a promising tool to achieve low complication rates after mechanical heart valve replacement. Annals of Thoracic Surgery2005;79(6):1909-14. KoertkeH , ZittermannA , TenderichG , WagnerO , El-ArousyM , KrianA , et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II. European Heart Journal2007;28(20):2479-84. KoertkeH , ZittermannA , WagnerO , EnnkerJ , SaggauW , SackFU , et al. Efficacy and safety of very low-dose self-management of oral anticoagulation in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2010;90(5):1487-93. KoertkeH , ZittermannA , WagnerO , KoerferR . Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Annals of Thoracic Surgery2007;83(1):24-9. ">Körtke 2001</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60.5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>78.3</i> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.001</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> ‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0028" title="VöllerH , GlatzJ , TaborskiU , BernardoA , DovifatC , HeidingerK . Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Zeitschrift fur Kardiologie2005;94(3):182-6. ">Voller 2005</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58.5 (19.8)**</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67.8 (17.6)**</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.0061</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0018" title="Menéndez-JándulaB , SoutoJC , OliverA , MontserratI , QuintanaM , GichI , et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Annals of Internal Medicine2005;142(1):1-10. ">Menendez‐Jandula 2005</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55.6 (19.6)**</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58.6% (14.3)**</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.02</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.9 (19.9)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.3 (14.3)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.2</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0008" title="FitzmauriceDA , MurrayET , McCahonD , HolderR , RafteryJP , HussainS , et al. Self management of oral anticoagulation: randomised trial. BMJ2005;331(7524):1057. McCahonD , FitzmauriceDA , MurrayET , FullerCJ , HobbsRF , AllanTF , et al. SMART: self-management of anticoagulation, a randomised trial. BMC Family Practice2003;4(1):11. MurrayE , FitzmauriceD , McCahonD , FullerC , SandhurH . Training for patients in a randomised controlled trial of self management of warfarin treatment. BMJ2004;328(7437):437-8. ">Fitzmaurice 2005</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>‐</i> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>‐</i> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐ </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68 (65.2‐70.6)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70 (68.1‐72.4)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0003" title="ChristensenTD , MaegaardM , SørensenHT , HjortdalVE , HasenkamJM . Self-management versus conventional management of oral anticoagulant therapy: A randomized, controlled trial. European Journal of Internal Medicine2006;17(4):260-6. ">Christensen 2006</a>, Denmark </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>‐</i> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>‐</i> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> ‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68.9 (59.3‐78.2)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78.7 (69.2‐81.0)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0023" title="SiebenhoferA , HemkensLG , RakovacI , SpatS , DidjurgeitU , SPOG 60+ Study Group. Self-management of oral anticoagulation in elderly patients - effects on treatment-related quality of life. Thrombosis Research2012;130:e60-e6. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thrombosis and Haemostasis2007;97(3):408-16. SiebenhoferA , RakovacI , KleespiesC , PisoB , DidjurgeitU . Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial. Thrombosis &amp; Haemostasis2008;100(6):1089-98. ">Siebenhofer 2007</a>, Austria<sup>†</sup> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57.1 (40.4‐72.4)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72.4 (53.5‐79.4)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.001</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66.5 (47.1‐81.5)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75.4 (59.4‐85.0)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.029</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0001" title="AzarnoushK , CamilleriL , Aublet-CuvelierB , GeoffroyE , DauphinC , DubrayC , et al. Results of the first randomized French study evaluating self-testing of the International Normalized Ratio. Journal of Heart Valve Disease2011;20(5):518-25. DauphinC , LegaultB , JaffeuxP , MotreffP , AzarnoushK , JolyH , et al. Comparison of INR stability between self-monitoring and standard laboratory method: preliminary results of a prospective study in 67 mechanical heart valve patients. Archives of Cardiovascular Diseases2008;101(11-12):753-61. ">Azarnoush 2009</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61.5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55.5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.0343</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0004" title="ChristensenH , LauterleinJJ , SørensenPD , PetersenERB , MadsenJS , BrandslundI . Home management of oral anticoagulation via telemedicine versus conventional hospital-based treatment. Telemedicine and e-Health2011;17(3):169-76. ">Christensen 2011</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79.9</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72.7</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.0001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0012" title="GrunauBE , WiensMO , HarderKK . Patient self-management of warfarin therapy: pragmatic feasibility study in Canadian primary care. Canadian Family Physician Medecin de Famille Canadien2011;57(8):e292-8. ">Grunau 2011</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82.4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80.2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.82</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82.2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>89.7</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.76</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0017" title="MatcharDB , DolorR , JacobsonA , LoveS , EdsonR , UyedaL . More frequent self-testing of prothrombin time results in improved time in target range. Circulation2012;126:21 Suppl. MatcharDB , JacobsonA , DolorR , EdsonR , UyedaL , PhibbsCS , et al, THINRS Executive Committee and Site Investigators. Effect of home testing of international normalized ratio on clinical events. New England Journal of Medicine2010;363(17):1608-20. ">Matchar 2010</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66.2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62.4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0019" title="RasmussenRS , CorellP , MadsenP , OvergaardK . Effects of computer-assisted oral anticoagulant therapy. Thrombosis Journal2012;10(1):17. ">Rasmussen 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intervention A 49</p> <p>Intervention B 55</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0024" title="Soliman HamadMA , vanEekelenE , vanAgtT , vanStratenAH . Self-management program improves anticoagulation control and quality of life: a prospective randomized study. European Journal of Cardiothoracic Surgery2009;35(2):265-9. ">Soliman Hamad 2009</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72.9</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53.9</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.01</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0026" title="ThompsonJL , BurkhartHM , DalyRC , DearaniJA , JoyceLD , SuriRM , et al. Anticoagulation early after mechanical valve replacement: improved management with patient self-testing. Journal of Thoracic and Cardiovascular Surgery2013;146:599-604. ">Thompson 2013</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.05</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003839-bbs2-0027" title="VerretL , CouturierJ , RozonA , Saudrais-JanecekS , St-OngeA , NguyenA , et al. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy2012;32(10):871-9. ">Verret 2012</a> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75.5</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.79</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>* 95% Confidence intervals</p> <p>** Standard Deviations</p> <p><sup>†</sup> Used median not mean </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Tests in range</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/full#CD003839-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003839-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Thromboembolic events</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Self‐monitoring and self‐management <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7594</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.45, 0.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Self‐management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3497</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.31, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Self‐monitoring</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4097</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.49, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Events by Clinical Condition <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4809</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.38, 0.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 Mechanical Valve</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1816</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.32, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 Atrial Fibrillation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>202</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 8.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.3 Any indication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2791</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.34, 0.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Events by Self‐management (sensitivity) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4558</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.36, 0.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Self‐management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3618</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.30, 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 Self‐monitoring</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>940</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.36, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Events by specialty <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7344</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.46, 0.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Specialised Care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4947</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.44, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 Primary Care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2397</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.38, 0.84]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Thromboembolic events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/references#CD003839-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003839-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">All‐cause mortality</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Events by Self‐management <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6358</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.71, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 Self‐management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3058</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.36, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 Self‐monitoring</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.78, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Events by Clinical Condition <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6645</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.71, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 Mechanical Valve</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1295</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.29, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 Atrial Fibrillation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.3 Any indication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5063</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.76, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Events by Self‐management (sensitivity) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.71, 1.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 Self‐management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2918</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.37, 0.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.2 Self‐monitoring</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3242</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.77, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Events by specialty <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6163</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.70, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 Specialised Care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4387</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.75, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.2 Primary Care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1776</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.43, 0.90]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">All‐cause mortality</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/references#CD003839-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003839-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Major haemorrhage</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Events by Self‐management <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.80, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 Self‐management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3980</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.79, 1.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.2 Self‐monitoring</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4038</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.74, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Events by Clinical Condition <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4594</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.66, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 Mechanical Valve</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1445</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.75, 1.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.2 Atrial Fibrillation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.90 [0.31, 27.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.3 Any indication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2862</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.41, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Events by Self‐management (sensitivity) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7337</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.81, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.1 Self‐management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3726</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.76, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.2 Self‐monitoring</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3611</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.76, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Events by specialty <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.81, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.1 Specialised Care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5054</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.80, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.2 Primary Care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2267</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.66, 1.30]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Major haemorrhage</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/references#CD003839-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003839-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Minor haemorrhage</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Events by Self‐management <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5365</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.67, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.1 Self‐management</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1862</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.47, 1.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.2 Self‐monitoring</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3503</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.95, 1.42]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Minor haemorrhage</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003839.pub3/references#CD003839-tbl-0008">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD003839.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD003839-note-0006">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD003839-note-0013">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD003839-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD003839-note-0012">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD003839-note-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD003839-note-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD003839-note-0008">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD003839-note-0007">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003839\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003839\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003839\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003839\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003839\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003839\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003839\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003839\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003839\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003839\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003839\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003839\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003839\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003839\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003839\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003839\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003839\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003839\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=eLIOL3Be&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003839.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003839.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD003839.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD003839.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003839.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714724247"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003839.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714724250"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003839.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d75ab2ab5937d',t:'MTc0MDcxNDcyNS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 